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ABSTRACT
Mitosis requires the control of mechanical forces generated by kinesin motors to
ensure equal segregation of chromosomes into two daughter cells. Two kinesins
contributing to these forces are KIF11 (or Eg5), which crosslinks and slides anti-parallel
microtubules, and KIF22 (or Kid), which binds to microtubules and chromosome arms.
This work addresses how post-translational modifications and pathogenic mutations alter
the structure and function of KIF11 and KIF22.
The homotetrameric kinesin KIF11 is subject to acetylation at lysine 146, a residue
in the a2 helix of the motor domain. The effect of this acetylation was assessed at the single
molecule and cellular levels using an acetylation mimetic mutant, KIF11 K146Q. In single
molecule optical trapping assays, KIF11 K146Q dimers are more likely than wild type
(WT) dimers to stall rather than dissociate from the microtubule under load. Based on these
results, acetylated KIF11 motors would be predicted to stall microtubule sliding during
spindle formation, acting as a brake and slowing pole separation. To test this prediction,
mCherry (mCh) tagged KIF11 WT and K146Q motors were expressed at low levels in
HeLa cells. To compare the functional activity of WT and K146Q KIF11, cells were treated
with the KIF11 inhibitor monastrol, resulting in mitotic arrest and the formation of
monopolar spindles. Bipolar spindle formation following monastrol washout was then
imaged and measured. While spindle lengths at the completion of pole separation were
similar in cells expressing mCh-KIF11 WT or K146Q, pole separation occurred at a
significantly slower velocity in cells expressing mCh-KIF11 K146Q than in cells
expressing mCh-KIF11 WT. This velocity difference is consistent with KIF11 acetylated
at K146 stalling rather than dissociating from the microtubule and acting as a brake during
pole separation. Acetylation at a2 helix lysine 146 represents a mechanism by which the
activity of KIF11 may be controlled in mitotic cells.
Structural changes in the a2 helix also affect the activity of KIF22. Point mutations
at P148 and R149 in this domain, as well as at V475 in the tail of the motor, dominantly
cause a skeletal developmental disorder. The effect of these pathogenic mutations on the
function of KIF22 in mitosis was investigated. KIF22 uses plus end-directed motility and
direct binding to chromosome arms to generate polar ejection forces, which contribute to
chromosome congression and alignment in metaphase. Mutant KIF22 generated forces to
move chromosomes toward microtubule plus ends in prometaphase, indicating that mutant
motors are active. As cells proceeded through mitosis, however, mutations disrupted
anaphase chromosome segregation and caused chromosome recongression, which resulted
in reduced proliferation, abnormal daughter cell nuclear morphology, and, in a subset of
cells, cytokinesis failure. This phenotype could be explained by a failure of KIF22 to
inactivate in anaphase, resulting in continued generation of polar ejection forces and
impaired anaphase chromosome segregation. Consistent with this model, a
phosphomimetic mutation in the tail of KIF22 which constitutively activates the motor
phenocopied the effect of pathogenic mutations. Mimicking the phosphorylation of a2
helix residue T158 also prevented the inactivation of KIF22 in anaphase, demonstrating
the importance of this region of the motor domain in controlling KIF22 activity.
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CHAPTER 1: INTRODUCTION
1.1 MITOSIS AND THE MITOTIC SPINDLE
Mitosis is the process by which a cell divides and produces two daughter cells
with the same number of chromosomes as the parental cell. This process has been described
by cytologists for over one hundred years (Flemming, 1882; Mitchison & Salmon, 2001)
and is vital for human health and development, as an individual’s cells must divide
approximately 10 quadrillion times over their lifespan (Milo & Philips, 2015; Weinberg,
2006).
In the first phase of mitosis, prophase, the chromosomes condense (Figure 1-1)
(Morgan, 2007). Sister chromatids are held together by the cohesin complex (Nasmyth &
Haering, 2009). The cell’s entry into prophase is controlled by the activity of cyclin
dependent kinases (CDKs) (Morgan, 1995) (Figure 1-2). Cyclin B1 forms a complex with
CDK1, which is activated by dephosphorylation (Gould & Nurse, 1989). The active cyclin
B1-CDK1 complex is initially cytoplasmic. Cyclin B1-CDK1 is translocated to the nucleus
at the end of prophase to promote nuclear envelope breakdown, which marks the beginning
of the next phase of mitosis, prometaphase (Takizawa & Morgan, 2000). In prometaphase
chromosomes must be moved to the center of the dividing cell (Figure 1-1). Chromosome
movements require the assembly of the mitotic spindle, a molecular machine composed of
microtubules and microtubule-associated proteins (Inoué & Sato, 1967). As the spindle
forms, a subset of spindle microtubules attaches to chromosomes at the kinetochores to
form k-fibers (Brinkley & Stubblefield, 1966), and proteins on spindle microtubules
interact with the kinetochores (Schaar, Chan, Maddox, Salmon, & Yen, 1997) and
1

chromosome arms (Mazumdar & Misteli, 2005). Prometaphase concludes when
chromosomes are attached to spindle microtubules and congressed at the center of the cell.
After prometaphase, the cell enters metaphase, which is characterized by the alignment of
the chromosomes at the center of the spindle, at the metaphase plate (Figure 1-1).

Figure 1-1: Phases of mitosis. Chromosomes condense and spindle pole separation begins in prophase.
Nuclear envelope breakdown marks the onset of prometaphase, and in this phase the bipolar mitotic
spindle forms and chromosomes congress. In metaphase, chromosomes align at the center of the spindle.
In anaphase, chromosomes segregate to ultimately form the nuclei of two daughter cells.

Figure 1-2: Cyclin B-CDK1 activity levels in mitosis. Cyclin B-CDK1 activity levels rise as cells enter
mitosis. Cyclin degradation results in a dramatic decrease in CDK1 activity at the metaphase to anaphase
transition (Nasa & Kettenbach, 2018).
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The transition from metaphase to the next phase of mitosis, anaphase, is carefully
controlled to ensure chromosome segregation does not begin until all chromosomes are
attached to the mitotic spindle (Rieder, Schultz, Cole, & Sluder, 1994). Cells must satisfy
the spindle assembly checkpoint to allow the activation of the anaphase promoting complex
(APC), a ubiquitin ligase that causes irreversible entry into anaphase by targeting cell cycle
regulatory proteins for proteasomal degradation (Morgan, 1999). The targets of the APC
include mitotic cyclins, and the degradation of cyclins results in the inactivation of CDKs
(Morgan, 1999). This means that the activity of cyclin B-CDK1 drops sharply at the
metaphase to anaphase transition (Figure 1-2). The APC also targets securin for
degradation, which releases inhibition of the enzyme separase (Hagting et al., 2002).
Separase then cleaves cohesin complexes to allow sister chromatids to separate (Hauf,
Waizenegger, & Peters, 2001).
In anaphase, sister chromatids separate and move toward the spindle poles to
segregate to each daughter cell (Morgan, 2007; Strasburger, 1884) (Figure 1-1). The
movement of subcellular structures in anaphase is accomplished by two processes, named
anaphase A and anaphase B (Ris, 1949; Vukušić, Buđa, & Tolić, 2019) (Figure 1-3).
Anaphase A describes the movements of the chromosomes towards the spindle poles
(Asbury, 2017). In vertebrate cells, anaphase A is driven by the depolymerization of
microtubules attached to chromosomes at the kinetochore, meaning that the kinetochores
move towards the poles and the chromosome arms trail behind as kinetochore microtubule
depolymerization occurs (Asbury, 2017; Rieder, Davison, Jensen, Cassimeris, & Salmon,
1986). Anaphase B describes the movement of the spindle poles away from one another.
3

The driving force of anaphase B is the sliding of antiparallel microtubules emanating from
the two spindle poles (J. M. Scholey, Civelekoglu-Scholey, & Brust-Mascher, 2016). The
relative timings and importance of anaphase A and B vary between organisms and cell
types; in cultured human cells both processes contribute to chromosome segregation and
occur concurrently (Vukušić et al., 2019).

Figure 1-3: Anaphase A and Anaphase B. In anaphase A (top), segregating chromosomes move towards
the spindle poles (blue arrows). In anaphase B, the spindle poles move away from one another (grey
arrows). In cultured human cells these processes occur simultaneously (Vukušić et al., 2019).

In the last phase of mitosis, telophase, chromosome segregation is completed and
the nuclear envelope begins to re-form. The cells now undergo cytokinesis, which
physically divides the cytoplasm to form daughter cells. Cytokinesis, like anaphase, cannot
occur until CDK1 is inactivated (Wheatley et al., 1997). Additionally, the abscission
checkpoint prevents the final physical separation of daughter cells if chromatin is present
in the intercellular bridge (Nähse, Christ, Stenmark, & Campsteijn, 2017). The mechanical
forces necessary for cytokinesis are generated by the contractile ring, a structure composed
of actin, non-muscle myosin II, and associated regulatory proteins (Glotzer, 2005). The
4

contraction of this ring generates the cleavage furrow and ultimately drives the formation
of two daughter cells with distinct cell membranes and cellular contents.

1.2 KINESIN MOTORS IN MITOSIS
Mitosis requires the control of mechanical forces to move chromosomes, spindle
microtubules, and other cellular structures. Many of these mechanical forces are generated
by kinesin motors (J. M. Scholey, Porter, Grissom, & McIntosh, 1985), which are proteins
that bind to microtubules and hydrolyze adenosine triphosphate (ATP) in order to generate
mechanical forces in cells (Brady, 1985; Vale, Reese, & Sheetz, 1985). The 45 identified
members of the kinesin superfamily (Miki, Setou, Kaneshiro, & Hirokawa, 2001)
contribute to myriad cellular processes and are organized into subfamilies based on
structural and functional similarities (Hirokawa, Noda, Tanaka, & Niwa, 2009).
Kinesin superfamily members use a conserved mechanochemical cycle to
generate movement and force in cells (Cross & McAinsh, 2014; Mandelkow & Johnson,
1998). ATP is bound by the catalytic motor domain of kinesins bound to the microtubule
lattice. Microtubule binding increases the ATPase activity of kinesins (Kuznetsov &
Gelfand, 1986), and after ATP is hydrolyzed and inorganic phosphate is released, the
affinity of the motor domain, or motor head, for the microtubule lattice is reduced, and the
head detaches from microtubule. When the kinesin motor re-binds the microtubule, ADP
is released, increasing the affinity of the motor for the microtubule. This mechanochemical
cycle can then repeat when ATP is bound again.

5

Some kinesin motors move processively as dimers, taking one 8 nm step along
the microtubule per hydrolyzed ATP (Schnitzer & Block, 1997). In processive kinesin
dimers, the mechanochemical cycle of each motor domain is coordinated with the other by
the movement of the neck linker, a flexible region adjacent to the catalytic motor domain
(S. Rice et al., 1999; Rosenfeld, Fordyce, Jefferson, King, & Block, 2003). Changes in the
position of the neck linker promote the detachment and re-binding of the trailing kinesin
head, allowing processive motor movement along the microtubule. However, not all
kinesins dimerize and move processively. Some kinesins, such as KIF2C (MCAK) move
only diffusively on the microtubule lattice (Helenius, Brouhard, Kalaidzidis, Diez, &
Howard, 2006), while others, such as KIFC1 (HSET), are capable of processive movement
only when clustered (Norris et al., 2018).
Structurally, kinesin superfamily members share a highly conserved catalytic
motor domain (Vale & Fletterick, 1997). Representative motor domains from KIF11 (Eg5)
and KIF22 (Kid, kinesin-like DNA-binding protein) are presented in Figure 1-4. The
position of the motor domain varies between kinesin families. The motor domain may be
located at the amino (N) terminus, the carboxy (C) terminus, or the middle of a kinesin
protein (Hirokawa et al., 2009; Vale & Fletterick, 1997). The relative position of the motor
domain affects kinesin function: broadly, kinesins with N-terminal motor domains move
towards the plus-end of microtubules, kinesins with C-terminal motor domains are minusend directed, and kinesins with internal motor domains are non-motile (Cross & McAinsh,
2014; Hirokawa et al., 2009).

6

Figure 1-4: Structures of KIF11 (Eg5) and KIF22 (Kid) motor domains. Crystal structures of the
motor domains of KIF11 (magenta, left) (PDB 1II6) and KIF22 (green, right) (PDB 6NJE) in complex
with ADP (orange). Structures were aligned to the structure of KIF18A bound to tubulin generated using
electron microscopy (PDB 5OGC) to model the orientation of the KIF11 and KIF22 motor domains bound
to tubulin (grey).

In contrast to the conserved motor domain, the tails of kinesin motors vary
significantly between families to allow for a diversity of kinesin functionality (Cross &
McAinsh, 2014; Hirokawa et al., 2009). Across families, these tails contain disordered
regions (Seeger, Zhang, & Rice, 2012), allowing for structural as well as functional
flexibility. The tail of KIF11 includes a coiled-coil domain for dimerization and a bipolar
assembly domain that facilitates the formation of homotetramers (Acar et al., 2013; J. E.
Scholey, Nithianantham, Scholey, & Al-Bassam, 2014). Functional domains in the tail of
KIF22 include a predicted coiled-coil domain (Shiroguchi, Ohsugi, Edamatsu, Yamamoto,
& Toyoshima, 2003; Yajima et al., 2003), a microtubule binding domain (Shiroguchi et
al., 2003), and a C-terminal DNA binding domain, which includes a helix-hairpin-helix
motif (Tokai et al., 1996) (Figure 1-5).
7

Figure 1-5: Functional domains of KIF11 (Eg5) and KIF22 (Kid). The N-terminal domains of KIF11
(top) and KIF22 (bottom) are the enzymatic motor domains. The tail of KIF11 includes a coiled-coil stalk,
an antiparallel coiled-coil bipolar assembly (BASS) domain that facilitates tetramerization, and a Cterminal tail domain (Acar et al., 2013; Bodrug et al., 2020; J. E. Scholey et al., 2014). The tail of KIF22
includes a second microtubule binding domain, a predicted coiled-coil domain, and a C-terminal DNA
binding domain (Soeda, Yamada-Nomoto, & Ohsugi, 2016).

Dynamic processes depend on kinesin motors throughout mitosis (Cross &
McAinsh, 2014; Wordeman, 2010). In prophase, kinesin motors control the separation of
the centrosomes to form the poles of the mitotic spindle. The kinesin KIF11 (or Eg5) slides
antiparallel microtubules to push the centrosomes apart (Blangy et al., 1995; BrustMascher, Sommi, Cheerambathur, & Scholey, 2009; Hata et al., 2019; Sawin, LeGuellec,
Philippe, & Mitchison, 1992; Smith et al., 2011) (Figure 1-6). This antiparallel sliding
activity occurs because of the formation of bipolar KIF11 homotetramers, which allow the
motor to bind simultaneously to two microtubules (Kapitein et al., 2008; 2005; Kashina,
Rogers, & Scholey, 1997). Inhibition of Eg5 via antibody microinjection (Blangy et al.,
1995) or the small molecule inhibitor monastrol (Mayer et al., 1999) prevents the
separation of the spindle poles, resulting in the formation of monopolar spindles. The forces
generated by KIF11 are opposed by those generated by another homotetrameric kinesin,
8

KIFC3 (Hata et al., 2019; Noda et al., 2001; Z. Yang et al., 2001). The minus-end directed
activity of KIFC3 pulls the centrosomes towards one another, and the balance of the
activities of KIF11 and KIFC3 allows for control of centrosome separation (Hata et al.,
2019).

Figure 1-6: Functions of KIF11 (Eg5) and KIF22 (Kid) in mitosis. Antiparallel sliding forces generated
by KIF11 (top, magenta) contribute to centrosome separation in prophase, establishment and maintenance
of spindle bipolarity in prometa- and metaphase, poleward microtubule flux, and spindle pole separation
in anaphase (Blangy et al., 1995; Brust-Mascher, Civelekoglu-Scholey, Kwon, Mogilner, & Scholey,
2004; Brust-Mascher, Sommi, Cheerambathur, & Scholey, 2009; Hata et al., 2019; Kashina, Rogers, &
Scholey, 1997; Mitchison, 2005; Miyamoto, Perlman, Burbank, Groen, & Mitchison, 2004; Sawin,
LeGuellec, Philippe, & Mitchison, 1992; Smith et al., 2011; Straight, Sedat, & Murray, 1998; Vukušić,
Ponjavić, Buđa, Risteski, & Tolić, 2021). KIF22 generates polar ejection forces (bottom, green) to
contribute to chromosome congression and alignment in prometa- and metaphase (Iemura & Tanaka,
2015; Levesque & Compton, 2001; Wandke et al., 2012). These forces are attenuated in anaphase to allow
chromosome segregation (Soeda et al., 2016; Su et al., 2016; Wolf, Wandke, Isenberg, & Geley, 2006).

The sliding of antiparallel microtubules by KIF11 continues as the spindle forms
in prometaphase (Figure 1-6). Another kinesin motor, KIF15, also contributes to this
process (Tanenbaum et al., 2009; Vanneste, Takagi, Imamoto, & Vernos, 2009). KIF15 is
capable of maintaining spindle bipolarity in cells with reduced KIF11 activity (Tanenbaum
9

et al., 2009), and KIF15 can drive spindle pole separation in cells resistant to treatment
with KIF11 inhibitors (Raaijmakers et al., 2012; Sturgill & Ohi, 2013; Sturgill, Norris,
Guo, & Ohi, 2016). In prometaphase, the activity of KIF11 and KIF15 is balanced by the
action of a minus-end directed motor protein outside of the kinesin family, dynein (van
Heesbeen, Tanenbaum, & Medema, 2014). The balance between the forces generated by
these motors is critical: while depletion of single motors has deleterious effects, depletion
of KIF11, KIF15, and dynein results in a balanced lack of force that allows the formation
of a bipolar spindle (van Heesbeen et al., 2014).
As the spindle forms in prometaphase, kinesins associated with spindle
microtubules begin to move chromosomes towards the center of the cell (Rieder & Salmon,
1994). One contributor to this process is KIF10 (CENP-E), a kinesin that binds to the
kinetochore and uses plus-end directed motility to contribute to chromosome congression
(Iemura & Tanaka, 2015; Wood, Sakowicz, Goldstein, & Cleveland, 1997). Forces
generated by KIF22 also contribute to chromosome congression in prometaphase (Iemura
& Tanaka, 2015; Levesque & Compton, 2001; Wandke et al., 2012) (Figure 1-6). KIF22
is a plus-end directed chromokinesin which binds to chromosome arms via its C-terminal
DNA binding domain (Figure 1-5) and microtubules via its motor domain. The forces
generated by KIF22 are termed polar ejection forces, as they push chromosome arms away
from the spindle poles (Marshall, Marko, Agard, & Sedat, 2001; Rieder et al., 1986; Rieder
& Salmon, 1994). In addition to congression, prometaphase polar ejection forces also
contribute to chromosome arm orientation (Levesque & Compton, 2001; Wandke et al.,
2012). A second chromokinesin, KIF4A, also binds to chromosome arms. In contrast to
10

KIF22, KIF4A affects the position of chromosomes by altering microtubule dynamics
rather than by generating forces to move chromosome arms (Stumpff, Wagenbach, Franck,
Asbury, & Wordeman, 2012; Wandke et al., 2012).
In metaphase, the antiparallel microtubule sliding activity of KIF11 promotes the
maintenance of spindle bipolarity (Figure 1-6). The ability of KIF15 to compensate for a
loss of KIF11 activity is higher in metaphase than in prometaphase – inhibition of KIF11
in metaphase-arrested cells results in the formation of far fewer monopolar spindles than
inhibition in prometaphase, and this effect depends on the activity of KIF15 (Tanenbaum
et al., 2009; Vanneste et al., 2009). The antiparallel microtubule sliding forces generated
by KIF11 and KIF15 are balanced by the activity of KIFC1 (HSET), a minus-end directed
kinesin (Mountain et al., 1999). In addition to the maintenance of spindle bipolarity, the
activity of KIF11 in metaphase is also responsible for the generation of poleward
microtubule flux (Brust-Mascher et al., 2009; Mitchison, 2005; Miyamoto, Perlman,
Burbank, Groen, & Mitchison, 2004), which also requires the activity of the
depolymerizing kinesins KIF2A and KIF2C (MCAK) (Ganem, Upton, & Compton, 2005).
The movements of chromosomes in metaphase are controlled by kinesin motors.
Metaphase chromosomes align at the center of the spindle, and aligned chromosomes
oscillate, switching from poleward to anti-poleward movement as microtubules attached to
the kinetochore switch between polymerization and depolymerization (Skibbens, Skeen, &
Salmon, 1993). Attenuation of microtubule dynamics by KIF18A (Mayr et al., 2007;
Stumpff et al., 2012; Stumpff, Dassow, Wagenbach, Asbury, & Wordeman, 2008) and
polar ejection forces generated by KIF22 (Antonio et al., 2000; Funabiki & Murray, 2000;
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Levesque & Compton, 2001; Levesque, Howard, Gordon, & Compton, 2003; Stumpff et
al., 2012; J. Takagi, Itabashi, Suzuki, & Ishiwata, 2013; Tokai-Nishizumi, Ohsugi, Suzuki,
& Yamamoto, 2005) (Figure 1-6) contribute to metaphase chromosome alignment and
oscillations. The depolymerizing kinesins KIF2B and KIF2C also act on kinetochore
microtubules. These motors promote depolymerization at microtubule plus-ends to
contribute to error correction (Bakhoum, Thompson, Manning, & Compton, 2009;
Wordeman, Wagenbach, & Dassow, 2007).
Kinesin motors help control the movements of chromosomes in anaphase A and
spindle microtubules in anaphase B (Asbury, 2017; Cross & McAinsh, 2014; J. M. Scholey
et al., 2016). Poleward microtubule flux, a process requiring KIF11, KIF2A, and KIF2C,
is a contributor to poleward chromosome movements (Ganem et al., 2005; Vukušić et al.,
2017), although it is important to note that depolymerization of microtubules attached to
the kinetochores is the major force generator of anaphase A (Asbury, 2017; Ganem et al.,
2005; Vukušić et al., 2019). These kinetochore microtubule dynamics are regulated by
KIF18A, which limits the rate of chromosome movements in anaphase A (Stumpff et al.,
2008). The forces responsible for spindle pole separation in anaphase B are generated
primarily in the spindle midzone, which is composed of overlapping antiparallel
microtubules (McIntosh & Landis, 1971). Kinesin motors in the midzone, including KIF11
(Brust-Mascher, Civelekoglu-Scholey, Kwon, Mogilner, & Scholey, 2004; Kashina et al.,
1997; Straight, Sedat, & Murray, 1998; Vukušić, Ponjavić, Buđa, Risteski, & Tolić, 2021)
(Figure 1-6) and KIF23 (MKLP1) (Fu et al., 2009; Krüger, Sanchez, Paoletti, & Tran,
2019; Nislow, Lombillo, Kuriyama, & McIntosh, 1992) move the spindle poles apart by
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sliding overlapping microtubules, and KIF4A regulates dynamics of midzone microtubules
to control spindle elongation (Hu, Coughlin, Field, & Mitchison, 2011) (Vukušić et al.,
2021). Anaphase chromosome segregation also requires the inactivation of KIF22 to
reduce polar ejection forces (Soeda et al., 2016; Su et al., 2016; Wolf et al., 2006), but
whether polar ejection forces affect anaphase A or anaphase B is unknown (Figure 1-6).

1.3 CONTROL OF MITOTIC KINESIN MOTORS
Spindle assembly and chromosome segregation in mitosis require spatial and
temporal control of the activity of kinesin motors. One mechanism by which the activity
of kinesins is temporally regulated as the cell cycle progresses is the regulation of protein
levels (Verhey & Hammond, 2009; Yount, Zong, & Walczak, 2015). The expression of
KIF22 increases after cells replicate their DNA and enter the G2 (Growth 2) and M
(Mitosis) phases of the cell cycle (Funabiki & Murray, 2000; Germani et al., 2000). Then,
in mitosis, ubiquitination of KIF22 results in an increase in its proteasomal degradation at
the metaphase to anaphase transition. This ubiquitination has been reported to be facilitated
by the E3 ubiquitin ligase SIAH-1 (Seven in Absentia Homologue), and overexpression of
SIAH-1 increases proteasomal degradation of KIF22 (Germani et al., 2000). However,
there is some disagreement about the ligase responsible for ubiquitination of KIF22, as
other work identifies KIF22 as a target of the anaphase promoting complex (APC) rather
than SIAH-1 (Feine, Zur, Mahbubani, & Brandeis, 2007). Both studies agree, however,
that the level of KIF22 changes as mitosis progress. The kinesins KIF10 (Brown, Coulson,
Yen, & Cleveland, 1994) and KIF2C (Ganguly, Bhattacharya, & Cabral, 2008) are also
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degraded in anaphase. In contrast, APC-mediated degradation of Cin8p, a yeast homologue
of KIF11, occurs as cells exit mitosis and enter the G1 (Growth 1) phase of the cell cycle
(Hildebrandt & Hoyt, 2001).
The localization of kinesin motors represents one level of spatial control of
activity. Before the onset of mitosis, some kinesins, including KIF18A (Du, English, &
Ohi, 2010), KIF23 (X. Liu & Erikson, 2007), KIFC1 (S. Cai, Weaver, Ems-McClung, &
Walczak, 2009), and KIF22 (Tahara et al., 2008) are sequestered in the nucleus to limit
interactions with spindle microtubules. In addition to interphase nuclear sequestration, the
nuclear localization signals (NLSs) in the tails of KIF22 and KIFC1 also regulate their
localization and activity after nuclear envelope breakdown. Importin proteins bind the
NLSs and limit the interaction of KIFC1 with microtubules (S. Cai et al., 2009) and of
KIF22 with chromosome arms (Tahara et al., 2008). In mitotic cells, a gradient of activity
of the small GTPase Ran is centered around mitotic chromosomes because the guanine
nucleotide exchange factor (GEF) regulator of chromosome condensation 1 (RCC1) is
bound to chromosomes (Kaláb, Pralle, Isacoff, Heald, & Weis, 2006; Ohtsubo, Okazaki,
& Nishimoto, 1989). Ran-GTP disrupts the interaction of importin proteins with the NLSs
of KIFC1 and KIF22, locally promoting their interaction with microtubules and
chromosomes, respectively (S. Cai et al., 2009; Tahara et al., 2008).
The binding of importins to the tails of KIF22 and KIFC1 provides one example
of a common regulatory mechanism for mitotic kinesin motors: the tail can regulate motor
domain activity via intermolecular interactions (Verhey & Hammond, 2009; Yount et al.,
2015). KIF18B (Stout et al., 2011), KIFC3 (Gouveia et al., 2010; Honnappa et al., 2009),
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and KIF11 (Jiang et al., 2012) interact with microtubule plus-end tracking end binding
(EB) proteins via canonical SxIP or related EB binding motifs in their tails (Honnappa et
al., 2009). The tails of kinesin motors can also interact with the microtubules themselves.
The tail of KIF18A acts to tether the motor to the microtubule, increasing motor
processivity and promoting motor accumulation at microtubule plus-ends (Mayr, Storch,
Howard, & Mayer, 2011; Stumpff et al., 2011; Weaver et al., 2011). The tail of KIF22 also
contains a domain which binds microtubules in vitro in the absence of the motor domain.
This domain does not alter the velocity of KIF22, suggesting that the interaction between
the tail microtubule binding domain and the microtubule lattice is not strong or long-lasting
(Shiroguchi et al., 2003). However, this interaction between the tail and the microtubule
has been proposed to inactivate KIF22 to suspend polar ejection forces in anaphase (Soeda
et al., 2016).
Intramolecular interactions between the tail and the motor domain also regulate
kinesin activity. Autoinhibition of transport kinesins in the kinesin-1, kinesin-2, and
kinesin-3 family has been well described (Chiba, Ori-McKenney, Niwa, & McKenney,
2021; Coy, Hancock, Wagenbach, & Howard, 1999; Friedman & Vale, 1999; Hammond,
Blasius, Soppina, Cai, & Verhey, 2010; Hammond et al., 2009; Imanishi, Endres,
Gennerich, & Vale, 2006; Ren et al., 2018; Verhey & Hammond, 2009; Verhey et al.,
1998). In mitosis, a direct interaction between the head and the tail regulates the activity of
KIF10 (CENP-E) (Espeut et al., 2008). This interaction is regulated by phosphorylation.
The tail of KIF10 is phosphorylated by CDK1 (Espeut et al., 2008; Liao, Li, & Yen, 1994)
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and monopolar spindle 1 (MPS1) (Espeut et al., 2008), and phosphorylation by either
kinase prevents inhibition of the motor domain by the tail (Espeut et al., 2008).
Regulatory phosphorylation sites have been identified in the tail of other kinesin
motors in addition to KIF10 (Verhey & Hammond, 2009; Yount et al., 2015).
Phosphorylation of T927 in the tail of KIF11 by CDK1 or CDK2 allows the motor to
localize to spindle microtubules when mitosis begins in order to generate force for
centrosome separation (Blangy et al., 1995; Cahu et al., 2008; Sawin & Mitchison, 1995;
Smith et al., 2011) (Figure 1-7). KIF11 is also phosphorylated at S1033 by NEK6/7, and
this phosphorylation is necessary for centrosome separation in cultured mammalian cells
(Bertran et al., 2011) (Figure 1-7). Conversely, the minus-end directed motor KIFC3,
which opposes KIF11 during centrosome separation, is phosphorylated by NEK2 at the
onset of mitosis to promote dissociation of the motor from the centrosomes (Hata et al.,
2019). The combined activation of KIF11 and inactivation of KIF23 by phosphorylation
events shift the balance of forces to allow the centrosomes to separate during prophase
(Hata et al., 2019).
The function of KIF11 is also regulated by acetylation. Nucleolar acetylase
NAT10 acetylates KIF11 at K771 in the tail. This acetylation promotes the localization of
KIF11 to the centrosomes in prometaphase, and depletion of NAT10 disrupts mitosis
(Zheng et al., 2022). In addition to KIF11, the kinesins KIF5B, KIF3A, KIF21B, KIF2C,
and KIF15 are also reported to be acetylated, although the functional roles of these
acetylations have not yet been determined (Mertins et al., 2013; Choudhary et al., 2009;
Zhao et al., 2010; Beli et al., 2012).
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Figure 1-7: Characterized post-translational modifications of KIF11 (Eg5) and KIF22 (Kid).
Characterized sites of phosphorylation in KIF11 (top) include Y125, Y211, and Y231 in the motor
domain (Bickel et al., 2017) and K771, T927, and S1033 in the tail (Bertran et al., 2011; Blangy et al.,
1995; Cahu et al., 2008; Sawin & Mitchison, 1995; Smith et al., 2011; Zheng et al., 2022).
Phosphorylation sites T427 and T463 have been identified in KIF22 (Ohsugi et al., 2003) (bottom).

Phosphorylation of the tail also controls the activity of the chromokinesin KIF22
(Figure 1-7). KIF22 is phosphorylated at tail residues S427 and T463 specifically in mitosis
(Ohsugi et al., 2003). The kinase responsible for phosphorylation of S427 is unknown, but
it has been established that T463 is phosphorylated by CDK1 (Ohsugi et al., 2003).
Phosphorylation at T463 promotes the localization of KIF22 to chromosomes and the
generation of polar ejection forces in prometaphase (Ohsugi et al., 2003; Soeda et al.,
2016). CDK1 activity drops at the metaphase to anaphase transition (Morgan, 1999), and,
correspondingly KIF22 dephosphorylation in anaphase reduces polar ejection forces to
allow for anaphase chromosome segregation (Soeda et al., 2016). Mimicking
phosphorylation of T463 in anaphase causes chromosome recongression. This process
requires the microtubule binding and coiled-coil domains in the tail of KIF22 – deletion of
either domain also results in recongression (Soeda et al., 2016). This finding is consistent
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with work demonstrating that expression of nondegradable cyclin B1, which results in
aberrant CDK1 activity in anaphase, also causes chromosome recongression, and that this
recongression depends on the expression of KIF22 (Wolf et al., 2006). The
phosphoregulation of KIF22 at the metaphase to anaphase transition depends not only on
phosphorylation by CDK1 but also on dephosphorylation by phosphatases. The inhibition
of phosphatases PP1 and PP2A via treatment with Okadaic acid (P. Cohen, Holmes, &
Tsukitani, 1990), which would allow more KIF22 to remain phosphorylated in anaphase,
promotes the movement of chromosomes away from the poles in anaphase, and these
movements are reduced in cells depleted of KIF22 (Su et al., 2016).

1.4 MITOTIC KINESINS IN DEVELOPMENT AND DISEASE
Cancer is a disease characterized by the uncontrolled division of abnormal cells.
Since kinesin motors are essential for division and changes in kinesin activity can alter
rates of cellular proliferation, mitotic kinesin motors are potential targets for anti-cancer
therapeutics (Huszar, Theoclitou, Skolnik, & Herbst, 2009; Rath & Kozielski, 2012).
KIF11, particularly, has been explored as a therapeutic target because loss of KIF11
activity prevents the separation of the spindle poles and arrests cells in mitosis (Mayer et
al., 1999) and because high KIF11 expression levels are associated with poor clinical
outcomes for patients with bladder urothelial, renal cell, or pancreatic carcinoma (Myers
& Collins, 2016). Multiple small molecules that inhibit KIF11 and cause mitotic arrest have
been identified, including monastrol (Mayer et al., 1999), S-trityl-L-cysteine (STLC)
(DeBonis et al., 2004), and ispinesib (Lad et al., 2008). Treatment with KIF11 inhibitors
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reduced proliferation in cell culture models, even in cells resistant to treatment with
microtubule stabilizing taxanes (Marcus et al., 2005), and reduced tumor growth in
xenografts (Purcell et al., 2010).
Multiple KIF11 inhibitors advanced to clinical trials, but the success of these trials
has been limited (Komlodi-Pasztor, Sackett, & Fojo, 2012; Myers & Collins, 2016; Rath
& Kozielski, 2012). One explanation for the difference in efficacy seen between preclinical and clinical models is that the doubling time of tumors is on the order of hundreds
of days, which is much longer than the doubling times of xenografts (~3-5 days) and
cultured cells (hours to days) (Komlodi-Pasztor et al., 2012). KIF11 inhibitors only target
cells in mitosis, and these rates indicate tumors have fewer cells in mitosis at a given time,
meaning KIF11 inhibitors will target a smaller percentage of cells in tumors than in
xenografts or cell culture. Additionally, the ability of KIF15 to compensate for loss of
KIF11 function (Raaijmakers et al., 2012; Sturgill et al., 2016; Sturgill & Ohi, 2013) may
limit the efficacy of KIF11 inhibitors.
Other mitotic kinesins are also being investigated as targets for cancer therapy.
The minus-end directed motor KIFC1 acts to cluster centrosomes into a pseudo-bipolar
spindle in cells with supernumerary centrosomes (Kwon et al., 2008). This activity could
allow cancer cells with centrosome duplication to continue to divide, and KIFC1
overexpression is associated with poor clinical outcomes (Grinberg-Rashi et al., 2009; Y.
Li et al., 2015; Pawar et al., 2014). Inhibiting KIFC1 to generate multipolar spindles in
cancer cells is an area of ongoing study (Watts et al., 2013). Relatedly, depletion of the
kinesin KIF18A results in the formation of multipolar spindles in and reduced proliferation
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of chromosomally unstable cancer cells (Marquis et al., 2021). As such, KIF18A inhibitors
are also being tested as cancer therapies (Tamayo et al., 2022). Inhibition of KIF10, which
attaches kinetochores laterally to microtubules to contribute to chromosome congression
in prometaphase, is also the subject of pre-clinical (Mullen et al., 2022) and clinical
investigation (V. Chung et al., 2012).
Outside of the context of cancer, cell division is vital for human development, and
aberrant division can be pathogenic. Since kinesin motors contribute to myriad processes
as cells divide, changes in mitotic motor function can affect development or cause disease
(Konjikusic, Gray, & Wallingford, 2021; Mandelkow & Mandelkow, 2002). Loss of
KIF18A function causes infertility due to germ cell depletion in mice. Somatic cells
expressing mutant KIF18A are capable of division, but germ cells in the same animals
arrest in mitosis and undergo apoptosis (Czechanski et al., 2015). Patients heterozygous
for point mutations in KIF11 develop the related microcephaly syndromes microcephalylymphedema-chorioretinal dysplasia (MLCRD) and chorioretinal dysplasia, microcephaly,
and mental retardation syndrome (CDMMR) (Mirzaa, Enyedi, et al., 2014a; Y. Wang,
Smallwood, Williams, & Nathans, 2020). The kinesin-6 family member KIF20B
contributes to midbody organization, furrow ingression, and abscission, and loss of
KIF20B function disrupts the development of the cerebral cortex in mice (Janisch,
McNeely, Dardick, Lim, & Dwyer, 2018; Janisch et al., 2013). Mutations in KIF10 cause
microcephalic primordial dwarfism, and analysis of cells from two patients with KIF10
mutations demonstrates mitotic defects (Mirzaa, Vitre, et al., 2014b). Inhibition of KIF10
in zebrafish disrupts early development and results in fish with head malformation and
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small bodies, consistent with the pathology observed in humans with KIF10 mutations (K.W. Yu, She, Wei, & Zhong, 2020).
Mutations in KIF22 affect the development of the skeletal system, causing the
developmental disorder spondyloepimetaphyseal dysplasia with joint laxity- leptodactylic
type (SEMDJL2, also called Hall Type or lepto-SEMDJL) (Boyden et al., 2011; Min et al.,
2011; Tüysüz, Yılmaz, Erener-Ercan, Bilguvar, & Günel, 2014). Four point mutations in
two amino acids have been identified in SEMDJL2 patients, in adjacent residues proline
148 and arginine 149 (Boyden et al., 2011; Min et al., 2011; Tüysüz et al., 2014) (Figure
1-8). All identified patients are heterozygous for a single mutation in KIF22.. A primary
symptom of SEMDJL2 is short stature, resulting from shortening of both the trunk and the
limbs. Additionally, patients present with joint laxity, midface hypoplasia, scoliosis, and
leptodactyly (Boyden et al., 2011; Min et al., 2011). In very young children, the softness
of the cartilage in the larynx and trachea can cause respiratory issues (Boyden et al., 2011).
Growth plate radiology demonstrates delayed maturation of the metaphyses and epiphyses
in SEMDJL2 patients, and symptoms become more pronounced as patients age (Tüysüz et
al., 2014). Leptodactyly, specifically, is only observed in older (young adult) patients
(Boyden et al., 2011). KIF22 mutations have resulted in both de novo and inherited cases
of SEMDJL2 (Boyden et al., 2011; Min et al., 2011). Familial cases with inheritance of
P148L, P148S, and R149Q mutations have been documented. Genetic and clinical
assessment of these families demonstrates that mutations dominantly cause SEMDJL2
(Boyden et al., 2011; Min et al., 2011).
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Figure 1-8: Pathogenic mutations in KIF22. Mutations in proline 148 and arginine 149 in the motor
domain of KIF22 have been identified in patients diagnosed with spondyloepimetaphyseal dysplasia with
joint laxity, leptodactylic type (SEMDJL2) (Boyden et al., 2011; Min et al., 2011; Tüysüz et al., 2014).

The pathology seen in patients with SEMDJL2 is consistent with a defect in
endochondral ossification, which may result from impaired chondrocyte proliferation,
maturation, or function, as these cells set the scale of skeletal development. Chondrocytes
are organized into the resting, proliferative, and hypertrophic zones of the growth plate
(Hunziker, 1994) (Figure 1-9). A small number of divisions occur in the lacunae of the
resting zone, but the majority of chondrocytes divide in the proliferative zone, where the
cells are spatially constrained. In this proliferative zone, chondrocytes are arranged into
columns surrounded by extracellular matrix proteins, including collagen (Myllyharju,
2014). The organization of proliferative chondrocytes into columns physically limits how
cells can change position and morphology during mitosis. Examination of histological
preparations of growth plates has demonstrated that proliferative chondrocytes divide by
forming a mitotic spindle oriented perpendicular to the long axis of the column of cells
(Dodds, 1930). After cytokinesis, daughter cells crawl over and under one another to
restore columnar structure, with one daughter cell ultimately positioned directly above the
second daughter cell in the column (Dodds, 1930). Each division even represents an
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increase in bone length of 7 µm, the height of one chondrocyte (Hunziker, 1994). Cells do
not extend out into the extracellular matrix during this process; division is physically
constrained within the columnar zone.

Figure 1-9: Organization of chondrocytes in the growth plate. The tissue architecture of the growth
plate organizes chondrocytes into the resting zone, the proliferative zone, where cells divide and the
hypertrophic zone, which represents a transition to bone.

In addition to spatial constraints, chondrocyte proliferation is subject to temporal
and developmental constraints. Pulse labeling of DNA suggests that cells occupy the
proliferative zone for approximately four days, and that each chondrocyte divides multiple
times while in the proliferative zone (Farnum & Wilsman, 1993; Wilsman, Farnum, Green,
Lieferman, & Clayton, 1996). The rate at which chondrocytes progress through the cell
cycle while in the proliferative zone represents a mechanism by which the length of long
bones can be regulated (Wilsman et al., 1996). On a longer time scale, long bone growth
and chondrocyte proliferation are restricted to childhood and young adulthood in humans.
Chondrocyte proliferation rates decrease with age, and ultimately chondrocytes no longer
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proliferate, allowing for epiphyseal fusion and the replacement of growth plate cartilage
with bone (Nilsson & Baron, 2004).
Chondrocytes produce the cartilage template that defines the size and shape of
bones, so a defect in chondrocyte proliferation resulting from mutations in KIF22 could
result in insufficient production of cartilaginous matrix, and subsequently, insufficient
bone growth. The presence of symptoms in other cartilaginous tissues, such as the larynx
and trachea (Boyden et al., 2011), in SEMDJL2 patients also supports KIF22 mutations
causing disease pathology by affecting chondrocytes, and the documented expression
pattern of KIF22 is consistent with a functional role for the protein in proliferating
chondrocytes. KIF22 is expressed in mouse and bone cartilage (Min et al., 2011), and in
mouse growth plates mRNA expression levels of KIF22 are approximately nine-fold higher
in the proliferative zone than in the hypertrophic zone (Boyden et al., 2011). KIF22 is
expressed ubiquitously in the human body (Takahashi, Lassmann, Murata, & Carninci,
2012; Uhlen et al., 2015; 2017), and expression of KIF22 in bone, cartilage, and primary
cultured chondrocytes from human donors has also been reported (Min et al., 2011).

1.5 SCOPE AND PURPOSE
Mitosis is a carefully controlled process, and as such the activities of kinesin
motors generating forces to move cellular structures during mitosis must also be closely
regulated. The balance of forces generated by kinesins must shift, particularly, as cells
transition from aligning and congressing chromosomes in prometa- and metaphase to
segregating chromosomes to daughter cells in anaphase. However, many open questions
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remain regarding how the activity of kinesins is spatially and temporally regulated, and
what the consequences are when this regulation is disrupted.
Post-translational modification, for example, is an established mechanism by
which the activity of kinesin motors can be controlled (Verhey & Hammond, 2009; Yount
et al., 2015). However, previous studies have focused on post-translational modification in
the tail (Bertran et al., 2011; Blangy et al., 1995; Cahu et al., 2008; Hata et al., 2019; Ohsugi
et al., 2003; Sawin & Mitchison, 1995; Smith et al., 2011) (Figure 1-7) rather than the
enzymatic motor domain. One exception is the characterization of phosphorylation of
tyrosines 125, 211, and 231 in the motor domain of KIF11 (Bickel et al., 2017) (Figure 17). Mimicking phosphorylation of Y125 or Y211 decreased the microtubule sliding
velocity of KIF11, and mimicking phosphorylation of Y125, Y211, or Y231 reduced the
binding affinity of the KIF11 inhibitor S-trityl-L-cysteine. These effects were strongest for
KIF11 Y211E, so the consequences of expressing this phosphomimetic construct in cells
were assessed. KIF11 Y211E-mEmerald demonstrated a reduced ability to separate spindle
poles in cells depleted of endogenous KIF11 compared to KIF11 Wild Type-mEmerald,
resulting in the formation of monopolar spindles (Bickel et al., 2017).
To better understand how motor domain post-translational modifications regulate
the activity of mitotic kinesins, we investigated the effect of post-translational
modifications of the a2 helices of KIF11 and KIF22. In chapter 2, we assess how
mimicking the acetylation of KIF11 at K146 affects the function of the motor at the
structural, biophysical, and cell biological levels (Figure 1-10). In chapter 3, we
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demonstrate that mimicking phosphorylation of T158 alters the regulation of KIF22
function at the metaphase to anaphase transition (Figure 1-10).

Figure 1-10: Uncharacterized post-translational modifications in the motor domains of KIF11
(Eg5) and KIF22 (Kid). Phosphorylation of a2 helix residues K146 in KIF11 (top), T134 in KIF22,
and T158 in KIF22 (bottom) has been reported (Choudhary et al., 2009; Kettenbach et al., 2011;
Nalawansha, Gomes, Wambua, & Pflum, 2017; Olsen et al., 2010; Rigbolt et al., 2011; Sol et al., 2012).

The consequences of altered kinesin function in mitosis are demonstrated by the
pathologies that result from altered or lost motor activity. In chapter 3, we focus on one
example where mutations in a mitotic kinesin cause a developmental disorder. Mutations
in KIF22 have been identified in patients with the skeletal developmental disorder
SEMDJL2 (Boyden et al., 2011; Min et al., 2011; Tüysüz et al., 2014), but the mechanism
by which mutations in KIF22 affect skeletal development is unknown. We assess whether
pathogenic mutations affect the function of KIF22 in mitosis. Motor domain pathogenic
mutations in KIF22 are located in the a2 helix (P148 and R149), allowing the comparison
of the effects of pathogenic mutations to the effects of post-translational modification of
T158 in the same structural region.
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The structure of the motor domain of kinesins Is highly conserved (Vale &
Fletterick, 1997), and as such a better understanding of the regulation of the activity of
KIF11 and KIF22 could inform our understanding of other motors as well. Additionally,
comparing and contrasting regulatory mechanisms between motors allows for a better
understanding of how kinesins are specialized for different mitotic functions, and why
mutations in different mitotic kinesins have disparate effects on human physiology.
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CHAPTER 2: A POST-TRANSLATIONAL MODIFICATION OF THE MITOTIC
KINESIN EG5 (KIF11) THAT ENHANCES ITS MECHANOCHEMICAL
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2.1 ABSTRACT
Numerous post-translational modifications have been described in kinesins,
yet their consequences on motor mechanics are largely unknown. We investigated
one of these—acetylation of lysine 146 in Eg5—by creating an acetylation-mimetic
lysine-to-glutamine substitution (K146Q). Lysine 146 is located in the a2 helix of
the motor domain, where it makes an ionic bond with aspartate 91 on the neighboring
a1 helix. Molecular dynamics simulations predict that disrupting this bond enhances
catalytic site-neck linker coupling. We tested this using structural kinetics and
single-molecule mechanics and found that the K146Q mutation increases motor
performance under load and coupling of the neck linker to catalytic site. These
changes convert Eg5 from a motor that dissociates from the microtubule at low load
into one that is more tightly coupled and dissociation resistant — features shared by
kinesin 1. These features, combined with the increased propensity to stall, predict
that the K146Q Eg5 acetylation mimetic should act in the cell as a “brake” that slows
spindle pole separation, and we have confirmed this by expressing this modified
motor in mitotically active cells. Thus, our results illustrate how a post-translational
modification of a kinesin can be used to fine-tune motor behavior to meet specific
physiological needs.

2.2 SIGNIFICANCE STATEMENT
Members of the kinesin superfamily serve a wide variety of functions, and a
dominant narrative for these molecular motors has been that each member of the
superfamily is uniquely specialized to serve a very limited set of functions. However,
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it is now appreciated that many members of this group serve several distinct
physiological roles, and it has been unclear how these kinesins accomplish this
functional flexibility. In this report, we describe a post-translational modification of
the kinesin 5 family member Eg5 that dramatically alters its chemomechanical
behavior to make it function much more efficiently under load and in ensembles.
This work provides the biophysical context required to mechanistically understand
the effects of modified Eg5 in dividing cells.

2.3 INTRODUCTION
Members of the kinesin superfamily of molecular motors fulfill specific roles
in cell physiology. Some serve as transporters, others as regulators of microtubule
dynamics, and others still as mitotic motors (Bachmann & Straube, 2015; Hirokawa
& Tanaka, 2015; Vicente & Wordeman, 2015; Walczak, Gayek, & Ohi, 2013).
Nevertheless, individual kinesins can play multiple cellular roles. For example,
while kinesin 1 transports organelles, it also slides microtubules during axonal
elongation (Jolly et al., 2010). MCAK, a microtubule-depolymerizing mitotic
kinesin, can also drive cell motility (Braun et al., 2014). Microtubules (MTs) also
play multiple roles in cell physiology, and this adaptability is due in part to multiple
post-translational modifications (PTMs) (Janke, 2014; Sirajuddin, Rice, & Vale, 2014;
I. Yu, Garnham, & Roll-Mecak, 2015). Thus, some of the multi-functionality of
kinesin motors might reflect PTMs that modify their mechanochemical behavior.
PTMs have been identified in most kinesins, including many in the catalytic domain
of these enzymes (Hornbeck et al., 2015; Z. Liu et al., 2014). However, in nearly all
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cases, the consequences of these PTMs on motor function remain unknown. Multiple
PTMs in the motor domain of the mitotic kinesin Eg5 have been reported (Bickel et
al., 2017), including in Loop 5 and helices a2 and a3—all in the vicinity of the
catalytic site (Figure 2-1 A). As with other kinesins, Eg5 also plays multiple roles
in cell physiology, including not only formation of the mitotic spindle in dividing
cells, but also axonal branching and cell motility (Falnikar, Tole, & Baas, 2011;
Venere et al., 2015). These roles may be associated with distinct mechanochemical
requirements—which might be achieved via specific PTMs. One such PTM of Eg5
is acetylation of a lysine residue (K146) at the C terminal end of helix a2 (Figure 21 A) (Choudhary et al., 2009; Nalawansha, Gomes, Wambua, & Pflum, 2017; Sol et al.,
2012). Lysine 146 makes a salt bridge to aspartate 91 on helix a1, and its acetylation
disrupts this ionic interaction—an effect that can be mimicked by a lysine-toglutamine point mutation (T. J. Cohen et al., 2011; de Boor et al., 2015; Gorsky,
Burnouf, Dols, Mandelkow, & Partridge, 2016). The importance of acetylation in cell
biology is underscored by the recent findings that it regulates not only chromatin
activity, through its effects on histones (Marmorstein & Zhou, 2014), but also
transcription, metabolism, autophagy, and viral infection (Blee, Gray, & Brook, 2015;
Kouzarides, 2000; Menzies, Zhang, Katsyuba, & Auwerx, 2015; Y. Xie et al., 2015).
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Figure 2-1: Molecular dynamics simulations of the effect of the K146Q acetylation mimetic
mutation. A. Molecular structure of Eg5 highlighting major structural elements including loop
9/switch I (orange), loop 11/switch II (green), P-loop (yellow), helix a0 (blue), neck-linker (purple),
cover-strand (cyan), and helices a1 and a2 (red). Also shown is the wild-type salt-bridge residue pair
D91 and K146 (as bright blue spheres). Significant (p < 0.05) residue-residue distance changes
between wild-type and K146Q mutant simulations are displayed as red and blue lines with color
intensity representing the magnitude of change and matching that in panel B. Inset: enlarged view
of the catalytic site. B. Pairwise residue difference distance analysis of wild-type and K146Q
simulations. Significant (p < 0.05) residue-residue distance changes are displayed with size and color
intensity scaled by magnitude (red for shorter in K146Q and blue for shorter in wild-type). Major
secondary structure elements are displayed in the marginal plot regions (alpha helices in black and
beta strands in gray). Specific structural regions noted in the main text with distinct interactions with
the NL and switch I regions have been labeled in red and blue respectively. C. Free energy profile
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from well-tempered meta-dynamics simulation for neck-linker docking/undocking of wild-type
(blue) and K146Q mutant (red) as a function of the distances between residues N366 (NL) and G96
(helix a1). Arrow denotes the energy difference between WT and K146Q at point of hydrogen bond
formation.

Two key structural domains in kinesin 1 and Eg5—switch 1 (Sw1) and the
neck linker (NL)—alternate between two orientations during the ATPase cycle (Cao
et al., 2019; Gigant et al., 2013; Muretta et al., 2015; S. Rice et al., 1999; Sindelar &
Downing, 2007).

Sw1 senses the g phosphate of ATP and it assumes “open”

(capable of binding ATP) and “closed” (capable of hydrolyzing ATP) conformations.
The NL moves in response to ATP binding between “undocked” (no forcegenerating) and “docked” (force-generating) orientations. We found that while Sw1
and the NL are tightly coupled in kinesin 1 (e.g., closed Sw1 associated with docked
NL), they are more loosely coupled in Eg5. Tight coupling is important for a highly
processive motor that operates in isolation, such as kinesin 1, as it helps ensure the
motor does not enter a weak microtubule binding state before it has docked its NL
and generated force. Conversely, this might be unnecessary for Eg5, which by
working in large ensembles, may not need to be highly processive. Here, we have
focused on the acetylation of K146, through molecular dynamics (MD) simulations,
transient time resolved kinetics, single-molecule mechanics, and time-lapse
microscopy of cells in mitosis. We find that a pseudo-acetylation mutant of Eg5
(K146Q) shows much tighter conformational coupling of Sw1 to the NL, and this is
associated with improved motor performance under load—features characteristic of
kinesin 1. Taken together, our results suggest that kinesin PTMs can act as a
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“molecular gear shift”—broadening a specific kinesin’s capabilities and enhancing
the flexibility a cell has to respond to a wide variety of physiological demands.

2.4 RESULTS
The K146Q acetylation mimetic has little effect on enzymatic turnover,
nucleotide binding, or microtubule dissociation.
We examined the consequences of the K146Q mutation on the steady state
enzymology of Eg5 by using a cysteine light Eg5 motor domain monomer, referred
to as Eg5NL, which contains the wild type lysine residue at position 146 as well as
reactive cysteines in the NL and b core. We previously reported that the behavior of
Eg5NL was nearly identical to a wild type Eg5 monomer with regard to: 1) the steady
state ATPase parameters (kcat, K0.5,MT, K0.5,ATP); 2) the kinetics of ATP (kb,ATP) and
ADP (kb,ADP) binding, as measured by the fluorescent nucleotide analogues 2’deoxy
3’ mant ATP (2’dmT) and 2’dmD; 3) the kinetics of ATP and ADP induced MT
dissociation (kd,ATP, kd,ADP); and 4) the force velocity relationship measured at the
single-molecule level (Muretta et al., 2015). Here we mutated lysine 146 to glutamine
to generate the corresponding pseudo-acetylated species, referred to in this text as
Eg5NLK146Q. We found that the values of kcat, K0.5,MT, K0.5,ATP for the Eg5NL and
Eg5NLK146Q at 20oC are very similar to each other (Figure 2-2 A, B, Table 2-1).
The rate constants for ATP binding to and release from Eg5NL and Eg5NLK146Q are
within 50% of each other at 20oC and are nearly identical at 10oC, where the binding
of 2’dmT is slower and can be measured more accurately (Figure 2-2 C, Table 2-1).
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The maximum rate for ADP binding to Eg5NLK146Q is 354 ± 108 sec-1 at 20oC
(Table 2-1). Although the corresponding experiment was not performed on Eg5NL,
prior experiments on a cysteine free Eg5 monomer that is nearly identical to Eg5NL
also demonstrate a very rapid rate constant for ADP binding (>>150 sec-1 (Rosenfeld,
Xing, Jefferson, & King, 2005)).

Table 2-1: Kinetic parameters of Eg5NL and Eg5NLK146Q.

Parameter
kcat
K0.5,MT
K0.5,ATP
kb,ATP
kb,ATP
kb,ADP
kd, ATP
kd, ADP

Temp
20oC
20oC
20oC
20oC
10oC
20oC
20oC
20oC

Eg5NL
6.9 ± 1.1 sec-1
3.2 ±1.3 µM
17.7 ± 6.5 µM
62-79 sec-1, a
45.1 ± 6.5 sec-1
>>150 sec-1, a
7.3 ± 0.6 sec-1
8.8 ± 0.3 sec-1

a

Eg5NLK146Q
7.3 ± 0.8 sec-1
2.0 ± 0.6 µM
13.6 ± 4.3 µM
97.7 ± 13.0 sec-1
47.0 ± 4.3 sec-1
354 ± 108 sec-1
12.1 ± 0.5 sec-1
11.7 ± 0.7 sec-1

(Bickel et al., 2017)
kcat:
Steady state catalytic rate constant for microtubule-activated ATPase
K0.5,MT: Michaelis constant for microtubules
K0.5,ATP: Michaelis constant for ATP
kb,ATP:
Maximum rate constant for ATP induced conformational change, measured using the
fluorescence of 2’ deoxy 3’ mant ATP.
kb,ADP:
Maximum rate constant of ADP induced conformational change, measured using the
fluorescence of 2’ deoxy 3’ mant ADP.
kd,ATP:
Maximum rate constant for ATP induced microtubule dissociation, measured by turbidity.
kd,ADP:
Maximum rate constant for ADP induced microtubule dissociation, measured by turbidity.
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Figure 2-2: Steady state ATPase and kinetics of nucleotide binding and MT dissociation are not
affected by the K146Q acetylation mimetic mutation. A. ATPase rate as a function of [MT] for Eg5NL
(blue) and Eg5NLK146Q (red). Values of kcat and K0.5,MT are summarized in Table 2-1. Conditions: 50
mM potassium acetate, 25 mM HEPES, 5 mM magnesium acetate, 1 mM EGTA, pH 7.50, 20oC. B.
ATPase rate as a function of [ATP]. Conditions as in A, with [MT] set at 2 µM. C. Rates of binding of
2’dmT (solid circles) and 2’dmD (open circles) to a 4:1 MT:Eg5NLK146Q complex at 20oC. Values of
rate constants versus [nucleotide] were fit to hyperbolae for 2’dmT (solid curve) and 2’dmD (dashed
curve), yielding maximum rates summarized in Table 2-1. Conditions as in A. D. Rates of binding of
2’dmT to a 4:1 MT:Eg5NL complex (blue) and to a 4:1 MT:Eg5NLK146Q complex (red) at 10oC versus
[2’dmT]. Data were fit to hyperbolae yielding maximum rate constants summarized in Table 2-1. E.
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Kinetics of nucleotide induced MT dissociation. Complexes of 4 µM Eg5NL (blue) or Eg5NLK146Q (red)
+ 6 µM MTs were mixed with ATP (closed circles) or ADP (open circles) in the stopped flow, and the
change in turbidity was monitored at 350 nm. Fits of the turbidity transients to a single exponential decay
+ linear phase yielded rate constants, and a plot of rate constant versus [nucleotide] to hyperbolae revealed
maximum rates summarized in Table 2-1. Conditions as in A.

ATP binding to Eg5 produces a conformational change in the catalytic site,
and the K146Q mutation has little effect on this process. However, this local
conformational change produces secondary effects transmitted through the motor
domain that alter microtubule binding and NL orientation (Atherton et al., 2014;
Goulet et al., 2012; 2014). We therefore performed molecular dynamics (MD)
simulations to obtain an unbiased assessment of what the global effects of the
K146Q mutation might to be.

Molecular dynamics simulations predict that the K146Q acetylation mimetic
enhances NL docking, catalytic site closure, and the coupling between these two
regions.
We performed four replicate 300 ns molecular dynamics simulations of wild
type and K146Q Eg5 complexed with ADP and bound to tubulin heterodimers.
Analysis across replicates was used to predict statistically significant differences in
residue-wise interactions and energetics. Significant changes in residue-residue
interactions associated with the K146Q mutation are evident for two functionally
important domains. The first involves structures that are responsible for generating
the “power stroke”, and they include the neck-linker (NL), the cover-strand (CS),
Loop 13, and b7 (Figure 2-1 A, B). The K146Q mutation shortens distances and
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enhances interactions between the CS and the NL, the CS and Loop 13, and the NL
and b7. These changes are summarized in Figure 2-1 B (red labels). Other charged
residue interactions, including those between E14 (CS) and E92 (a1), the N-terminal
portion of a1 with the neighboring Loop 13/b8, and E20 (b1) to R329 (Loop13) are
also enhanced. In aggregate, these explain why we find that the NL spends a
significantly greater proportion of time in the docked orientation in the mutant
compared to wild type (72% of simulation frames versus 40%, Figure 2-3 A) and they
are a consequence of the small displacements of a1 that result from removing the salt
bridge between D91 (a1) and K146 (a2b). Thus, while the average distance between
K146 to D91 is 3.6 ± 1.5 Å in wild type Eg5, the corresponding Q146 to D91 distance
in the K146Q mutant is 4.9 ± 1.2 Å, with a corresponding 5.3 kcal/mol decrease in
interaction energy.
The second domain includes structures that bind and coordinate
nucleotide39luorophog Loop 9/switch 1, the P-loop, b1/helix a0, and Loop 14
(Figure 2-1 A). The largest change is seen for Loop 9/switch 1. The closed
conformation for this loop, which is necessary for ATP hydrolysis, is more frequently
seen in the mutant (75% of simulation time versus 18%); and this leads to shorter
average distances to the P-loop, illustrated by a decrease in the G108 (P Loop) to
N229 (switch 1) distance of 3 Å. Distances between switch 1 and switch 2, and
between switch 1 and Loop 14/a6 also decrease in the mutant Figure 2-1 B (see blue
labels). The K146Q mutation also causes the a0 helix to move away from Loop 2a
and toward switch 1, Loop 14, and a6 (Figure 2-3 B). Other inter-residue distances,
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including W127 (Loop 5) to E215 (a3), D118 (Loop 5) to bound nucleotide, and
D186 (Loop 8) to R312 (Loop 12), are also significantly shorter in the mutant.
Additional simulations of acetyl lysine at position 146 revealed equivalent enhanced
catalytic site closure, with the switch 1 region exhibiting a closed conformation for
70% of simulation time versus 18% for wild type, and less dramatic, but still
significant (p < 0.05) a1, a2b and NL distance differences leading to enhanced
docking of the NL (71% of simulation time versus 18% in wild type). Overall these
results indicate that the K146Q mutation results in dynamic perturbations both
locally—reflected in an increase in the a1 to a2 distance—and at more distant
functional regions, which appear to collectively enhance coordination of the structural
states of the NL with switch 1 regions.

Figure 2-3: Distance distribution histograms. Histograms of distance distributions of b7 to the necklinker (A) and a0 to switch I (B) during molecular dynamics simulations. Values plotted, and their listed
average, were obtained from the last half of all simulation replicates.

40

Meta-dynamics simulations were used to further probe the energetic effects of
the K146Q mutation on NL docking. Residue G96 at the C-terminal end of a1 forms
a hydrogen bond with residue N366 in the NL, and this interaction is important for
NL docking in kinesin 1 (Hwang, Lang, & Karplus, 2008). We therefore chose the
G96-N366 distance as a collective variable for characterizing the free energy of NL
docking via 700 ns meta-dynamic simulations (Figure 2-1 C). The resulting free
energy profiles indicate that the K146Q mutation favors formation of this hydrogen
bond compared to wild-type, with a relative total system free energy difference of 8.8
kcal/mol for docked versus undocked (Figure 2-1 C, arrow). This predicts that NL
docking should be energetically more favorable in the K146Q mutant and further
highlights the structural importance of the salt bridge between a1 and a2b for
modulating NL docking. Taken together, our simulations imply that a major
consequence of K146 acetylation is enhanced conformational coupling between
switch 1 and the NL. In our previous study (Muretta et al., 2015), we demonstrated
that we could measure how conformational coupling between switch 1 and the NL
changes during the motor mechanochemical ATPase cycle through use of a novel
combination of transient kinetics and time resolved fluorescence, termed TR2FRET.
We therefore applied this technique in order to experimentally test the predictions
made by molecular dynamics.

TR2FRET measures the kinetics and thermodynamics of NL docking and Sw1
closure in Eg5.
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In our prior study (Muretta et al., 2015), we used TR2FRET to measure the
transient changes in mole fraction of docked NL and closed Sw1 for Eg5 and kinesin
1 that occur after mixing with nucleotide. We found that while NL docking and Sw1
closure are tightly coupled in kinesin 1, they are less so in Eg5—a finding that
explains many of the functional differences between these two motors. Our
molecular dynamics studies suggest that the K146Q mutation enhances the
conformational coupling of the NL to Sw1 in a manner reminiscent of kinesin 1. We
therefore generated two monomeric Eg5 constructs, each containing the K146Q
mutation, that have pairs of reactive cysteines for labeling with a FRET donor
(AEDANS) and acceptor (DDPM). The first, Eg5NLK146Q, has been described
above. The second, Eg5Sw1K146Q, has reactive cysteines in the Sw1 Loop (residue
228) and in a reference point (residue 30), along with the K146Q acetylation mimetic
substitution.
We mixed donor only (AEDANS) or donor + acceptor (AEDANS/DDPM)labeled Eg5NLK146Q and Eg5Sw1K146Q + MTs with ATP in the stopped flow and
then acquired TR2FRET waveforms during subsequent ATP binding, hydrolysis,
and MT-dissociation.

Figure 2-4 illustrates representative waveforms for MT

complexes of Eg5NLK146Q (panel A) and Eg5Sw1K146Q (panel B) following mixing
with 2 mM ATP. As in our prior study (Muretta et al., 2015), we performed our
experiments at 10oC in order to observe all phases of the resulting fluorescence
transients. The acquired waveforms were analyzed as described previously (Muretta
et al., 2015) to determine the mole fractions of docked versus undocked NL in
Eg5NLK146Q and closed versus open Sw1 in Eg5Sw1K146Q as a function of time
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after mixing with ATP (Figure 2-4, panel C and D respectively). The mole fraction
transients for Eg5NLK146Q were fit by minimal multi-exponential functions and the
dependence of the rate constants and pre-exponential amplitudes evaluated as
function of [ATP] or [ADP]. The mole fraction transients for Eg5Sw1K146Q were
modeled by kinetic simulation (described below) as in our previous work (Muretta
et al., 2015).
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Figure 2-4: TR2FRET of ATP binding to rigor Eg5K146 or Eg5K146Q bound to MTs. A, B.
Representative waveforms after mixing 2 mM ATP with 1 µM AEDANS/DDPM-labeled
Eg5NLK146Q (A) or Eg5Sw1K146Q (B) bound to 2.5 µM MTs. C, D. Mole fraction of docked
NL (C) or closed switch-1 (D) for MT bound K146 (blue) or K146Q (red) samples as in A and
B. Data in were C fit by bi-exponential functions (black lines) while data in D were fit by a
sequential 4-step kinetic mechanism. E. Rate constant versus [ATP] for the fast (closed) and slow
(open) phases of bi-exponential fits to mole fraction transients as in C for Eg5NLK146 (blue) or
Eg5NLK146Q (red). F. Rate constant versus [ATP] for the fast phase (closed) of the mole fraction
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transients as in D for Eg5Sw1K146Q fit by a single-exponential function over the first 50
milliseconds, or a single-exponential function over a range from 50 milliseconds to 300
milliseconds. Data in E and F are fit to hyperbolic functions. Conditions: 25 mM HEPES, pH
7.50, 50 mM potassium acetate, 5 mM magnesium acetate, 1 mM EGTA, 10oC. n = 3–9.

In Eg5NL, both ATP binding and subsequent hydrolysis induce NL docking,
and, we find the same is true for Eg5NLK146Q. However, the K146Q mutation does
alter NL movement in two ways. First, it accelerates NL docking during the ATP
binding step three-fold (Figure 2-4 E). Second, it increases the fraction of motors
that dock their NL during this step, from 50% to 76%. Combined, these effects
should make force production more rapid and complete with initial ATP binding. In
our prior study, we also found that ATP binding alters the conformation of Sw1 by
means of a four-step kinetic scheme (Muretta et al., 2015):

where M stands for the microtubule-bound motor, subscripts c and o stand for closed
and open Sw1 conformations, respectively, T is ATP, D is ADP, and Pi is inorganic
phosphate. We were able to fit our data for both Eg5 and kinesin 1 by assuming: (1)
both closed and open Sw1 conformations are populated in the absence of nucleotide
and are in rapid equilibrium; (2) ATP only binds to the open state; (3) ATP
hydrolysis requires Sw1 to close; and (4) phosphate release is associated with Sw1
reopening. One of the major differences between Eg5 and kinesin 1 is in the value
of K4, the equilibrium constant for Sw1 reopening after ATP hydrolysis, which is
nearly 10-fold larger in Eg5 than in kinesin 1. This implies that after hydrolysis, the
open and closed conformations of Sw1 in Eg5 are in a slow equilibrium that
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markedly favors the open state, while in kinesin 1, they are in a more rapid
equilibrium where both open and closed states are roughly equally populated. When
we applied our simulation to fit the corresponding data for Eg5Sw1K146Q (Figure 24 D) we found that this mutation had no effect on steps 1 and 2, and only a minor
effect on step 3. However, it reduces K4 to a value essentially identical to that for
kinesin 1. This indicates that a major effect of the mutation is to significantly
increase the fraction of motors with Sw1 in a closed conformation after ATP
hydrolysis. The value of k4 at the temperature of our experiments (10oC) is slightly
more than twice the rate constant for phosphate release measured at a higher
temperature (7.9 ± 0.9 sec-1 at 20oC (Behnke-Parks et al., 2011)), implying that this
difference is considerably greater than two-fold when comparing rate constants at
the same temperature. We conclude from this that Sw1 reopening precedes the
phosphate release step.
In our prior study (Muretta et al., 2015), we examined how Sw1 and the NL
are coordinated in Eg5 and kinesin 1 by monitoring the coupling ratio, defined as
the mole fraction of docked NL divided by the mole fraction of closed Sw1, and
calculated it from the evolution of corresponding TR2FRET waveforms over time
after mixing with ATP. A ratio of 1.0 implies tight NL/Sw1 coupling. For kinesin 1
this ratio is 0.99 in the absence of nucleotide (Muretta et al., 2015). Mixing with 2
mM ATP causes the ratio to rise (Figure 2-5 A, light gray, data reproduced from
(Blee et al., 2015)) and fitting to a single-exponential rate equation (solid black line)
yields a rate constant of 32.3 ± 0.5 sec-1 and a final coupling ratio of 2.1. By contrast,
the coupling ratio for Eg5 (Figure 2-5 A, dark gray, reproduced from (Blee et al.,
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2015)) is 0.29 in the absence of nucleotide, and fitting the data subsequent to mixing
with 2 mM ATP yields a rate constant of 3.8 ± 0.1 sec-1 and an extrapolated coupling
ratio of 7.9 (solid black curve). The rate constants for both kinesin 1 and Eg5 are
consistent with the values of kcat at the temperature of this experiment (10oC). We
interpret this to mean that for kinesin 1, Sw1 and the NL are tightly coupled through
ATP binding and hydrolysis—when NL docking occurs—and remain moderately
coupled with entry into the steady state. By contrast, Sw1 and the NL for Eg5 are
poorly coupled in the absence of nucleotide. Coupling improves with ATP binding
and hydrolysis, but Sw1 and the NL become markedly uncoupled again with entry
into the steady state. We performed a similar analysis on the K146Q mutant, as well
as on a second mutant (K146M), which provides an additional way of testing the
importance of the a1-a2b salt bridge in Eg5 function; and as in our prior study
(Muretta et al., 2015), plotted the evolution of the coupling ratio over time from the
TR2FRET waveforms that are illustrated in Figure 2-4. The plot of coupling ratio
versus time after mixing with 2 mM ATP is depicted in Figure 2-5 B for the K146Q
(red) and K146M (magenta) constructs. Coupling ratios for these two constructs in
the absence of nucleotide are 0.63 and 1.02 for K146Q and K146M, respectively.
After mixing with ATP, this increases for both mutants, and fitting to the same rate
equation (solid black lines) reveals rate constants and final coupling ratios of 4.2 ±
0.1 sec-1 and 3.4 for K146Q, and 4.1 ± 0.1 sec-1 and 2.1 for K146M. We interpret
these data to imply that two Eg5 mutations that abolish the a1-a2b salt bridge
enhance NL/Sw1 coupling to levels that resemble kinesin 1.
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Figure 2-5: Transient changes in NL/Switch-1 coupling. A. Plot of the coupling ratio, defined as
the ratio of mole fraction of docked NL to mole fraction of closed switch-1, versus time after mixing
Eg5 (dark gray) kinesin 1 (light gray) Sw1 and NL FRET-labeled constructs with 2 mM ATP (data
reproduced from (Blee et al., 2015)). A ratio of 1.0 implies tight conformational coupling of the NL
to Sw1, with deviation in either direction implying looser coupling. Fitting to a single exponential
rate equation (solid black lines) yields rate constants and extrapolated coupling ratios described in
the text. B. Corresponding experiments for Eg5K146Q (red) and Eg5K146M (magenta). For both
constructs, the coupling ratio resembles kinesin 1 more than unmodified Eg5.

In kinesin 1, the position of the NL regulates the kinetics of ATP
hydrolysis—a process that depends in turn on the structure of Sw1 (Clancy, BehnkeParks, Andreasson, Rosenfeld, & Block, 2011). In such a highly coupled system, load
could thereby regulate the ATPase cycle of this motor. Since the K146Q mutation
increases the conformational coupling between Sw1 and the NL, we might expect
that it would also alter the load dependence of the motor mechanochemical ATPase
cycle. We therefore next examined how load affects the mechanics of the K146Q
acetylation mimetic at the single-molecule level.

Single-molecule mechanics reveal that the K146Q mutation alters motor
function under load.
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The function of single Eg5 motors was characterized via a standard optical
trap bead assay (Block, Goldstein, & Schnapp, 1990; Jun, Tripathy, Narayanareddy,
Mattson-Hoss, & Gross, 2014; Q. Li, King, Gopinathan, & Xu, 2016). Because wild
type Eg5 run-lengths are short, it is difficult to turn off the optical trap before bead
detachment. Thus, to characterize unperturbed motion, we used the weakest trap
possible (<0.0005 pN nm-1) and left it on, allowing Eg5-driven beads to walk out of
the trap. The maximum force these motors experienced was about 0.07 pN, at a
position 150 nm from the trap center. Higher trap strengths were then used to
characterize the response of the motors to load. We first tested a dimeric construct
(“D”), consisting of the cys-light Eg5 motor domain, neck linker, and neck coiledcoil (human Eg5 residues 1-402), fused to the kinesin 1 hinge and coiled coil (human
kinesin 1 residues 372-560). As noted in prior studies (Düselder, Thiede, Schmidt,
& Lakämper, 2012; Lakämper et al., 2010), fusion to the kinesin 1 coiled coil tail is
necessary to generate dimeric constructs containing the Eg5 motor domain that
produce appreciable run lengths. We compared the in vitro single-molecule
mechanics of D to corresponding studies of a dimer that also contains the K146Q
mutation (referred to herein as DK146Q). Consistent with prior studies (Muretta et
al., 2015; Valentine, Fordyce, Krzysiak, Gilbert, & Block, 2006b), we observed that D,
like a wild type Eg5 dimer, is quite insensitive to load, with single motors moving
through a moderate-power optical trap at approximately constant velocity, even
though load increases as the motor moves away from the trap center (Shojania
Feizabadi et al., 2015). Here we carried out a more systematic set of measurements
to determine the force-velocity curves for D (Figure 2-6 A and Figure 2-7 A, B). We
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found that D maintains an approximately constant velocity until ~2.25 pN. It is able
to advance under higher load, although velocity decreases as the load increases
beyond 2.25 pN (Figure 2-6 A). By contrast, the K146Q mutation increases the
sensitivity to load, and a significant velocity decrease occurs by 1.75 pN, and
continues to decrease more substantially above this force. While moving quite
slowly (Figure 2-6 A), the K146Q mutation also allows the motor to access higher
forces. Overall, the distribution of force production is shifted to higher forces for the
K146Q motor (Figure 2-6 B), and the durations of force production are increased
even more, relative to the wild-type. We think several effects contribute to this.
First, the decreased probability of detachment leads to achievement of higher forces
and longer runs. Second, the slower velocity under load increases the duration of
runs. Third, the increased stall probability and duration of stalls both contribute to
longer periods of force generation. Figure 2-6 B depicts the histogram from the‘'bes’'
events, which will undercount the short duration events. We note that short runs,
especially those with lower force production, are likely to be undetected, so the actual
single-molecule experimental data likely contains more short events than are detected
experimentally.
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Figure 2-6: Single-molecule force-velocity curves for dimeric Eg5 constructs. A. Force-Velocity
curves from experimental single-molecule data of D and DK146Q in bead assays. Compared to the
D dimer, the K146Q-modified dimer demonstrates increased sensitivity to load, with a slower
velocity at all loads tested. B. Maximum forces and durations for D and DK146Q single motorcontaining beads (best 15 traces from each single motor-containing bead). Overall, the distribution of
force production is shifted to higher forces for the K146Q motor C. Stalling probabilities for D and
DK146Q. D. Stall durations for D and DK146Q single motor-containing beads.
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Figure 2-7: Force velocity relationship and detachment probabilities for dimeric Eg5 constructs. A.
Single molecule force-velocity data with fits, for D1, D1K146Q, D2, and D2K146Q. Data were fit to an
exponential force velocity relationship. B. Detachment probability as a function of applied load, for single
motor beads driven by D1, D1K146Q, D2, and D2K146Q.

It has previously been shown (Kunwar, Vershinin, Xu, & Gross, 2008; Mallik,
Petrov, Lex, King, & Gross, 2005) that sensitivity of velocity to load leads to optimal
load sharing. In a team of such motors moving under load, the leading motors feels
increased force and slow down, allowing the trailing motors to catch up. This
improves load sharing and system performance, assuming the forward motors do not
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detach prematurely. Consequently, we next examined the effect of load on the Eg5
detachment probability. We found that for any given load, DK146Q has a lower
probability of detachment than D (Figure 2-7 B). We next examined the effect of the
K146Q mutation on stall propensity and duration. To identify stalls, we used a 100
millisecond minimum cutoff, and less than or equal to 0.5 pN change in average
force. Statistical distributions of observed stalls suggested that DK146Q was much
more likely to stall (Figure 2-6 C), and stalled for a much longer duration (Figure 26 D) than D. We also used a set of automated velocity-only criteria, where we looked
at smoothed velocities of individual traces as a function of load and determined the
percentage of such traces whose velocity went below 20 nm/sec at that load. At each
load, we observed more extremely low-velocity traces for the K146Q mutant. Thus,
as well as decreasing the probability of detachment under load, the K146Q mutation
increases stall probability and duration, as well as the overall duration of force
production (Figure 2-6 C, D). Since analyzing runs that display stalls potentially
introduces a selection bias, we also compiled statistics on all recognizable runs,
using a 1 pN cut off to avoid noise. The presence of the K146Q mutation shifts the
entire population of events to higher forces of longer mean duration. In summary,
our data implies that Eg5 motors acetylated at K146 are less likely to fall off the MT
while under load and more likely to maintain higher forces for longer durations—
features that would improve the summation of forces generated from multiple
motors in an ensemble, enhancing overall system function.
To better understand how acetylation could affect motor function at the
ensemble level, we employed Monte-Carlo simulations with motor parameters
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chosen from our single-molecule measurements (Figure 2-8). These revealed
improved ensemble force production in the K146Q mutant, reflected in larger mean
forces, longer duration events, and an improved ability to escape from a fixed
position optical trap (Figure 2-8). This effect is progressively enhanced as the
number of motors increases (Figure 2-8). During metaphase, Eg5 works in large
ensembles in a “tug of war” with cytoplasmic dynein. Our results suggest that in the
presence of opposing load, Eg5 acetylation will cause the motor to slow down—
unlike wild type Eg5. This effect, along with its enhanced ability to stall, means that
acetylated Eg5, even when present in low concentrations, will act as a “brake” by
interfering with non-acetylated Eg5 motors. We therefore predict that expression of
low molar fractions of the K146Q acetylation mimetic in cells will slow spindle pole
separation during metaphase. To test this, we next examined the effect of the K146Q
mutation on spindle dynamics in cells.
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Figure 2-8: Simulated forces and escape percentages for dimeric Eg5 constructs. A. Monte Carlo
simulations of forces as a function of increasing number of D and DK146Q dimers on a bead moving
in a fixed strength optical trap (4.5pN/100nm). Simulations are carried out using forces and
detachment probabilities derived from single motor experiment (Figure 2-6). Notice the shifts
towards higher values for the K146Q mutant. B. Escape percentages from a fixed strength optical
trap, simulated using forces and detachment probabilities derived from single motor experiment
(Figure 2-6).
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Expression of the K146Q acetylation mimetic reduces spindle pole separation
velocity in mitotically active cells.
To assess the functional consequence of K146 acetylation, mCherry (mCh)tagged full length wild type or K146Q Eg5 protein was expressed in HeLa cells. Based
on quantitative Western blot analyses, we estimate that mCh-tagged Eg5 proteins were
present at ~25% of the level of endogenous Eg5 (Figure 2-9 A, B). Importantly, both
WT and K146Q versions of the motor localized to the mitotic spindle in metaphase cells
(Figure 2-10 A). Measurements of mCh fluorescence along the pole-to-pole axis
indicated that the spindle distribution of mCh-Eg5 K146Q did not differ from that for
mCh-Eg5 WT (Figure 2-10 B). To compare the functional activity of WT and K146Q
Eg5, HeLa cells expressing GFP-tubulin and equivalent levels of mCh-Eg5 WT or mChEg5 K146Q were treated with the Eg5 inhibitor monastrol, resulting in mitotic arrest and
the formation of monopolar spindles (Figure 2-10 C). Bipolar spindle formation was then
measured following monastrol washout (Figure 2-10 C, D). Spindle lengths at the
completion of pole separation were similar in cells expressing mCh-Eg5 WT or K146Q
(11.02 ± 0.29 µm WT, 10.87 ± 0.26 µm K146Q, mean ± SEM, Figure 2-10 E). However,
pole separation occurred at a significantly slower velocity in cells expressing mCh-Eg5
K146Q (0.84 ± 0.07 µm/minute) than in cells expressing mCh-Eg5 WT (1.35 ± 0.15
µm/minute, Figure 2-10 F, p=0.0009, unpaired t-test). Furthermore, expression of mChEg5 WT did not alter pole separation velocity compared to control cells expressing mCh-
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tubulin (Figure 2-9 C). Taken together, these data indicate that low levels of Eg5-K146Q
in mitotic cells can act as a brake to slow spindle pole separation.

Figure 2-9: Expression of mCherry-Eg5 in HeLa cells. A. Expression levels of mCherryEg5 WT or K146Q were compared to endogenous Eg5 levels by Western blot. B. Densities of
Eg5 and mCh-Eg5 bands were compared in cells from three independent transfections. On
average, 21.3 ± 1.0% and 21.7 ± 1.7% of total Eg5 protein obtained from cells transfected with
mCh-Eg5 WT or K146Q, respectively, was mCh-Eg5. Given that 80.8% and 78.4% of cells
imaged after transient transfection with mCh-Eg5 WT or K146Q, respectively, were positive
for mCherry signal, on average an mCh-positive cell would contain approximately 26.4%
mCh-Eg5 WT or 27.7% mCh-Eg5 K146Q of total Eg5. C. Expression of mCherry- Eg5 WT
does not alter spindle pole separation velocity when compared to expression of mCherrytubulin (p=0.89, unpaired t-test).
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Figure 2-10: Expression of mCh-Eg5 K146Q slows pole separation during spindle formation. A.
Full length mCh-Eg5 WT and mCh-Eg5 K146Q (red) localize to the mitotic spindle (green). Scale bar =
5 µm. B. mCh-Eg5 WT (upper) and mCh-Eg5 K146Q (lower) are similarly distributed along the length of
the spindle (n=43 cells per mCh-Eg5 construct from three independent experiments). C. Stills from
representative time-lapse movies of cells expressing GFP-tubulin and the indicated mCh-Eg5 construct.
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Time stamps indicate time after monastrol washout. Scale bar = 5 µm. D. Plot of mCh fluorescence levels
for mCh-Eg5 WT and mCh-Eg5 K146Q expressing cells analyzed in E and F. E. Plot of final spindle
length at the conclusion of pole separation following monastrol washout (n=19 mCh-Eg5 WT, n=29 mChEg5 K146Q cells from four independent experiments, p=0.71 unpaired t-test). F. Plot of pole separation
velocity in cells expressing mCh-Eg5 WT and mCh-Eg5 K146Q (1.35 ± 0.15 mean ± SEM WT versus 0.84
± 0.07 K146Q, n=19 WT, n=29 K146Q, p=0.0009 unpaired t-test).

Acetylation of K146 in Eg5 is present in low abundance in tumor cell lysates
and can occur non- enzymatically.
Although acetylation of K146 in Eg5 has been repeatedly observed in the
literature (Choudhary et al., 2009; Nalawansha et al., 2017; Sol et al., 2012), we wished
to determine how abundant this modification is in interphase cells. We therefore
generated

lysates

from

two

primary

patient-derived

glioma

xenografts,

immunoprecipitated Eg5, treated the SDS-PAGE-resolved Eg5 band to tryptic and
chymotryptic digestion, and subjected the resulting peptides to LC-MS/MS analysis.
The resolved peptides covered approximately 65-85% of the total protein sequence.
In particular, a chymotryptic digest revealed a low abundance peptide (∼0.6%)
whose mass is consistent with the acetylated form of the EKLTDNGTEF peptide,
and the mass difference between the y9 and y8 ions in this spectrum is consistent
with acetylation at K146.
There are at least 17 lysine acetyl transferases (Allis et al., 2007) that catalyze
the nucleophilic attack by the e amino group of protein lysines onto acetyl CoA to
generate the acetylated PTM. However, lysine acetylation can also occur nonenzymatically in cells (Pietrocola, Galluzzi, Pedro, Madeo, & Kroemer, 2015; Wagner
& Hirschey, 2014; Wagner & Payne, 2013). We wished to expose Eg5 to conditions
conducive to non-enzymatic acetylation as a means to determine if K146 is
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sufficiently surface exposed for this modification to occur and to further support our
in vivo finding. We therefore incubated dimer D with 1 mM acetyl CoA at room
temperature at pH 7.5 for 12 hours and subjected the material to LC-MS/MS
analysis, comparing our results to a control D sample that was not exposed to acetyl
CoA. D contains the first 401 residues from Eg5, and we concentrated our analysis
on this portion of the chimera. Samples were subjected to tryptic and chymotryptic
digestion, and the resulting peptides covered approximately 80-95% of the protein
sequence. While the first 401 residues of D contain 31 lysines, we could detect
acetylation in only 10 of these, including K146, which was identified in two
peptides. No acetylated peptides could be detected in the control samples. The
Kacetyl/K ratio for peptides containing K146 was approximately 2.5%.

2.5 DISCUSSION
Multiple elements of the cytoskeleton are subject to post-translational
modifications.
Components of both the actomyosin and microtubule cytoskeleton are
frequently modified post-translationally (Buss & Kendrick-Jones, 2008; Skoumpla,
Coulton, Lehman, Geeves, & Mulvihill, 2007; Terman & Kashina, 2013). The role of
PTMs in regulating microtubule dynamics and function plays a central role in
regulating microtubule function and has been referred to as the “tubulin code”
(Janke, 2014; Sirajuddin et al., 2014; I. Yu et al., 2015). By comparison, less is known
about the roles that PTMs have on kinesin function, and even less still about their
effects on motor function. In kinesin 1, serine 175, at the amino terminal end of the
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a3 helix, can be phosphorylated by the JNK3 kinase, which reduces stall force by
20% (DeBerg et al., 2013). A recent report has also described src-mediated
phosphorylation of tyrosine residues in the motor domain of Eg5, including those
located in the a3 helix and in Loop 5—in close proximity to residue K146 (Bickel et
al., 2017). However, these studies do not provide insight into how PTMs alter motor
mechanochemistry. Furthermore, these modifications all reduce motor function—
acting in essence as “on/off” switches. In our prior studies of Eg5 (Behnke-Parks et
al., 2011; Muretta et al., 2015), we demonstrated that Loop 5, which splits the a2 helix
into a2a (N-terminal) and a2b (C-terminal), functions in part by regulating the
conformational coupling between the catalytic site and the NL, and that a mutation
at the junction of Loop 5 with a2b (P131A) had profound effects on this coupling.
This motivated us to look for a well-documented PTM in a2b whose local structural
effects could be predicted, and this in turn led us to examine the mechano-chemical
consequences of lysine 146 acetylation.
While acetylation has long been recognized as a PTM of histones (Forsberg
& Bresnick, 2001; Jenuwein & Allis, 2001; Marmorstein & Zhou, 2014; Shilatifard,
2006; Verdone, Caserta, & Di Mauro, 2005), it has been more recently appreciated
that it also occurs in components found throughout the cell, including transcription
factors, metabolic enzymes, and structural proteins (Blee et al., 2015; Kouzarides,
2000; Menzies et al., 2015). Our proteomics results demonstrate that acetylation of
K146 can be detected in low abundance in non-synchronized glioma cells. They also
demonstrate that in the motor domain and neck coiled coil of Eg5, only about 30%
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of lysine residues—including K146—are sufficiently reactive to undergo nonenzymatic acylation by acetyl CoA. In this study, we did not determine which lysine
acetyl transferases are responsible for K146 acetylation or to what degree nonenzymatic acetylation occurs intracellularly. However, our results demonstrate that
K146 acetylation can occur non-enzymatically, and if this turns out to be
physiologically relevant, it raises the possibility that regulation of this PTM may
occur at the level of deacetylases. The low abundance of acetylated K146 that we
observe in non-synchronized tumor cells suggests either that: 1) low levels of
acetylated K146 Eg5 are sufficient to affect ensemble motor function—consistent
with our finding that modification of only a minority of Eg5 is sufficient to
significantly slow spindle pole separation; or, 2) that acetylation is a cell cycle
regulated event.

Disrupting the a1-a2b salt bridge in Eg5 enhances allosteric communication
between the catalytic site and the NL.
Our molecular dynamics simulations predicted large-scale effects from
eliminating the a1-a2b salt bridge. This includes increased interactions and
conformational couplings between a1, b7, the CS, L13, and the NL, as well as
between a0, the P-loop, and switch 1 (Figure 2-1). In particular, a cluster of charged
residues including E92 (a1), K17 (CS), K362 (NL) and R329 (Loop 13) display
increased interactions upon salt-bridge disruption that together maintain the CS and
NL in a state that is more frequently coordinated and docked. Metadynamics
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simulations also revealed an enhanced NL docking potential for the mutant (Figure
2-1 C). In concert with these changes, switch 1 more frequently adopts a closed
conformation due primarily to increased Loop 9, a0 and P-Loop coordination.
Collectively these results suggest that acetylation of K146 produces a motor where
nucleotide binding/hydrolysis and NL docking are tightly coupled. Loose coupling in
unmodified Eg5 would prevent one motor from acting as a “brake” that could slow
or stop other motors in the ensemble. However, in some circumstances Eg5 tonically
opposes the effects of cytoplasmic dynein, and under these conditions, there may be
a need for Eg5 to act more like kinesin 1—stalling rather than dissociating. Utilizing
TR2FRET, we have found both the K146Q and K146M acetylation mimetics
accelerate ATP-induced NL docking 2.2-3.4-fold (Figure 2-4) and enhance the mole
fraction of closed Sw1 after ATP hydrolysis (Figure 2-4). This ensures that Sw1 and
the NL remain conformationally coupled through ATP hydrolysis and Pi release,
when the power stroke occurs, and indicates that K146 acetylation makes Eg5
resemble kinesin 1. In a prior study (Muretta et al., 2015), we observed that when Sw1
in Eg5 is closed, it stabilizes switch 2 into a strong MT-binding conformation. The
increased mole fraction of closed Sw1 that we observe with the K146Q mutant
following ATP hydrolysis (step K4, above) implies that acetylation should enhance
the fraction of the time the motor is strongly bound to the MT. Taken together, our
molecular dynamics and TR2FRET studies predict that the consequences of K146
acetylation should be particularly apparent under load, and our single-molecule
mechanics studies confirm this.
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Unlike other kinesin PTMs, K146 acetylation produces a “gain in function”
which enhances Eg5’s ability to work in teams to overcome dynein-produced
opposing load. At the single-molecule level, there are four qualitative changes. First,
detachment under load is decreased (Figure 2-7 B), so single motors reach higher
forces (Figure 2-6 A, B). Second, the probability to transition into a “stalled” state,
increases 3-fold (Figure 2-6 C). This favors multiple-motor load sharing. Third, the
duration of stalls is longer (Figure 2-6 D), which means that acetylated motors
remain attached and provide other motors more time to attach and contribute to
ensemble function. Finally, even when such motors do not stall, they are more
slowed down by load (Figure 2-6 A), which means that they spend more time
supporting higher loads before detaching. These effects lead to better ensemble
motor function under load, and the capabilities that they provide Eg5 are remarkably
similar to those provided for dynein by its cofactors NudE and Lis1. NudE and Lis1
alter dynein detachment kinetics under load, with individual dynein motors holding
on to microtubules longer, allowing better group function as motors share load, and
enabling the complex to transport a cargo against significant opposition (McKenney,
Vershinin, Kunwar, Vallee, & Gross, 2010; Reddy et al., 2019). Remarkably,
acetylation of K146 does essentially the same thing for Eg5. On average, dynein with
Lis1 and NudE holds on to MTs 60% longer before detaching, compared to dynein
alone (McKenney et al., 2010), an effect of comparable magnitude to what we
observed in the K146Q mutation. This appears to be a form of convergent evolution,
and it implies that the ability to modulate a motor’s performance under load is an
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important variable for multiple molecular motors, regardless of their evolutionary
source.

Disrupting the a1-a2b salt bridge alters Eg5 mitotic function.
By increasing conformational coupling and the lifetime of strong MTbinding states, the K146Q acetylation-mimetic mutation alters the force velocity
landscape of Eg5 so as to enhance motor efficiency in ensembles, reduce velocity in
the presence of opposing load, and increase the probability of stalling. This would
enable modified Eg5 to act as a “brake”, slowing centrosome separation by
generating drag force against unmodified Eg5 motors. Spindle function involves a
complex orchestration of multiple motors that during at least part of the spindle
lifetime work in opposition to each other, and fine-tuning of motor mechanical
output is necessary to fine tune this balance of forces. While ubiquitination and
proteolysis of mitotic kinesins is a well-recognized form of regulation, this seems
unlikely to enable the cell to adjust motor output on the moment-by-moment basis
that may be needed to balance opposing forces. Our biophysical results predict that
acetylation of only a fraction of Eg5 is capable of slowing centrosome separation,
and we observed this in our time-lapse microscopy studies (Figure 2-10).
Eg5 is a member of the kinesin 5 family of mitotic motors, and we note that
at least one other member of this family—BMK-1 from C. elegans—has also been
reported to act as a spindle brake (Saunders, Powers, Strome, & Saxton, 2007). Unlike
Eg5, BMK-1 is not essential for mitosis or normal development.
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Its deletion

accelerates spindle pole separation over two-fold, implying that it provides a force
that opposes spindle elongation. Alignment of the BMK-1 sequence with that for
Eg5 reveals that the a1-a2b salt bridge seen in the latter is absent in the former. In
particular, Eg5 residues D91 (a1) and K146 (a2b) replaced in BMK-1 by residues
K83 and Q136, respectively. Our results, in conjunction with this prior work,
implies that there is an evolutionarily conserved need for some kinesin-5 motors to
act for at least part of the cell cycle as a “brake”; and that this need in some organisms
is served by synthesis of a non-essential kinesin 5, while in others it is served through
a reversible PTM that provides cells with functional flexibility.

K146 acetylation highlights the importance of the a1-a2b salt bridge in tuning
the mechanochemical properties of kinesins.
That both the K146Q and K146M mutations have very similar effects on
conformational coupling implies that the effects of these mutations—and of the
K146 acetylation which these mutants mimic—are due to loss of the a1-a2b salt
bridge, and not to side chain interactions requiring acetyl-lysine. The increased
conformational coupling that we observe with both the mutations are largely a result
of the 3-fold acceleration of NL docking, which allows this process to track with
Sw1 closure. Our work therefore leads us to predict that NL docking should be
relatively slow for kinesins with an a1-a2b ionic bond and appreciably faster in
kinesins that lack it. This prediction is consistent with the limited set of data on the
kinetics of NL docking, which shows that it is slow in both Eg5 (60-80 sec-1 at 20oC
(S. Rice et al., 1999)) and CENP-E (∼29 sec-1 at 20oC (Rosenfeld et al., 2009)). Both
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of these motors contain an a1-a2 salt bridge, with D91 and K146 in Eg5
corresponding to D72 and K116 in CENP-E (Garcia-Saez, Blot, Kahn, & Kozielski,
2004). By contrast, kinesin 1 is devoid of this ionic interaction (Kull, Sablin, Lau,
Fletterick, & Vale, 1996). We would therefore predict a priori that NL docking in
kinesin 1 should be faster than in wild type Eg5 or CENP-E; and in fact it is (>800
sec-1 at 20oC (Rosenfeld et al., 2003)). Critically testing the relationship between the
a1-a2b interaction and NL docking kinetics will require additional comparisons
to other kinesins. Two examples could serve as the basis for future studies.
First, we note that KIF15, another mitotic kinesin, is also devoid of an a1-a2 salt
bridge (Klejnot et al., 2014), and our results would predict that NL docking should
be rapid. Second, at least one other kinesin (KIF22) has a documented PTM in a2b
(J. V. Olsen et al., 2010; Rigbolt et al., 2011) — phosphorylation of T158,
corresponding to position 147 in Eg5. Phosphorylated T158 could make a salt bridge
with arginine 113, corresponding to residue D91 in Eg5. It seems likely that the
approach that we have utilized in our study of K146 acetylation in Eg5 should be
readily applicable to elucidate the consequences of altering the interaction between
a1 and a2 in these and other kinesins as well.

2.6 MATERIALS AND METHODS
Cell Culture and Transfections
HeLa cells were cultured in Minimal Essential Media-α supplemented with 10%
fetal bovine serum (Gibco). Cells were maintained at 37°C with 5% CO2. Transient
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transfections of plasmid DNA were performed via electroporation using a Nucleofector 4D
system (Lonza). Cells were plated onto 12 mm glass coverslips (Electron Microscopy
Sciences) for fixed cell immunofluorescence or 4-chamber 35 mm glass-bottom dishes
(Greiner Bio-One) for live cell imaging. Cells were fixed, imaged, or lysed approximately
48 hours after transfection.
Monastrol Washout
Cells were treated with 100 μM monastrol (Selleckchem) overnight (approximately
16 hours) prior to live cell imaging. Before beginning the washout assay, complete HeLa
media with 100 μM monastrol was replaced with 100 μM monastrol in CO2 independent
media (Gibco) supplemented with penicillin and streptomycin. Immediately prior to
imaging a given chamber, media with monastrol was removed and cells were washed four
times with 500 μL CO2 independent media. After washout, cell fields were imaged at 37°C
once each minute for the duration of pole separation (approximately 25 minutes).
Immunofluorescence
Cells were treated with 20 μM MG132 (Selleckchem) 2 hours prior to fixation.
Cells were fixed for 10 minutes in 1% paraformaldehyde (Electron Microscopy Sciences)
in ice-cold methanol (Thermo-Fisher). Cells were incubated with the following primary
antibodies for 1 hour at room temperature: mouse anti-α- tubulin (1:500, Sigma-Aldrich)
and rabbit anti-γ-tubulin (1:500, AbCam). Secondary antibodies conjugated to Alexa Fluor
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488 and 647 (1: 500, Life Technologies) were incubated for 1 hour at room temperature.
Cells were mounted in ProLong Gold with DAPI (Thermo-Fisher).
Microscopy and Image Analysis
Imaging was performed using a Nikon Ti-E inverted microscope controlled by NIS
Elements software (Nikon Instruments) with a Plan APO 60X/1.42 NA oil immersion
objective or APO 100X/1.49 NA oil immersion objective (Nikon Instruments), Spectra-X
light engine (Lumencore), and Clara CCD camera (Andor). Image processing was
performed using NIS Elements (Nikon Instruments) and ImageJ (NIH). Data analysis and
statistical comparisons were performed using Igor Pro (WaveMetrics) and Prism
(GraphPad Software).
Western Blotting
Cells were lysed in PHEM buffer (60 mM PIPES, 25 mM HEPES, 10 mM EGTA,
4 mM MgSO4) with Halt Protease and Phosphatase Inhibitor cocktail (Thermo-Fisher) on
ice. Lysates were extracted on ice for 10 minutes and centrifuged at 21,130 x g for 10
minutes. An equal volume of 4X Laemmli buffer (Bio- Rad) was added to the supernatant
and samples were heated to 95°C for 10 minutes. Lysates were separated by electrophoresis
on 4-15% Tris-glycine polyacrylamide gels (Bio-Rad) and transferred to polyvinylidene
fluoride membranes (Bio-Rad). Membranes were blocked in Odyssey blocking reagent
(LI- COR) diluted 1:1 in tris-buffered saline. Antibodies used for blotting were rabbit antiEg5 (1:1000, Novus NB500-181), mouse anti-glyceraldehyde-3-phosphate dehydrogenase
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(1:10,0000, Millipore MAB374), donkey anti-mouse IgG DyLight 680 conjugate
(1:10,0000, Thermo-Fisher), and goat anti-rabbit IgG DyLight 800 conjugate (1:10,000,
Thermo-Fisher). Membranes were incubated with primary antibodies overnight at 4°C,
washed, and incubated with secondary antibodies for one hour at room temperature.
Secondary antibody fluorescence was imaged using an Odyssey CLX system (LI-COR)
and quantified using Image Studio Lite (LI-COR).
Eg5 Immunoprecipitation
Eg5 was immunoprecipitated from primary patient-derived brain tumor xenografts
T4121 and T3691. Specimens were obtained in compliance with an Institutional Review
Board-approved protocol and maintained as subcutaneous xenografts in the flanks of NOD
scid gamma (NSG) mice. Animal studies were approved by the Cleveland Clinic
Foundation Institutional Animal Care and Use Committee and conducted in accordance
with the NIH Guide for the Care and Use of Laboratory Animals. Whole cell extracts were
made in lysis buffer (50 mM Tris pH 8.0, 120 mM NaCl, 0.5% NP-40) with phosphatase
and protease inhibitors (Roche; #11836153001 and #04906845001) for 45 minutes at 4°C
followed by centrifugation at 13,000 g for 15 minutes at 4°C. Samples underwent overnight
immunoprecipitation at 4°C using 1.2 mg of rabbit Eg5 antibody (Novus Biologicals;
#NB100-57514) that was pre-incubated with 40 mL Protein A/G PLUS-Agarose (Santa
Cruz Biotechnology, Inc.; sc-2003). Samples were washed four times with lysis buffer
before elution from the beads in Laemmli 2x concentrate sample buffer (Sigma, S3401)
and loading onto a 4-12% NuPAGE Bis-Tris precast gel (ThermoFisher Scientific,
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NP0321BOX). After electrophoresis, the gel was stained with GelCode Blue Stain Reagent
as per manufacturers instructions (ThermoFisher Scientific, #24590) and taken to the
Lerner Research Institute Mass Spectrometry Laboratory for Protein Sequencing for
proteomic analysis of post-translational modifications.
Non-Enzymatic Acetylation with Acetyl CoA.
Recombinant dimer D1 (Figure 2-6) was dialyzed into 25 mM HEPES, 50 mM
potassium acetate, 5 mM magnesium acetate, 1 mM EGTA, pH 7.5 and diluted in this
buffer to a concentration of 20 μM. Acetyl CoA (Sigma-Aldrich) was added to a 1 mM
final concentration, and the sample was incubated at room temperature for 12 hours.
Unreacted acetyl CoA was removed by gel filtration on Sephadex G25 prepacked columns
(GE Healthcare) and the samples were submitted to the Lerner Research Institute Core
Proteomics Facility for LC-MS/MS analysis.
Protein Digestion and LC-MS/MS Analysis
The Eg5 protein from glioma cells that was immunoprecipitated and fractionated
on SDS- PAAGE gel was subjected to an in-gel digestion. The bands were cut from the
gel, washed and de- stained in 50% ethanol -% acetic acid, and reduced with dithiothreitol
and alkylated with iodoacetamide. The gel pieces were then dehydrated in acetonitrile,
dried in a Speed-Vac, and digested by adding 5 μL of 10 ng/μL of trypsin or chymotrypsin,
in 50 mM ammonium bicarbonate, followed by incubation overnight. The peptides were
extracted into two portions of 30 μL each 50% acetonitrile, 5% formic acid. The combined
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extracts were evaporated to <10 μL in a Speed-Vac and then re-suspended in 1% acetic
acid to make up a final volume of ~30 μL for LC-MS analysis.
The D1 dimer protein was isolated and subjected to in-solution proteolytic
digestion. A 10 μg aliquot of the protein was dried down in a Speed-Vac and reconstituted
in 50 μl 6M urea buffer. The samples were then reduced with DTT and alkylated with
iodoacetamide. The reduced and alkylated samples were diluted with 100 μl 50mM
ammonium bicarbonate to adjust the pH. The samples were then digested with by adding
either trypsin or chymotrypsin in 50 mM ammonium bicarbonate at a ratio of 50:1
(Protein:Trypsin) and incubating overnight at room temperature. A second aliquot of
protease was added and digestion was allowed to proceed for an additional 6 hours. The
peptides that were formed were desalted using a PepClean c-18 spin column. The samples
were then reconstituted in 30 μL 1% acetic acid for LC-MS analysis.
The LC-MS system is a Finnigan LTQ-Obitrap Elite hybrid mass spectrometer
(ThermoScientific). The HPLC column is a Dionex 15 cm x 75 μm id Acclaim Pepmap
C18, 2μm, 100 Å reversed-phase capillary chromatography column. Five μL volumes of
the extract were injected and the peptides, eluted from the column in an acetonitrile, 0.1%
formic acid gradient at a flow rate of 0.25 μL/min, were introduced into the source of the
mass spectrometer on-line. The micro-electrospray ion source was operated at 2.5 kV. The
digest was analyzed using the data dependent multitask capability of the instrument
acquiring full scan mass spectra to determine peptide molecular weights and product ion
spectra to determine amino acid sequence in successive instrument scans. The LC-MS/MS
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data was searched with the programs Mascot and Sequest against both the full human
reference sequence database and specifically against the sequence of Eg5. The parameters
used in this search include a peptide mass accuracy of 10 ppm, fragment ion mass accuracy
of 0.6 Da, carbamidomethylated cysteines as a constant modification, and oxidized
methionine and acetylation of K residues as a dynamic modification. The results were
filtered based on Mascot ion scores and Sequest xCorr scores. All positively identified
acetylated peptide were manually validated.
Expression, Purification, and ATPase Assays of Eg5 Constructs
We generated the Eg5NL, Eg5NLK146Q, Eg5Sw1, and Eg5Sw1K146Q constructs
with reactive cysteines at positions 256 and 365 (Eg5NL, Eg5NLK146Q), and 30 and 228
(Eg5Sw1, Eg5Sw1K146Q) and a C-terminal His6-tag, by chemical synthesis of the insert
(GenScript, Piscataway, NJ). The constructs D1, D1K146Q, D2, and D2K146Q were also
generated by chemical synthesis of an insert that also contained a C-terminal His6-tag
(GenScript, Piscataway, NJ). These constructs were expressed and purified using methods
previously described (Rosenfeld et al., 2005). ATPase activity was determined in ATPase
buffer (50 mM potassium acetate, 25 mM HEPES, 5 mM magnesium acetate, 1 mM
EGTA, pH 7.50) by measuring phosphate production in the presence of a minimum of a 5fold molar excess of microtubules, using a commercially-available kit (EnzChek,
Molecular Probes) at 20oC.
Molecular Simulations
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Simulated wild-type and mutant kinesin-5 systems in complex with ATP and
tubulin were constructed based on the crystallographic structure of Eg5-AMP.PNP (Parke,
Wojcik, Kim, & Worthylake, 2010) (PDB code 3HQD) superimposed on helix α4 of
kinesin-1-AMP.PNP-tubulin (Gigant et al., 2013) (PDB code 4HNA).
Simulations utilized the AMBER 12 package (Case et al., 2012) and corresponding
all-atom potential function ff99SB (Hornak et al., 2006). The structures were inserted in a
cubic box (margins located at 12Å from the closest protein atom) filled with TIP3P water
molecules and sodium counter ions. For all systems, four runs of 4000 cycles each of
energy minimization were performed alternating the steepest descent and conjugate
gradient algorithms. Positional restrains of 500 kcal / (mol*Å2) were applied on protein
and ligand atoms in the first run, on backbone atoms in the second run, and on the water
and ions in the third run. No atoms were restrained in the fourth run. Two consecutive
molecular dynamics simulations runs were then used to heat the systems from 100K to
300K for 10ps and to equilibrate them at 300K for 300ps. Four production runs of 300ns
each were performed to evaluate the internal dynamics of the motor domain in the different
states. Full particle mesh-Ewald electrostatics and a 12Å cutoff value were used to treat
non-bonded interactions. Periodic boundary conditions, 2fs time step, and constant
pressure (1atm) were applied. Covalent bonds formed by hydrogen atoms were constrained
with the SHAKE algorithm.
To study the partial undocking process of the neck-linker, well-tempered
metadynamics simulations (Barducci, Bussi, & Parrinello, 2008) were then employed on
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both the kinesin-5 WT and K146Q systems. The Gromacs 5.0.4 package (Abraham et al.,
2015), AMBER ff99SB force field and Plumed 2.1.2 routine (Bonomi et al., 2009) were
used. The energetic bias was added on a collective variable corresponding to the distance
of the hydrogen bond formed by the backbone oxygen atom of residue G96 (helix α1) and
the side chain nitrogen atom of residue N366 (neck- linker). Each system was studied for
700ns, setting the initial deposition height for the biasing Gaussian to 1kj/mol and the width
to 0.125Å. The bias factor was equal to 9, the deposition rate to 10ps, and the temperature
to 300K. An upper potential wall with an energetic constant of 700kj/mol was applied at
12Å. The free energy profile was obtained using the Plumed routine sum_hills, and the
convergence of the simulations was monitored through the changes in the free energy
surface expressed using G96 to N366 collective variable.
Simulation Analysis
The Bio3D package (Grant, Rodrigues, ElSawy, McCammon, & Caves, 2006;
Skjærven, Yao, Scarabelli, & Grant, 2014) was used for all simulation analysis. The
ensemble difference distance matrix (eDDM) analysis routine was used to identify intramolecular distance vectors that exhibit significant structural perturbations upon mutation.
This approach highlights statistically significant residue-residue contact differences
between WT and mutant systems without the need for pre-alignment or structural
superposition to reference conformation. Analysis entailed extracting 100 equally timespaced conformations from each simulation replica to yield a total of 400 conformations
for each WT and mutant system. Intra-conformer residue-residue distance matrices were
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then determined for all conformations by calculating the minimal distance vector between
all the heavy atoms of every residue pair. The Wilcox t- test was then used to evaluate the
significance of the atomic distance variation between WT and mutant systems. Residue
pairs showing a p-value < 0.05 and an average distance difference > 1Å were considered
statistically significant residue-residue contact differences for further analysis (see Figure
2-1).
To further characterize correlated atomic fluctuations in each simulation, the heavyatom residue- wise Pearson correlation was determined as follow:
Cij = <Δri* Δrj> / (<Δr2i><Δr2j>)1/2
where Δri is the displacement from the mean position of the ith atom in a trajectory. This
analysis was performed separately on each replica, resulting in four matrices per protein
state. The absolute value correlation matrices were then filtered by a contact map matrix
built using the distance between carbon alpha atoms in the following way:
Cmapij = 1, if Dcalpha-calpha <= 10A and present in at least 1% of frames
Cmapij = 0, if Dcalpha-calpha > 10A or not present in at least 1% of frames
A principal component analysis transformation was then applied on the
accumulated correlation matrices to identify the structural regions showing the largest
variation between simulated wild-type and K146Q mutant trajectories.
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Molecular mechanics with generalized Born and surface area solvation (MMGBSA) energy calculations were performed on each simulation with the GBOBC model
(Onufriev, Bashford, & Case, 2004) in AMBER 12 (Case et al., 2012).
Transient Kinetic Methodologies
The kinetics of MT dissociation of the Eg5 constructs by nucleotide were measured
in a KinTek SF- 2004 stopped-flow with an instrument dead time of 1.2 milliseconds in
ATPase buffer at 20oC. Microtubule dissociation was monitored by means of the turbidity
change at 350 nm. Binding of the fluorescent nucleotide analogues 2’dmT and 2’dmD to
4:1 complexes of MTs:Eg5 were measured by mixing with an excess of fluorescent
nucleotide in the stopped flow at either 20oC (2’dmT, 2’dmD) or 10oC (2’dmT). Samples
were made nucleotide free prior to mixing by incubating for 20 minutes with 0.2 U/ml
apyrase (Type VII, Sigma Aldrich). Fluorescence enhancement of the mant77luorophorer
was monitored by energy transfer from vicinal tryptophans by exciting at 295 nm and
montoring 90o from the incident beam through a 450 nm broad bandpass filter (Omega
Optical).
Transient Time-Resolved FRET Methodologies
(TR)2FRET experiments were designed and carried out as described in our
previous publication (Muretta et al., 2015). The instrumentation for these experiments is
discussed there and in prior reports (Muretta et al., 2010; Nesmelov et al., 2011). Time77

resolved FRET experiments were analysed as described (Muretta et al., 2015). For detailed
descriptions of this analysis, see previous published work and references cited therein.
Kinetic Simulations
Kinetic simulations of switch-1 dynamics were performed as described in our prior
work (Muretta et al., 2015), utilizing KinTek Explorer Global Analysis Software (Johnson,
Simpson, & Blom, 2009). In this analysis, we assumed:: 1) the closed and open states of
switch-1 are both populated in rigor and the equilibrium constant, defined as
[closed]/[open], is 0.28 for both K146 and K146Q, based on the measured ratio
[closed]/[open] in the absence of nucleotide on the microtubule; 2) ATP only binds to the
open state; 3) ATP hydrolysis requires switch 1 to close; and; 4) phosphate release is
associated with switch 1 reopening.
Force-Processivity Measurements
To prepare single motor coated beads, ~ 20 nM of purified wild type/mutant Eg5
motors (D and DK146Q) and ~ 1 pM of carboxylated polystyrene beads (0.5μm,
Polysciences) were mixed in 30 μL motility buffer (80mM Pipes pH 6.9, 50mM
CH3CO2K, 4mM MgSO4, 1mM DTT, 1mM EGTA, 10 μM taxol, 1mg/ml casein) and
incubated for 20 min at RT. This bead concentration was chosen to have optimum number
of beads in the field of view, and was kept constant for all the motors examined here. At
the end of 20 minutes of incubation, motor-bead mixture were flown into flow cells with
preassembled microtubules (Block et al., 1990), and all measurements were carried out at
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RT in motility buffer, supplemented with 1mM ATP, and an oxygen-scavenging system
(0.25 mg/ml glucose oxidase, 30μg/ml catalase, 4.5mg/ml glucose). Bead- microtubule
binding was tested using an optical trap (trap stiffness, ktrap ~ 0.005pN/nm) to position
each bead near a microtubule. The bead-binding fraction of 10-15% was used to reduce the
probability of multiple motor beads. For force-velocity measurements trap stiffness, ktrap,
was set at ~ 0.045pN/nm. Unloaded bead motility was measured with very low trap
stiffness just enough to hold the bead in position (0.0005pN/nm).
Force Velocity Curves
Load dependent velocity of the motors was determined in bead assays using the
optical trap and analyzed as previously described (Muretta et al., 2015). Briefly the highresolution force-time traces of predominantly single motor coated beads along the MTs
were recorded using the Position sensitive silicon detector (at 2 kHz). The force traces of
the motor carrying the bead in the stiff trap (ktrap~ 0.045pN/nm) were recorded for about
600 sec, for at least 15 different beads in each case (D and DK146Q). The force time traces
were passed through 5 point averaging filter and all the peaks/events above 0.5pN were
selected. Selected events/data were differentiated to get the force-velocity traces. Force
binning (bin size of 0.25pN) was adopted to evaluate the force-velocity dependence for
each event and the data was averaged.
Modeling
Simulations of the force-time traces for the Eg5 motors (D1, D1K146Q, D2, and
D2K146Q) binding and walking on a microtubule were carried out using Monte Carlo approach
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published earlier
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. Load dependent motor stepping rates were estimated by fitting the

experimental force-velocity data to the equation:
𝐹!"# )
)
(𝑣
)
𝑣(𝐹!"# = $%"&' ∗ (1 − +
, 𝐹(
for each motor. Where Fs is the stall force, Fmot is the force on the motor head, 𝑣$%"&' is the no
load velocity of the motor, w-constant that determines the extent of nonlinearity in the forcevelocity relation. The table below summarizes the parameters extracted from the best fit to the
experimental data and were used in the simulation.

Construct

v0 (nm/sec)

Fs (pN)

w

D1
60.64552+/- 1.21685 3.66269+/-0.13959 4.9134+/-0.98815
D1K146Q 47.81485+/-0.86423 4.26026+/-0.28021 2.2826+/-0.33367
D2
55.34428 +/-1.78648
3.5 (fixed)
~ 4 x 1011*
D2K146Q 110.98334 +/-2.49946 5.42259+/-0.58625 0.27689+/-0.0227
*Note that the experimental data for D2 shows no change in velocity with force. Thus D2 cannot
be adequately modeled by the above formula, so w and Fs cannot be precisely determined via
fitting. Nonetheless, for the sake of comparison to D2, Fs was fixed at 3.5 pN, since there were
no higher-force experimental events observed. Because all values of Fmot were smaller than 3.5
pN, the large value for the exponent w ensures that .1 − .

*!"# )
*$

/ / ≅ 1, which would make

velocity independent of load.
In the simulations, force-velocity dependence for stepping rate of motor was set as:
𝑣
𝐹𝑚𝑜𝑡 )
. / ∗ (1 − +
, 𝑘→(#,- (𝐹) = 2 𝑑
𝐹(
0
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Motor detachment probability from the MTs for opposing load was estimated from the
experimental detachment forces measured using bead assay in the optical trap
(ktrap=0.045pN/nm) for each motor. Maximum detachment forces were scored for all the
detachment events in the trap and force binning was carried out to estimate the likelihood of
detachment. The data was fitted to a second order polynomial:
P = a + b*x + c*x2
In order to obtain the following coefficients:
Construct
D1
D1K146Q
D2
D2K146Q

a
0.140
0.143
0.1072
0.0388

b
-0.069
-0.156
0.386
0.034

c
0.076
0.095
-0.026
0.107

Assisting load detachment sensitivity of Eg5 was assumed to be similar to the experimental data
reported in previously for kinesin-120, which could be reproduced in the simulations with the
following load dependence
𝜀& = 𝜀$ ∗ 0.92 ∗ 𝑒𝑥𝑝 +

4𝐹!"#
,
𝐹'

and hence the same was adopted for all the four motors (D1, D1K146Q, D2, and D2K146Q). In
the above equation 𝜀$ is the detachment rate of the motor under no load and Fd is the detachment
force (= 0.8*Fs, stall force). Advancement of the moving cargo inside the trap between any time
interval 𝑡 and 𝑡 + ∆𝑡 is
𝑥⃗(𝑡 + ∆𝑡) = 𝑥⃗(𝑡) + 𝑥⃗.&/'"! +

0⃗
234.

(∆𝑡)

The force on the cargo due to multiple Eg5 motors working under constant applied load was
calculated as
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5

𝑓⃗ = 𝑘#.&- (𝑥 − 𝑥#.&- ) + G 𝑘!"# ∆𝑙6
678

In the above equations, v- velocity of the motor (nm/sec), d- step size of the motor (8 nm), ktraplaser trap stiffness (0.045pN/nm), N-total number of motors, kmot -stiffness of the motor
(0.32pN/nm), ∆𝑙6 is extension of the walking motor j beyond its rest length l (50nm), r- radius of
the cargo (250 nm), 𝑥⃗.&/'"! -Brownian displacement, ∆𝑡 =1e-6 sec is the time step,
𝜂 −Viscosity of the solution (~2x water near the surface).
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3.1 ABSTRACT
The chromokinesin KIF22 generates forces that contribute to mitotic chromosome
congression and alignment. Mutations in the a2 helix of the motor domain of KIF22 have
been identified in patients with abnormal skeletal development, and we report the
identification of a patient with a novel mutation in the KIF22 tail. We demonstrate that
pathogenic mutations do not result in a loss of KIF22’s functions in early mitosis. Instead,
mutations disrupt chromosome segregation in anaphase, resulting in reduced proliferation,
abnormal daughter cell nuclear morphology, and, in a subset of cells, cytokinesis failure.
This phenotype could be explained by a failure of KIF22 to inactivate in anaphase.
Consistent with this model, constitutive activation of the motor via a known site of
phosphoregulation in the tail phenocopied the effects of pathogenic mutations. These
results suggest the motor domain a2 helix may be an important site for regulation of KIF22
activity at the metaphase to anaphase transition. In support of this conclusion, mimicking
phosphorylation of a2 helix residue T158 also prevents inactivation of KIF22 in anaphase.
These findings demonstrate the importance of both the head and tail of the motor in
regulating the activity of KIF22 and offer insight into the cellular consequences of
preventing KIF22 inactivation and disrupting force balance in anaphase.

3.2 INTRODUCTION
Mitosis requires mechanisms that mechanically control chromosome movements
to ensure equal segregation of chromosomes to daughter cells. Forces that move mitotic
chromosomes are generated by microtubule dynamics within the mitotic spindle and by
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molecular motor proteins. The chromokinesin KIF22 (or Kid, kinesin-like DNA-binding
protein) is a plus-end directed member of the kinesin-10 family (Yajima et al., 2003).
KIF22 and its orthologs, including Nod (Drosophila melanogaster) (P. Zhang, Knowles,
Goldstein, & Hawley, 1990) and Xkid (Xenopus laevis) (Antonio et al., 2000; Funabiki &
Murray, 2000; J. Takagi et al., 2013), generate forces that move chromosomes away from
the spindle poles. Structurally, KIF22 contains a conserved kinesin motor domain
responsible for ATP hydrolysis and microtubule binding (Tokai et al., 1996; Yajima et al.,
2003), a second microtubule binding domain in the tail (Shiroguchi et al., 2003), a
predicted coiled-coil domain (Shiroguchi et al., 2003), and a C-terminal DNA binding
domain, which includes a helix-hairpin-helix motif (Tokai et al., 1996) (Figure 3-1 A).
Precisely how KIF22’s force generating activity is regulated in mitotic cells and how this
regulation contributes to spindle function and cell viability remain incompletely
understood.
In interphase, KIF22 localizes to the nucleus (Levesque & Compton, 2001; Tokai
et al., 1996). As cells enter mitosis, chromosomes condense and KIF22 binds along
chromosome arms (Levesque & Compton, 2001; Tokai et al., 1996). In prometaphase,
chromosomes must congress and align at the center of the spindle. The interactions of the
KIF22 motor domain with spindle microtubules and the KIF22 tail with chromosome arms
allows the motor to generate polar ejection forces (Bieling, Kronja, & Surrey, 2010;
Brouhard & Hunt, 2005), which push the arms of chromosomes away from the spindle
poles and towards the center of the spindle (Marshall et al., 2001; Rieder et al., 1986; Rieder
& Salmon, 1994), contributing to chromosome congression in prometaphase (Iemura &
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Tanaka, 2015; Levesque & Compton, 2001; Wandke et al., 2012), as well as chromosome
arm orientation (Levesque & Compton, 2001; Wandke et al., 2012). In metaphase, polar
ejection forces also contribute to chromosome oscillation and alignment (Antonio et al.,
2000; Funabiki & Murray, 2000; Levesque et al., 2003; Levesque & Compton, 2001;
Stumpff et al., 2012; J. Takagi et al., 2013; Tokai-Nishizumi et al., 2005). Purified KIF22
is monomeric (Shiroguchi et al., 2003; Yajima et al., 2003), and the forces generated by
KIF22 on chromosomes arms may represent the collective action of many monomers. In
anaphase, KIF22 is inactivated to reduce polar ejection forces and allow chromosomes to
segregate towards the spindle poles (Soeda et al., 2016; Su et al., 2016; Wolf et al., 2006)
The generation of polar ejection forces by KIF22 is regulated by the activity of
cyclin-dependent kinase 1 (CDK1)/cyclin B, which is high in prometa- and metaphase, and
drops sharply at the metaphase to anaphase transition when cyclin B is degraded (Hershko,
1999; Morgan, 1995). KIF22 is phosphorylated by CDK1/cyclin B at T463, a residue in
the tail of the motor between the second microtubule binding and coiled-coil domains.
Phosphorylation of T463 is required for polar ejection force generation in prometa- and
metaphase, and dephosphorylation of T463 is necessary for the suspension of polar ejection
forces to allow chromosome segregation in anaphase (Soeda et al., 2016). Although a
reduction of polar ejection forces in anaphase is a necessary step for proper anaphase
chromosome segregation, it is not clear how this contributes to a shift in force balance
within the spindle at the metaphase to anaphase transition. Furthermore, while several
regions of the KIF22 tail are known to contribute to KIF22’s inactivation as cells transition
to anaphase, how motor activity is downregulated has not been resolved.
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Phosphoproteomic studies have identified sites of phosphorylation within KIF22’s a2 helix
(Kettenbach et al., 2011; J. V. Olsen et al., 2010; Rigbolt et al., 2011), suggesting this
region, in addition to the tail, may also be important for the regulation of motor activity.
The study of pathogenic mutations can often provide insight into the regulation and
function of cellular proteins. Mutations in KIF22 cause the developmental disorder
spondyloepimetaphyseal dysplasia with joint laxity, leptodactylic type (SEMDJL2, also
referred to as Hall Type or lepto-SEMDJL) (Boyden et al., 2011; Min et al., 2011; Tüysüz
et al., 2014). Four point mutations in two amino acids have been reported in SEMDJL2
patients (Boyden et al., 2011; Min et al., 2011; Tüysüz et al., 2014) (Figure 3-1 A). These
mutations occur in adjacent residues P148 and R149 in the a2 helix of the KIF22 motor
domain (Figure 3-1 B). P148 and R149 are conserved in kinesin-10 family members across
species (Figure 3-1 C) and in many human members of the kinesin superfamily (Figure 31 D). However, no pathogenic mutations in the homologous proline or arginine residues
have been recorded in OMIM (Online Mendelian Inheritance in Man, https://omim.org/).
All identified patients are heterozygous for a single mutation in KIF22. Mutations in KIF22
dominantly cause SEMDJL2, and patients with both de novo and inherited mutations have
been identified (Boyden et al., 2011; Min et al., 2011).
Although KIF22 mRNA is expressed throughout the body (Human Protein Atlas,
http://www.proteinatlas.org (Uhlen et al., 2015)), the effects of these mutations are largely
tissue-specific, and the development of the skeletal system is most affected in SEMDJL2
patients. A primary symptom of SEMDJL2 is short stature, resulting from shortening of
both the trunk and the limbs. Additionally, patients presented with joint laxity, midface
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hypoplasia, scoliosis, and leptodactyly, a narrowing of the fingers (Boyden et al., 2011;
Min et al., 2011). In very young children with SEMDJL2, the softness of the cartilage in
the larynx and trachea caused respiratory issues (Boyden et al., 2011). Growth plate
radiology demonstrated delayed maturation of the metaphyses and epiphyses in SEMDJL2
patients, and symptoms became more pronounced as patients aged (Tüysüz et al., 2014).
Leptodactyly, specifically, was only observed in older (young adult) patients (Boyden et
al., 2011).
Pathogenic mutations in the KIF22 motor domain were predicted to be loss of
function mutations (Min et al., 2011). However, KIF22 knockout in mice did not affect
skeletal development. Loss of KIF22 was lethal early in embryogenesis for approximately
50% of embryos, but mice that survived past this point developed to adulthood and
demonstrated no gross abnormalities or pathologies (Ohsugi et al., 2003). As such, the
cellular mechanism by which mutations in KIF22 affect development is unknown.
Here we characterize an additional patient with a mutation in KIF22 and assess the
effect of previously reported and novel pathogenic mutations on the function of KIF22 in
mitosis. We demonstrate that mutations are not loss of function mutations, and do not alter
the localization of the motor or the generation of polar ejection forces in prometaphase.
Instead, mutations disrupt anaphase chromosome segregation, consistent with continued
KIF22 activation and consequent polar ejection force generation in anaphase. Defects in
anaphase chromosome segregation affect daughter cell nuclear morphology and, in a subset
of cells, prevent cytokinesis. These findings demonstrate that anaphase inactivation of
KIF22 is critical for daughter cell fitness. As such, mitotic defects may contribute to
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pathogenesis in patients with KIF22 mutations. Additionally, we demonstrate that aberrant
polar ejection force generation in anaphase primarily affects the segregation of
chromosomes by limiting chromosome arm movements in anaphase A and spindle pole
separation in anaphase B, offering insight into the balance of forces required for accurate
chromosome segregation in anaphase. Finally, we demonstrate that mimicking
phosphorylation of T158 in the a2 helix disrupts anaphase chromosome segregation,
confirming that the region of the motor domain affected by SEMDJL2 mutations also
contributes to the mechanism by which KIF22 is inactivated in anaphase.

3.3 RESULTS
A novel mutation in KIF22 affects development
We report the identification and characterization of a patient with a novel mutation
in KIF22 (Figure 3-1 E). The patient is a 15-year-old male with a history of short stature,
cryptorchidism and shawl scrotum, minimal scoliosis, secondary enuresis, and skin
hyperpigmentation. He presented for evaluation at 9 years of age. At that time, his height
was just below 3% for age, weight was at 40% for age, and BMI was 82% for age. He was
noted to have relative macrocephaly, with a head circumference at 93% for age. He had a
broad forehead and hypertelorism, round face, flaring of eyebrows, and ankyloglossia. He
also had mild brachydactyly (Figure 3-1 F). He had a history of short stature since infancy,
but followed a trajectory close to the third percentile. Growth hormone and thyroid function
were normal. Bone age showed a normal, age-appropriate bone maturation with normal
epiphyseal ossification centers. However, skeletal survey at age 11 years disclosed mild
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foreshortening of both 4th metacarpals (Figure 3-1 F), mild scoliosis of 14 degrees, as well
as mild increase of the central anteroposterior diameter of several lower thoracic vertebrae
with mild "bullet-shaped" appearance, and mild posterior scalloping of the lumbar
vertebrae (Figure 3-1 G).
Genetic testing was performed to determine the cause of these developmental
differences. Clinical whole exome sequencing revealed two variants of uncertain
significance:

a

maternally

inherited

heterozygous

SLC26A2

variant

[NM_000112.3(SLC26A2): c.1046T>A (p.F349Y)] (SCV000782516.1), as well as a de
novo heterozygous KIF22 variant [NM_007317.3(KIF22):c.1424T>G (p.V475G)]
(SCV000782515.1) (Figure 3-1 E). The SLC26A2 gene encodes the diastrophic dysplasia
sulfate transporter (Haila et al., 2001; Rossi & Superti-Furga, 2001). However, results of
carbohydrate deficient transferrin testing were not consistent with a congenital disorder of
glycosylation (transferrin tri-sialo/di-oligo ratio 0.07).
The c.1424T>G, p.(V475G) KIF22 variant has not been observed previously in the
Genome Aggregation Database (gnomAD). This missense variant has mixed in silico
predictions of significance (Table 3-1). According to American College of Medical
Genetics 2015 criteria, the variant was classified as a variant of uncertain significance
(VUS). V475 is located in the coiled-coil domain in the tail of KIF22 (Figure 3-1 A). This
residue is conserved in most kinesin-10 family members across species (Figure 3-1 C).
However, the tail domains of kinesin motors diverge in both structure and function, and as
such meaningful alignments to assess the conservation of V475 across the human kinesin
superfamily were not possible.
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Figure 3-1: Identification of a novel pathogenic mutation in the tail of KIF22. (A) Schematic of the
domains of KIF22 with pathogenic mutations in the motor domain (magenta) and coiled-coil domain
(yellow) indicated. (B) Location of amino acids P148 and R149 in the a2 helix of the KIF22 motor domain
(PDB 6NJE). (C) Alignment of amino acid sequences of kinesin-10 family members to assess
conservation of motor domain (P148 and R149, left) and coiled-coil domain (V475G, right) residues
across species. (D) Alignment of amino acid sequences of human kinesin motors to assess conservation
of motor domain residues across the kinesin superfamily. For C and D, alignments were performed using
Clustal Omega. (E) Pedigree identifying the de novo V475G (1424 T>G) mutation. (F) Radiograph of the
patient’s hand, posteroanterior view. Arrowhead indicates mild foreshortening of the 4th metacarpal. (G)
Radiographs of the patient’s spine. Left: anteroposterior view, right: lateral view. Arrowheads indicate
“bullet-shaped” lower thoracic vertebrae.

Table 3-1: Predictions of significance of the c.1424C>G, p.(V475G) KIF22 variant.
Algorithm
Sorting Intolerant from Tolerant
(SIFT) (Vaser, Adusumalli, Leng,
Sikic, & Ng, 2015)
Polymorphism Phenotyping
(PolyPhen-2) (Adzhubei et al., 2010)

Prediction
Deleterious: score 0.01 with scores ranging from 0 to 1 and
scores below 0.05 considered deleterious

MutationTaster (J. M. Schwarz,
Rödelsperger, Schuelke, & Seelow,
2010)
Combined Annotation Dependent
Depletion (CADD) (Rentzsch, Witten,
Cooper, Shendure, & Kircher, 2018)
Deleterious Annotation of Genetic
Variants Using Neural Networks
(DANN) (Quang, Chen, & Xie, 2015)
Rare Exome Variant Ensemble
Learner (REVEL) (Ioannidis et al.,
2016)

Deleterious

Benign: score 0.437

Deleterious: scaled C-score 15.3800, with a score of greater
than or equal to 10 indicating a deleterious substitution
Deleterious: score 0.99 with scores ranging from 0 to 1 and
higher values indicating a variant is more likely to be
deleterious
Benign: score 0.28 with scores ranging from 0 to 1 and
scores >0.803 classified as pathogenic

Pathogenic mutations in KIF22 do not disrupt the localization of the motor
To assess the effect of published pathogenic mutations in the motor domain and
the novel pathogenic mutation in the tail on the function of KIF22 in mitosis, we generated
human cervical adenocarcinoma (HeLa-Kyoto) cell lines with inducible expression of
KIF22-GFP. Treatment of these cells with doxycycline induced KIF22-GFP expression at
a level approximately two- to three-fold higher than the level of expression of endogenous
KIF22 as measured by immunofluorescence (Figure 3-2 A-C). To facilitate both
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overexpression of and rescue with KIF22-GFP constructs, siRNA-resistant silent mutations
were introduced into exogenous KIF22 (Figure 3-2 D-E). siRNA knockdown reduced
levels of endogenous KIF22 by 87% (mean knockdown efficiency across HeLa-Kyoto cell
lines) (Figure 3-2 D). Initial experiments were performed using HeLa-Kyoto cell lines
expressing each known pathogenic mutation in KIF22 (P148L, P148S, R149L, R149Q,
and V475G), and a subset of experiments then focused on cells expressing one
representative motor domain mutation (R149Q) or the coiled-coil domain mutation in the
tail (V475G). Additionally, we generated inducible retinal pigmented epithelial (RPE-1)
cell lines expressing wild type and mutant KIF22-GFP to assess any differences between
the consequences of expressing mutant KIF22 in aneuploid cancer-derived cells (HeLaKyoto) and genomically stable somatic cells. RPE-1 cells are human telomerase reverse
transcriptase (hTERT)-immortalized (Bodnar et al., 1998), and metaphase chromosome
spreads demonstrated that these cell lines are near-diploid, with a modal chromosome
number of 46, even after selection to generate stable cell lines (Figure 3-2 F-G). The
expression level of siRNA-resistant KIF22-GFP in RPE-1 cell lines was approximately
four- to seven-fold higher than the level of expression of endogenous KIF22 (Figure 3-2
H-K), and siRNA knockdown reduced levels of endogenous KIF22 by 67% (mean
knockdown efficiency across RPE-1 cell lines measured using immunofluorescence). As
measurements of KIF22 depletion by immunofluorescence may include non-specific
signal, this estimate of knockdown efficiency may underestimate the depletion of KIF22.
KIF22 localizes to the nucleus in interphase, and primarily localizes to
chromosomes and spindle microtubules during mitosis (Tokai et al., 1996). KIF22-GFP
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with pathogenic mutations demonstrated the same localization pattern throughout the cell
cycle as wild type motor (Figure 3-3 A). In all cell lines, KIF22-GFP was localized to the
nucleus in interphase cells and was bound to condensing chromosomes in prophase. In
prometaphase, metaphase, and anaphase mutant and wild type KIF22-GFP localized
primarily to chromosome arms, with a smaller amount of motor signal visible on the
spindle microtubules. The same localization patterns were seen for mutant and wild type
KIF22-GFP expressed in RPE-1 cells (Figure 3-4 A).
Since mutations did not grossly disrupt localization of KIF22-GFP, fluorescence
recovery after photobleaching (FRAP) was used to compare the dynamics of mutant and
wild type KIF22 localization. In interphase nuclei, KIF22-GFP signal recovered
completely 220 seconds after bleaching (97% ± 3% of intensity before bleaching, mean ±
SEM), indicating a dynamic pool of KIF22-GFP (Figure 3-3 B and 3-4 B). Similar high
recovery percentages were also measured in interphase nuclei of cells expressing KIF22GFP R149Q and KIF22-GFP V475G (100% ± 6% and 103% ± 7% at 220 seconds,
respectively) (Figure 3-3 E and 3-3 H). In contrast, KIF22-GFP recovery was minimal in
cells bleached during metaphase and anaphase. Immediately after bleaching KIF22-GFP
in metaphase cells, intensity was reduced to 18 ± 3% of initial intensity, and intensity had
recovered to only 25% ± 3% after 220 seconds (Figure 3-3 C and 3-4 B). In anaphase,
KIF22-GFP intensity immediately after bleaching was 17% ± 2% of initial intensity, and
intensity recovered to 35% ± 6% of initial intensity after 220 seconds (Figure 3-3 D and
3-4 B). This limited recovery indicates that KIF22 stably associates with mitotic
chromosomes. Pathogenic mutations did not change these localization dynamics; recovery
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percentages in mitosis were also low in cells expressing KIF22-GFP R149Q (32 ± 3% of
initial intensity in metaphase 220 seconds after bleaching, 39 ± 6% in anaphase) (Figure 33 F-G) and KIF22-GFP V475G (29 ± 2% of initial intensity in metaphase, 35 ± 6% in
anaphase) (Figure 3-3 I-J). These data indicate that pathogenic mutations do not alter the
localization of KIF22 to chromosomes and spindle microtubules, and do not alter KIF22
localization dynamics in interphase, metaphase, or anaphase.
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Figure 3-2: HeLa-Kyoto and RPE-1 stable cell lines express mutant KIF22. (A) Immunofluorescence
images of HeLa-Kyoto cells expressing KIF22-GFP under the control of a doxycycline inducible
promoter. Images are maximum intensity projections in z of five frames at the center of the spindle. Fixed
approximately 24 hours after siRNA transfection and treatment with doxycycline to induce expression.
Scale bar 5 µm. KD: knockdown. (B-E) Quantification of KIF22 fluorescence intensity in untreated HeLaKyoto cells transfected with control siRNA (B), cells treated with doxycycline to induce expression and
transfected with control siRNA (C), untreated cells transfected with KIF22 siRNA (D), and cells treated
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with doxycycline and transfected with KIF22 siRNA (E) normalized to the mean intensity of uninduced,
control knockdown cells (endogenous KIF22 expression level) for each cell line (B). Data in B and D are
presented with the same y-axis scale as data in C and E for comparison (left), and with independently
scaled y-axes to show data variability (right). 27 GFP, 24 KIF22-GFP, 27 KIF22-GFP R149Q, 28 KIF22GFP P148L, 25 KIF22-GFP P148S, 27 KIF22-GFP R149L, and 30 KIF22-GFP V475G untreated cells
transfected with control siRNA (B), 24 GFP, 24 KIF22-GFP, 31 KIF22-GFP R149Q, 30 KIF22-GFP
P148L, 27 KIF22-GFP P148S, 30 KIF22-GFP R149L, and 33 KIF22-GFP V475G doxycycline-treated
cells transfected with control siRNA (C), 21 GFP, 31 KIF22-GFP, 27 KIF22-GFP R149Q, 32 KIF22-GFP
P148L, 22 KIF22-GFP P148S, 22 KIF22-GFP R149L, and 25 KIF22-GFP V475G untreated cells
transfected with KIF22 siRNA (D), 26 GFP, 26 KIF22-GFP, 32 KIF22-GFP R149Q, 28 KIF22-GFP
P148L, 28 KIF22-GFP P148S, 27 KIF22-GFP R149L, and 33 KIF22-GFP V475G doxycycline-treated
cells transfected with KIF22 siRNA (E) from 3 experiments. (F) DAPI-stained metaphase chromosome
spreads from uninduced RPE-1 cell lines with inducible expression of GFP, KIF22-GFP, KIF22-GFP
R149Q, or KIF22-GFP V475G. Scale bar 10 µm. Images are representative of 3 experiments. (G) Numbers
of chromosome pairs counted in metaphase spreads prepared from RPE-1 stable cell lines. Dashed line
indicates the expected chromosome number for diploid human cells (46). The mode for each cell line is
46. 55 GFP, 58 KIF22-GFP, 53 KIF22-GFP R149Q, and 57 KIF22-GFP V475G spreads from 3
experiments. (H-K) Quantification of KIF22 fluorescence intensity in untreated RPE-1 cells transfected
with control siRNA (H), cells treated with doxycycline to induce expression and transfected with control
siRNA (I), untreated cells transfected with KIF22 siRNA (J), and cells treated with doxycycline and
transfected with KIF22 siRNA (K) normalized to the mean intensity of uninduced, control knockdown
cells for each cell line (H). 23 GFP, 27 KIF22-GFP, 25 KIF22-GFP R149Q, and 27 KIF22-GFP V475G
untreated cells transfected with control siRNA (H), 24 GFP, 27 KIF22-GFP, 27 KIF22-GFP R149Q, and
28 KIF22-GFP V475G doxycycline-treated cells transfected with control siRNA (I), 21 GFP, 24 KIF22GFP, 24 KIF22-GFP R149Q, and 21 KIF22-GFP V475G untreated cells transfected with KIF22 siRNA
(J), 24 GFP, 29 KIF22-GFP, 26 KIF22-GFP R149Q, and 24 KIF22-GFP V475G doxycycline-treated cells
transfected with KIF22 siRNA (K) from 3 experiments. For B-E and H-K, bars indicate means. p values
from Brown-Forsythe and Welch ANOVA with Dunnett’s T3 multiple comparisons test. p values are
greater than 0.05 for comparisons without a marked p value.
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Figure 3-3: Pathogenic mutations in KIF22 do not disrupt the localization of the motor. (A)
Immunofluorescence images of HeLa-Kyoto cells expressing KIF22-GFP constructs in prophase (top two
rows) and metaphase (bottom two rows). KIF22-GFP was visualized using an anti-GFP antibody. Images
are maximum intensity projections in z of five frames at the center of the spindle (metaphase cells) or
maximum intensity projections in z of two frames (prophase cells). Fixed approximately 24 hours after

104

treatment with doxycycline to induce expression. Scale bars 5 µm. (B-J) Fluorescence recovery after
photobleaching (FRAP) of KIF22-GFP (B-D), KIF22-GFP R149Q (E-G), and KIF22-GFP V475G (H-J)
in interphase nuclei (B, E, H) or on metaphase (C, F, I) or anaphase (D, G, J) chromosomes. Bleaching
occurred at time zero. Thin lines are traces from individual cells and thick lines represent means. Intensity
values are normalized to the KIF22-GFP intensity in the first imaged frame before bleaching. Interphase
measurements (B, E, H) obtained from 6 KIF22-GFP cells from 4 experiments, 9 KIF22-GFP R149Q cells
from 5 experiments, and 6 KIF22-GFP V475G cells from 4 experiments. Metaphase measurements (C, F,
I) obtained from 6 KIF22-GFP cells from 4 experiments, 14 KIF22-GFP R149Q cells from 5 experiments,
and 12 KIF22-GFP V475G cells from 4 experiments. Anaphase measurements (D, G, J) obtained from 8
KIF22-GFP cells from 4 experiments, 7 KIF22-GFP R149Q cells from 5 experiments, and 7 KIF22-GFP
V475G cells from 3 experiments.
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Figure 3-4: Pathogenic mutations in KIF22 do not disrupt the localization of the motor in RPE-1
cells. (A) Immunofluorescence images of RPE-1 cells expressing KIF22-GFP constructs in prophase (top
two rows) and metaphase (bottom two rows). KIF22-GFP was visualized using an anti-GFP antibody.
Images are maximum intensity projections in z of five frames at the center of the spindle (metaphase cells)
or maximum intensity projections in z of three frames (prophase cells). Fixed approximately 18 hours after
treatment with doxycycline to induce expression. Scale bars 5 µm. (B) Time-lapse images of fluorescence
recovery after photobleaching (FRAP) in HeLa-Kyoto cells expressing KIF22-GFP. Bleaching occurred
at time zero, and arrowheads indicate bleached area. Scale bars 10 µm. Images are representative of 3 or
more experiments.

Mutations do not reduce polar ejection forces
In prometaphase and metaphase, KIF22 contributes to chromosome congression
and alignment by generating polar ejection forces (Brouhard & Hunt, 2005; Levesque &
Compton, 2001; Stumpff et al., 2012; Wandke et al., 2012). In cells treated with monastrol
to inhibit Eg5/KIF11 and generate monopolar spindles, polar ejection forces push
chromosomes away from a single central spindle pole (Levesque & Compton, 2001)
(Figure 3-5 A). A loss of KIF22 function causes chromosomes to collapse in towards the
pole in this system (Levesque & Compton, 2001) (Figure 3-5 A). To determine whether
overexpression of KIF22-GFP with pathogenic mutations has a dominant effect on polar
ejection force generation, wild type or mutant KIF22-GFP-expressing HeLa-Kyoto cells
were treated with monastrol to induce mitotic arrest with monopolar spindles. Relative
polar ejection forces were compared by measuring the distance from the spindle pole to the
maximum DAPI signal (Figure 3-5 A). Expression of mutant motor did not reduce polar
ejection forces (Figure 3-5 B-C). Rather, expression of KIF22-GFP R149L and R149Q
significantly increased the distance from the pole to the maximum DAPI signal (R149L
4.6 ± 0.13 µm, R149Q 4.3 ± 0.11 µm, GFP control 3.7 ± 0.04 µm, mean ± SEM), indicating
higher levels of polar ejection forces in these cells.
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The same assay was used to test whether mutant KIF22 could rescue polar ejection
force generation in cells depleted of endogenous KIF22. In control cells expressing GFP,
depletion of endogenous KIF22 resulted in the collapse of chromosomes towards the pole
(Figure 3-5 B), and the distance from the pole to the maximum DAPI signal was reduced
to 1.6 ± 0.11 µm, indicating a loss of polar ejection forces (Figure 3-5 D). This reduction
was not observed in cells expressing wild type or mutant KIF22-GFP, demonstrating that
KIF22-GFP with pathogenic mutations is capable of generating polar ejection forces
(Figure 3-5 B and D). In cells transfected with control siRNA and cells depleted of
endogenous KIF22, polar ejection force levels did not depend on KIF22-GFP expression
levels (Figure 3-5 E-F).
Together, the localization of mutant KIF22 and the ability of mutant KIF22 to
generate polar ejection forces indicate that pathogenic mutations P148L, P148S, R149L,
R149Q, and V475G do not result in a loss of KIF22 function during early mitosis.
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Figure 3-5: Pathogenic mutations in KIF22 do not reduce polar ejection forces. (A) Schematic of
changes in chromosome positions resulting from loss of polar ejection forces. In cells with monopolar
spindles, both spindle poles (magenta) are positioned together and chromosomes (blue) are pushed toward
the cell periphery by polar ejection forces (green) (left). In cells depleted of KIF22, polar ejection forces
are reduced and chromosomes collapse in toward the center of the cell (right). Relative polar ejection
forces were quantified using radial profile plots to measure the distance from the spindle pole to the
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maximum DAPI signal intensity. (B) Immunofluorescence images of monopolar HeLa-Kyoto cells.
KIF22-GFP was visualized using an anti-GFP antibody. Fixed approximately 2-3 hours after treatment
with monastrol and 24 hours after siRNA transfection and treatment with doxycycline to induce
expression. Scale bar 5 µm. Images are representative of 3 or more experiments. (C) Distance from the
spindle pole to the maximum DAPI signal, a measure of relative polar ejection force level, in cells
transfected with control siRNA. 59 GFP cells from 7 experiments, 69 KIF22-GFP cells from 6
experiments, 31 KIF22-GFP P148L cells from 3 experiments, 37 KIF22-GFP P148S cells from 3
experiments, 33 KIF22-GFP R149L cells from 3 experiments, 28 KIF22-GFP R149Q cells from 3
experiments, and 45 KIF22-GFP V475G cells from 3 experiments. (D) Distance from the spindle pole to
the maximum DAPI signal in cells transfected with KIF22 siRNA. 75 GFP cells from 7 experiments, 57
KIF22-GFP from 6 experiments, 28 KIF22-GFP P148L cells from 3 experiments, 30 KIF22-GFP P148S
cells from 3 experiments, 33 KIF22-GFP R149L cells from 3 experiments, 26 KIF22-GFP R149Q cells
from 3 experiments, and 34 KIF22-GFP V475G cells. For C-D, bars indicate means. p values from BrownForsythe and Welch ANOVA with Dunnett’s T3 multiple comparisons test. p values are greater than 0.05
for comparisons without a marked p value. (E-F) Background-subtracted GFP intensity plotted against the
distance from the spindle pole to the maximum DAPI signal to assess dependence of polar ejection force
generation on expression levels in cells transfected with control siRNA (E) (Pearson correlation coefficient
0.105, two-tailed p value 0.1031) or KIF22 siRNA (F) (Pearson correlation coefficient -0.005, two-tailed
p value 0.9427).

KIF22 mutations disrupt anaphase chromosome segregation
While pathogenic mutations did not disrupt the function of KIF22 in prometa- or
metaphase, HeLa-Kyoto cells expressing mutant KIF22-GFP exhibited defects in anaphase
chromosome segregation. In these cells, chromosomes did not move persistently towards
the spindle poles. Instead, chromosomes began to segregate, but then reversed direction
and moved back towards the center of the spindle or remained in the center of the spindle
until decondensation (Figure 3-6 A). This phenotype was dominant and occurred in the
presence of endogenous KIF22. Recongression was quantified by measuring the distance
between separating chromosome masses as anaphase progressed. In cells expressing wild
type KIF22-GFP, this value increases steadily and then plateaus. Expression of mutant
KIF22-GFP causes the distance between chromosome masses to increase, then decrease as
chromosomes recongress, and then increase again as segregation continues (Figure 3-6 B).
Recongression reduces the distance between chromosome masses 7 minutes after anaphase
onset in cells expressing KIF22-GFP with pathogenic mutations (median distance 2.0 – 7.2
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µm) compared to cells expressing wild type KIF22-GFP (median distance 12.9 µm) (Figure
3-6 C). Defects in anaphase chromosome segregation were also observed in RPE-1 cells
expressing KIF22-GFP R149Q or V475G (Figure 3-7 D-F). This gain of function
phenotype is consistent with a lack of KIF22 inactivation in anaphase, resulting in a failure
to suspend polar ejection force generation.
If recongression is the result of increased KIF22 activity in anaphase, we would
predict that increased levels of KIF22-GFP expression would cause more severe anaphase
chromosome segregation defects. Indeed, plotting the distance between chromosome
masses 7 minutes after anaphase onset against mean GFP intensity for each HeLa-Kyoto
cell demonstrated that these two values were correlated (Spearman correlation coefficient
-0.6246, one-tailed p value < 0.0001) (Figure 3-7 A). Considering only cells expressing
lower levels of KIF22-GFP (mean background subtracted intensity <100 arbitrary units)
emphasized the differences in the distance between chromosome masses as anaphase
progressed between cells expressing wild type and mutant motor (Figure 3-7 B-C).
In a subset of HeLa-Kyoto cells, expression of KIF22-GFP with pathogenic
mutations caused cytokinesis failure (Figure 3-6 D). This result is consistent with the
published observation that causing chromosome recongression by preventing cyclin B1
degradation can result in cytokinesis failure (Wolf et al., 2006). In cells expressing KIF22GFP with pathogenic mutations, cleavage furrow ingression began, but did not complete,
resulting in a single daughter cell. The percentage of cells failing to complete cytokinesis
was approximately ten-fold higher in cells expressing mutant KIF22-GFP (R149Q 36%,
V475G 25%) than in cells expressing wild type KIF22-GFP (3%). Additionally, the
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distance between chromosome masses at the time of cleavage furrow ingression was
reduced in cells expressing KIF22-GFP R149Q or V475G, suggesting that the position of
the chromosome masses may be physically obstructing cytokinesis (Figure 3-6 E).
Consistent with this hypothesis, cells that failed to complete cytokinesis tended to have
lower distances between chromosome masses than the distances measured in cells in which
cytokinesis completed despite expression of mutant KIF22-GFP (Figure 3-6 E).
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Figure 3-6: Pathogenic mutations in KIF22 disrupt anaphase chromosome segregation. (A) Timelapse images of dividing HeLa-Kyoto cells expressing KIF22-GFP R149Q or KIF22-GFP V475G. Times
indicate minutes after anaphase onset. Images are maximum intensity projections in z through the entirety
of the spindle. Imaged approximately 18 hours after treatment with doxycycline to induce expression.
Scale bar 5 µm. Images are representative of 3 or more experiments. (B) Distance between separating
chromosome masses throughout anaphase in HeLa-Kyoto cells. Lines represent the mean and the shaded
area denotes SEM. 43 KIF22-GFP cells from 10 experiments, 21 KIF22-GFP P148L cells from 6
experiments, 28 KIF22-GFP P148S cells from 7 experiments, 16 KIF22-GFP R149L cells from 6
experiments, 17 KIF22-GFP R149Q cells from 4 experiments, and 21 KIF22-GFP V475G cells from 21
experiments. (C) Distance between separating chromosome masses 7 minutes after anaphase onset. Bars
indicate medians. p values from Kruskal-Wallis test. p values are greater than 0.05 for comparisons without
a marked p value. Data represent the same cell populations presented in (B). (D) Time-lapse images of
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dividing HeLa-Kyoto cells expressing mCherry (mCh)-CAAX to visualize cell boundaries. Times indicate
minutes after anaphase onset. Arrowheads indicate cytokinesis failure. Imaged approximately 8 hours after
treatment with doxycycline to induce expression and 24-32 hours after transfection with mCh-CAAX.
Scale bars 20 µm. Images are representative of 3 or more experiments. (E) Distance between chromosome
masses at the time of cleavage furrow ingression. p values from Kruskal-Wallis test. p values are greater
than 0.05 for comparisons without a marked p value. 62 KIF22-GFP cells from 10 experiments, 52 KIF22GFP R149Q cells from 9 experiments, and 55 KIF22-GFP V475G cells from 9 experiments.

Figure 3-7: Anaphase recongression defects are KIF22-GFP expression level dependent and disrupt
chromosome segregation in RPE1 cells. (A) Background-subtracted GFP intensity plotted against the
distance between separating chromosome masses at 7 minutes to assess dependence of recongression on
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expression level (Spearman correlation coefficient -0.6246, one-tailed p value < 0.0001). Grey dashed line
indicates mean background subtracted GFP intensity of 100. 43 KIF22-GFP cells from 10 experiments,
21 KIF22-GFP P148L cells from 6 experiments, 28 KIF22-GFP P148S cells from 7 experiments, 16
KIF22-GFP R149L cells from 6 experiments, 17 KIF22-GFP R149Q cells from 4 experiments, and 21
KIF22-GFP V475G cells from 21 experiments. (B) Distance between separating chromosome masses of
cells expressing lower levels of KIF22-GFP (mean background subtracted GFP intensity less than 100).
Lines represent the mean and the shaded area denotes SEM. 27 KIF22-GFP cells from 9 experiments, 16
KIF22-GFP P148L cells from 6 experiments, 18 KIF22-GFP P148S cells from 6 experiments, 16 KIF22GFP R149L cells from 6 experiments, 6 KIF22-GFP R149Q cells from 3 experiments, and 7 KIF22-GFP
V475G cells from 3 experiments. (C) Distance between separating chromosome masses 7 minutes after
anaphase onset of cells expressing lower levels of KIF22-GFP (mean background subtracted GFP intensity
less than 100). Bars indicate medians. p values from Kruskal-Wallis test. p values are greater than 0.05 for
comparisons without a marked p value. Data represent the same cell populations presented in (B). (D)
Time-lapse images of dividing RPE-1 cells expressing KIF22-GFP R149Q or KIF22-GFP V475G.
Imaged approximately 12-18 hours after treatment with doxycycline to induce expression. Times indicate
minutes after anaphase onset. Images are maximum intensity projections in z through the entirety of the
spindle. Scale bar 5 µm. Images are representative of 3 or more experiments. (E) Distance between
separating chromosome masses throughout anaphase in RPE-1 cells. Lines represent the mean and the
shaded area denotes SEM. 25 KIF22-GFP cells from 7 experiments, 16 KIF22-GFP R149Q cells from 6
experiments, and 8 KIF22-GFP V475G cells from 6 experiments. (F) Distance between separating
chromosome masses 7 minutes after anaphase onset in RPE-1 cells. Bars indicate medians. p value from
Kruskal-Wallis test. p values are greater than 0.05 for comparisons without a marked p value. Data
represent the same cell populations presented in (E).

Mutations disrupt the separation of the spindle poles in anaphase
Anaphase chromosome segregation requires both that chromosome arms and
centromeres move towards the spindle poles (anaphase A) (Asbury, 2017) and that the
spindle poles move away from one another (anaphase B) (Ris, 1949). To test whether the
activity of mutant KIF22 in anaphase affects one or both of these processes, anaphase
was imaged in HeLa-Kyoto cells expressing fluorescent markers for the poles
(pericentrin-RFP) and centromeres (CENPB-mCh) (Figure 3-8 A). The reduced distance
between separating chromosome masses seen in these cells (Figure 3-8 B-C) was
compared to the distances between the centromeres (Figure 3-8 D-E) and the distances
between the poles (Figure 3-8 F-G) as anaphase progressed. The distances between all
three structures showed the same trend: in cells expressing wild type KIF22-GFP, the
distance between chromosome masses, between centromeres, and between the spindle
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poles increased throughout the measured time interval in anaphase. Pathogenic mutations
altered the movements of all three structures (Figure 3-8 B, D, F). The distance between
chromosome masses, between centromeres, and between the spindle poles 10 minutes
after anaphase onset was significantly reduced in cells expressing KIF22-GFP R149Q or
KIF22-GFP V475G (Figure 3-8 C, E, G). Comparing the distance between chromosome
masses and the spindle pole within each half spindle (Figure 3-8 H) with the distance
between centromeres and the spindle pole in the same half spindles (Figure 3-8 I)
demonstrated that expression of mutant KIF22 more potently reduced the segregation of
chromosome arms than centromeres, consistent with continued generation of polar
ejection forces in anaphase. This suggests that pathogenic mutations in KIF22 affect
anaphase A by altering the movement of chromosome arms, but not the shortening of the
k-fibers, and affect anaphase B by altering spindle pole separation.
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Figure 3-8: Mutations disrupt the separation of spindle poles in anaphase. (A) Time-lapse images of
dividing HeLa-Kyoto cells expressing pericentrin-RFP to mark the spindle poles and CENPB-mCh to
mark centromeres. Times indicate minutes after anaphase onset. Colored distances in the bottom right of
each greyscale image indicate the distance between the spindle poles in the image. Images are maximum
intensity projections in z through the entirety of the spindle. Imaged approximately 24 hours after
transfection and 12-18 hours after treatment with doxycycline to induce expression. Images depicting
pericentrin-RFP and CENPB-mCh signal were background subtracted by duplicating each frame, applying
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a gaussian blur (sigma 30 pixels), and subtracting this blurred image from the original. Scale bar 10 µm.
Images are representative of 3 or more experiments. (B) Distance between separating chromosome masses
throughout anaphase in HeLa-Kyoto cells. Lines represent the mean and the shaded area denotes SEM.
(C) Distance between separating chromosome masses 10 minutes after anaphase onset in HeLa-Kyoto
cells. Bars indicate medians. (D) Distance between centromeres (CENPB-mCh) throughout anaphase in
HeLa-Kyoto cells. Lines represent the mean and the shaded area denotes SEM. (E) Distance between
centromeres 10 minutes after anaphase onset in HeLa-Kyoto cells. Bars indicate medians. (F) Distance
between spindle poles (pericentrin-RFP) throughout anaphase in HeLa-Kyoto cells. Lines represent the
mean and the shaded area denotes SEM. (G) Distance between spindle poles 10 minutes after anaphase
onset in HeLa-Kyoto cells. Bars indicate medians. Measurements from the same cells (9 KIF22-GFP cells
from 5 experiments, 8 KIF22-GFP R149Q cells from 4 experiments, and 12 KIF22-GFP V475G cells from
6 experiments) are shown in B-G. For C, E, and G, p values from Kruskal-Wallis test. (H) Distance
between chromosome masses and spindle poles throughout anaphase in HeLa-Kyoto cells. Lines represent
the mean and the shaded area denotes SEM. (I) Distance between centromeres and spindle poles
throughout anaphase in HeLa-Kyoto cells. Lines represent the mean and the shaded area denotes SEM.
Measurements from the same cells (18 KIF22-GFP, 16 KIF22-GFP R149Q, and 24 KIF22-GFP V475G
half-spindles) as in B-G are shown in H and I.

Division of cells expressing KIF22 with pathogenic mutations results in daughter cells
with abnormally shaped nuclei
To understand the consequences of the observed defects in anaphase chromosome
segregation, we examined the daughter cells produced by the division of cells expressing
KIF22-GFP with pathogenic mutations. In these cells, the nuclei are lobed and fragmented
(Figure 3-9 A). The percentage of divisions resulting in nuclear morphology defects was
approximately ten-fold higher than in control cells (KIF22-GFP 6%, KIF22-GFP R149Q
64%, KIF22-GFP V475G 68%) when live divisions were observed (Figure 3-6 E). To
further quantify this phenotype, the solidity of fixed cell nuclei (the ratio of the area of each
nucleus to the area of the convex shape that would enclose it) was measured. A perfectly
oval nucleus would have a solidity value of one. Solidity values were reduced in cells
expressing KIF22-GFP with pathogenic mutations (Figure 3-9 B), indicating that these
cells had more irregularly shaped nuclei. This reduction in solidity was dominant and
occurred both in the presence of endogenous KIF22 and when endogenous KIF22 was
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depleted via siRNA knockdown. Using the fifth percentile solidity of control cells (control
knockdown, GFP expression) as a cut-off, 44-63% of cells expressing mutant KIF22-GFP
had abnormally shaped nuclei 24 hours after treatment with doxycycline to induce
expression of KIF22-GFP (Figure 3-9 C). Expression of wild type KIF22-GFP also resulted
in a small increase in the percentage of cells with abnormally shaped nuclei (12%). This
percentage was reduced when endogenous KIF22 was depleted (7%), consistent with
nuclear morphology defects resulting from an increase in KIF22 activity.
Expression of KIF22-GFP with pathogenic mutations also caused abnormally
shaped nuclei in RPE-1 cells (Figure 3-10 A). The solidity of nuclei in cells expressing
mutant KIF22-GFP was reduced (Figure 3-10 B), and 40-49% of RPE-1 cells expressing
mutant KIF22-GFP had abnormally shaped nuclei, again defined as a solidity value less
than the fifth percentile of control cells (Figure 3-10 C). In RPE-1 cells, expression of wild
type KIF22-GFP resulted in a higher percentage of cells with abnormally shaped nuclei
(18% in control knockdown cells, 15% with KIF22 knockdown) than was seen in HeLaKyoto cells. This may be a result of the higher expression level of KIF22-GFP in the RPE1 inducible cell lines (Figure 3-2 I-K).
To determine whether these nuclear morphology defects depended on the ability
of KIF22 to generate forces within the mitotic spindle, cells were treated with nocodazole
to depolymerize microtubules and reversine to silence the spindle assembly checkpoint,
allowing cells to enter and exit mitosis without assembling a spindle or segregating
chromosomes (Samwer et al., 2017; Serra-Marques et al., 2020) (Figure 3-9 D). The
solidity of nuclei was measured before chromosomes condensed (Figure 3-9 E) and after
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mitotic exit (Figure 3-9 F). At both time points, there was no difference in nuclear shape
between control cells and cells expressing KIF22-GFP with pathogenic mutations,
indicating that the effects of mutations on nuclear structure are spindle-dependent.
The effect of nuclear morphology defects on daughter cell fitness may partially
depend on whether the nuclear envelopes of abnormally shaped nuclei are intact. The
expression of mCherry (mCh) with a nuclear localization signal (NLS) indicated that
even highly lobed and fragmented nuclei in cells expressing mutant KIF22-GFP are
capable of retaining nuclear-localized proteins (Figure 3-9 G). This suggests that the
nuclear envelopes of these abnormally shaped nuclei are still intact enough to function
as a permeability barrier (Hatch, Fischer, Deerinck, & Hetzer, 2013).
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Figure 3-9: Division of cells expressing KIF22 with pathogenic mutations results in daughter cells
with abnormally shaped nuclei. (A) DAPI stained nuclei of cells expressing KIF22 with pathogenic
mutations. Values in the bottom right of each image indicate the solidity of the boxed nucleus. Fixed
approximately 24 hours after treatment with doxycycline to induce expression. Scale bar 20 µm. Images
are representative of 3 or more experiments. (B) Measured solidity of nuclei in HeLa-Kyoto cell lines.
Small circles represent the solidity of individual nuclei, and large circles with black outlines indicate the
median of each experiment. A dashed line marks a solidity value of 0.939, the fifth percentile of solidity
for control cells transfected with control siRNA and expressing GFP. (C) Percentage of nuclei with
abnormal shape, indicated by a solidity value less than 0.939, the fifth percentile of control (control
knockdown, GFP expression) cell solidity. A chi-square test of all data produced a p value < 0.0001.
Plotted p values are from pairwise post-hoc chi-square tests comparing control (control knockdown, GFP
expression) cells to each other condition. Applying the Bonferroni correction for multiple comparisons, a
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p value of less than 0.00385 was considered significant. p values are greater than 0.00385 for comparisons
without a marked p value. Data in (B) and (C) represent 1045 GFP cells transfected with control siRNA,
849 GFP cells transfected with KIF22 siRNA, 994 KIF22-GFP cells transfected with control siRNA, 980
KIF22-GFP cells transfected with KIF22 siRNA, 472 KIF22-GFP P148L cells transfected with control
siRNA, 442 KIF22-GFP P148L cells transfected with KIF22 siRNA, 382 KIF22-GFP P148S cells
transfected with control siRNA, 411 KIF22-GFP P148S cells transfected with KIF22 siRNA, 336 KIF22GFP R149L cells transfected with control siRNA, 376 KIF22-GFP R149L cells transfected with KIF22
siRNA, 466 KIF22-GFP R149Q cells transfected with control siRNA, 359 KIF22-GFP R149Q cells
transfected with KIF22 siRNA, 605 KIF22-GFP V475G cells transfected with control siRNA, and 386
KIF22-GFP V475G cells transfected with KIF22 siRNA. GFP and KIF22-GFP cells represent 6
experiments, data from all other cell lines represent 3 experiments. (D) Time-lapse images of HeLa-Kyoto
cells treated with nocodazole and reversine and stained with SPY595-DNA to visualize chromosomes.
Time indicates the number of minutes before or after chromosome condensation. Images are maximum
intensity projections in z of two focal planes, one at the level of interphase nuclei and one at the level of
mitotic chromosomes. Imaged approximately 8 hours after treatment with doxycycline to induce
expression, 1.5-2 hours after treatment with SPY595-DNA, and 0.5-1 hour after treatment with nocodazole
and reversine. Scale bar 10 µm. Images are representative of 3 or more experiments. (E) Nuclear solidity
of HeLa-Kyoto cells treated with nocodazole and reversine. Measurements were made 15 minutes before
chromosome condensation. (F) Nuclear solidity of HeLa-Kyoto cells treated with nocodazole and
reversine. Measurements were made 100 minutes after chromosome decondensation. Data in (E) and (F)
represent 56 GFP, 60 KIF22-GFP, 76 KIF22-GFP R149Q, and 67 KIF22-GFP V475G cells from 3
experiments per condition. For (E) and (F), bars indicate medians, and the Kruskal-Wallis test indicated
no significant difference between groups. (G) Time-lapse images of HeLa-Kyoto cells expressing
mCherry (mCh)-NLS to assess nuclear envelope integrity. Times indicate minutes before or after
chromosome condensation. Imaged approximately 8 hours after treatment with doxycycline to induce
expression and 24 hours after transfection with mCh-CAAX. Scale bar 20 µm. Images are representative
of 3 or more experiments.

121

Figure 3-10: Mutations cause abnormally shaped nuclei in RPE1 cells. (A) DAPI-stained nuclei of
RPE-1 cells expressing KIF22-GFP with pathogenic mutations. Fixed approximately 24 hours after
treatment with doxycycline to induce expression. Scale bar 20 µm. Images are representative of 3 or more
experiments. (B) Measured solidity of nuclei in RPE-1 cell lines. Small circles represent the solidity of
individual nuclei, and large circles with black outlines indicate the median of each experiment. A dashed
line marks a solidity value of 0.907, the fifth percentile of solidity for control cells transfected with control
siRNA and expressing GFP. (C) Percentage of nuclei with abnormal shape, indicated by a solidity value
less than 0.907, the fifth percentile of control (control knockdown, GFP expression) cell solidity. A chisquare test of all data produced a p value < 0.0001. Plotted p values are from pairwise post-hoc chi-square
tests comparing control (control knockdown, GFP expression) cells to each other condition. Applying the
Bonferroni correction for multiple comparisons, a p value of less than 0.00714 was considered significant.
p values are greater than 0.00714 for comparisons without a marked p value. Data in (B) and (C) represent
206 GFP transfected with control siRNA, 200 GFP cells transfected with KIF22 siRNA, 233 KIF22-GFP
cells transfected with control siRNA, 240 KIF22-GFP cells transfected with KIF22 siRNA, 214 KIF22GFP R149Q cells transfected with control siRNA, 207 KIF22-GFP R149Q cells transfected with KIF22
siRNA, 146 KIF22-GFP V475G cells transfected with control siRNA, and 244 KIF22-GFP V475G cells
transfected with KIF22 siRNA from 3 experiments.

Proliferation is reduced in cells expressing KIF22 with pathogenic mutations
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If defects in anaphase chromosome segregation and nuclear morphology affect
cellular function, they may impact the ability of cells to proliferate. To test this, HeLaKyoto cells expressing KIF22-GFP with pathogenic mutations were imaged over 96 hours
to count the numbers of cells over time (Figure 3-11 A). The growth rates of cells
expressing mutant KIF22 were reduced (Figure 3-11 B). After 96 hours, the fold change in
cell number was reduced by approximately 30% for cells expressing KIF22-GFP with
pathogenic mutations (GFP control median 5.3, KIF22-GFP R149Q 3.7, KIF22-GFP
V475G 3.8) (Figure 3-11 C).
To consider what might be limiting the proliferation rate of cells expressing
mutant KIF22-GFP, predictions for proliferation rate based on the observed rates of nuclear
morphology defects and cytokinesis failure were calculated. For these purposes, only data
from the first 48 hours of the proliferation assay were used, as cell growth rates plateaued
after this timepoint. The doubling time of control HeLa-Kyoto cells expressing GFP was
calculated to be 20.72 hours in these experiments, which is consistent with published data
(Y. Liu et al., 2018). Using this doubling rate, assuming exponential growth, and assuming
every cell divides, the normalized cell count at 48 hours (normalized to a starting cell count
of 1) was predicted to be 4.98. This is close to the experimental 48-hour cell count for
control cells (4.60), and higher than the experimental 48-hour cell count for cells
expressing KIF22-GFP R149Q (3.13) or V475G (3.60), as these cell lines have reduced
proliferation (Figure 3-11 B, square). If one assumed that cells with abnormally shaped
nuclei stop dividing, given that approximately 60% of mutant KIF22-GFP cell divisions
result in abnormally shaped nuclei (Figure 3-6 E), the predicted cell count at 48 hours
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would be 2.18 (Figure 3-11 B, triangle). This is lower than the experimental cell count for
cells expressing mutant KIF22-GFP, suggesting that cells with abnormally shaped nuclei
must be capable of additional divisions. If, instead, one assumed that only cells that fail
cytokinesis (30% of cells (Figure 3-6 E)) stop dividing, the predicted cell count would be
3.42 (Figure 3-11 B, diamond). This value is consistent with the experimental 48-hour cell
count for cells expressing KIF22-GFP with pathogenic mutations (3.13 – 3.60), suggesting
the rate of cytokinesis failure may limit the rate of proliferation in these cells. Consistent
with this possibility, an increased number of large cells that may have failed cytokinesis
are visible in proliferation assay images at 72 hours (Figure 3-11A).
To test the prediction that cells with nuclear morphology defects are capable of
division, KIF22-GFP expression was induced approximately 24 hours before imaging to
generate a population of cells with abnormally shaped nuclei. Division of these cells was
observed (Figure 3-11 D), demonstrating that nuclear morphology defects do not prevent
subsequent divisions. The percentage of cells that divided over the course of this
experiment was not reduced in cells expressing KIF22-GFP with pathogenic mutations
despite the abnormal nuclear morphology of cells in those populations (Figure 3-11 E).
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Figure 3-11: Proliferation is reduced in cells expressing KIF22 with pathogenic mutations. (A) Timelapse bright field images of HeLa-Kyoto cells to assess proliferation rate. Scale bar 500 µm. Images are
representative of 3 or more experiments. (B) Proliferation rates measured using automated bright field
imaging. Lines represent the mean cell count, normalized to the number of cells at 0 hours, and the shaded
area denotes SEM. Black outlined shapes indicate the predicted cell count for cell lines expressing
pathogenic mutations at 48 hours if every cell doubled every 20.72 hours (the doubling time measured
from 48 hours of control cell proliferation) (square), if the rate of cytokinesis failure limited proliferation
and 30% of cells did not divide (diamond), and if the rate of nuclear morphology defects limited
proliferation and 60% of cells did not divide (triangle). (C) Fold change of normalized cell counts after 96
hours. Bars indicate medians. p values from Kruskal-Wallis test. p values are greater than 0.05 for
comparisons without a marked p value. Data in (B) and (C) represent 8 KIF22 knockdown, 11 GFP, 9
KIF22-GFP, 16 KIF22-GFP R149Q, and 8 KIF22-GFP V475G technical replicates from 4 experiments.
(D) Time-lapse imaging of HeLa-Kyoto cells treated with doxycycline for 24 hours to induce expression
of KIF22-GFP with pathogenic mutations and stained with SPY595-DNA. Arrowheads indicate cells with
abnormally shaped nuclei that divide. Images are maximum intensity projections in z of two focal planes,
one at the level of interphase nuclei and one at the level of mitotic chromosomes. Scale bars 20 µm. Images
are representative of 3 or more experiments. (E) Nuclear morphology at the start of imaging (dark grey or
blue, oval; light grey or blue; abnormal morphology) and outcome (grey, cell divides during the
experiment; blue, the cell does not divide). The total number of dividing cells was compared between cell
lines using the chi-square test (p < 0.0001 across all conditions). Post-hoc chi-square tests comparing all
conditions to one another indicated that the proliferation rate of cells expressing KIF22-GFP R149Q is
statistically different than that of cells expressing GFP (p = 0.0025), KIF22-GFP (p = 0.0003), or KIF22GFP V475G (p < 0.0001). Applying the Bonferroni correction for multiple comparisons, a p value of less
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than 0.008 was considered significant. p values are greater than 0.008 for all other comparisons. 2461
GFP, 2611 KIF22-GFP, 1890 KIF22-GFP R149Q, and 2346 KIF22-GFP V465G cells.

Mimicking phosphorylation of T463 phenocopies pathogenic mutations
The phenotypes observed in cells expressing KIF22-GFP with pathogenic
mutations suggest that mutations may prevent inactivation of KIF22 in anaphase, and that
polar ejection forces in anaphase disrupt chromosome segregation. If this is the case, then
preventing KIF22 inactivation would be predicted to phenocopy the pathogenic mutations.
One mechanism by which KIF22 activity is controlled is phosphorylation of T463:
phosphorylation of this tail residue is necessary for polar ejection force generation, and
dephosphorylation at anaphase onset contributes to polar ejection force suppression (Soeda
et al., 2016). Therefore, we generated HeLa-Kyoto inducible cell lines expressing KIF22GFP with phosphomimetic (T463D) and phosphonull (T463A) mutations to test whether
preventing KIF22 inactivation in anaphase by expressing the constitutively active T463D
construct phenocopies the expression of KIF22-GFP with pathogenic mutations. When
treated with doxycycline, these cells expressed phosphomimetic and phosphonull KIF22GFP at levels comparable to those seen in cell lines expressing KIF22-GFP with pathogenic
mutations, which was approximately two- to three-fold higher than the level of expression
of endogenous KIF22 (Figure 3-13 A-D).
To assess the activity of KIF22-GFP T463D and T463A in HeLa cells, polar
ejection force generation in monopolar spindles was measured (Figure 3-12 A). In cells
with endogenous KIF22 present, expression of KIF22-GFP T463D increased the distance
from the spindle pole to the maximum DAPI signal (GFP control 3.7 ± 0.07 µm, KIF22GFP T463D 4.4 ± 0.12, mean ± SEM), indicating increased polar ejection forces, consistent
126

with phosphorylation of T463 activating KIF22 in prometaphase (Soeda et al., 2016)
(Figure 3-12 B). Conversely, when endogenous KIF22 was depleted, expression of KIF22GFP T463A was less able to rescue polar ejection force generation (distance from the
spindle pole to the maximum DAPI signal 3.0 ± 0.08 µm, mean ± SEM) than expression
of wild type KIF22-GFP (3.6 ± 0.07 µm) or KIF22-GFP T463D (3.7 ± 0.10 µm) (Figure
3-12 C). Again, this is consistent with previous work demonstrating that KIF22
phosphorylation at T463 activates the motor for prometaphase polar ejection force
generation (Soeda et al., 2016), although the reduction in polar ejection forces seen with
KIF22-GFP T463A rescue is less severe in our system, possibly due to differences in cell
type, level of depletion of endogenous KIF22, or the method used to quantify polar ejection
forces.
In anaphase, expression of phosphomimetic KIF22-GFP T463D, but not
phosphonull KIF22-GFP T463A, caused chromosome recongression (Figure 3-12 D-E).
The distance between chromosome masses at 7 minutes was reduced in cells expressing
KIF22-GFP T463D (median 5.8 µm) compared to cells expressing wild type KIF22-GFP
(12.5 µm) or KIF22-GFP T463A (10.8 µm) (Figure 3-12 F). As in cells expressing KIF22GFP with pathogenic mutations, the severity of anaphase chromosome recongression,
indicated by the distance between chromosome masses at 7 minutes, was dependent on
GFP expression level (Spearman correlation coefficient -0.3964, one-tailed p value 0.0004)
(Figure 3-13 E). When only cells expressing lower levels of KIF22-GFP (mean background
subtracted intensity <100 arbitrary units) were considered, the same effect (expression of
KIF22-GFP T463D causes recongression) was still observed (Figure 3-13 F-G). This
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recongression phenocopies the effect of pathogenic mutations on anaphase chromosome
segregation, consistent with pathogenic mutations preventing anaphase inactivation of
KIF22.
In addition to causing the same defects in anaphase chromosome segregation,
expression of KIF22-GFP T463D also affects daughter cell nuclear morphology. Cells
expressing KIF22-GFP T463D have lobed and fragmented nuclei (Figure 3-13 H) and
correspondingly reduced nuclear solidity measurements (Figure 3-12 G). An increased
percentage of cells expressing KIF22-GFP T463D in the presence of endogenous KIF22
(65%) or in cells depleted of endogenous KIF22 (72%) have abnormally shaped nuclei, as
indicated by a solidity value below the fifth percentile of control cell nuclear solidity
(Figure 3-12 H).
Expression of KIF22-GFP T463A also resulted in a small increase in the
percentage of abnormally shaped nuclei (26% in control or KIF22 knockdown conditions)
(Figure 3-12 H). Since expression of KIF22-GFP T463A does not cause anaphase
recongression (Figure 3-12 E), the level of compaction of the segregating chromosome
masses was explored as a possible explanation for this modest increase in the percentage
of cells with nuclear morphology defects. In KIF22 knockout mice, loss of KIF22 reduces
chromosome compaction in anaphase, causing the formation of multinucleated cells
(Ohsugi et al., 2008). The phosphonull T463A mutation reduces KIF22 activity and may
therefore exhibit a KIF22 loss of function phenotype. Measurement of the widths of
separating chromosome masses in anaphase (Figure 3-13 I) did demonstrate a modest
broadening of the chromosome masses in cells expressing KIF22-GFP T463A (Figure 3128

13 J-K), which may contribute to the modest defects in nuclear morphology seen in these
cells.

Figure 3-12: Phosphomimetic mutation of T463 phenocopies pathogenic mutations in KIF22. (A)
Immunofluorescence images of monopolar HeLa-Kyoto cells. KIF22-GFP was visualized using an anti-
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GFP antibody. Fixed approximately 2-3 hours after treatment with monastrol and 24 hours after siRNA
transfection and treatment with doxycycline to induce expression. Scale bar 5 µm. Images are
representative of 3 or more experiments. (B) Distance from the spindle pole to the maximum DAPI signal,
a measure of relative polar ejection force level, between HeLa-Kyoto cell lines expressing KIF22-GFP
with phosphomimetic and phosphonull mutations at T463. 26 GFP cells from 3 experiments, 26 KIF22GFP cells from 3 experiments, 29 KIF22-GFP T463D cells from 3 experiments, and 29 KIF22-GFP
T463A cells from 3 experiments. (C) Distance from the spindle pole to the maximum DAPI signal in cells
depleted of endogenous KIF22 and expressing KIF22-GFP with phosphomimetic and phosphonull
mutations at T463. 35 GFP cells from 4 experiments, 36 KIF22-GFP cells from 4 experiments, 27 KIF22GFP T463D cells from 3 experiments, and 47 KIF22-GFP T463A cells from 4 experiments. For B-C,
bars indicate means. p values from Brown-Forsythe and Welch ANOVA with Dunnett’s T3 multiple
comparisons test. p values are greater than 0.05 for comparisons without a marked p value. (D) Time-lapse
images of dividing HeLa-Kyoto cells. Cells expressing KIF22-GFP T463D exhibit recongression of the
chromosomes during anaphase. Times indicate minutes after anaphase onset. Images are maximum
intensity projections in z through the entirety of the spindle. Imaged approximately 18 hours after
treatment with doxycycline to induce expression. Scale bar 5 µm. Images are representative of 3 or more
experiments. (E) Distance between separating chromosome masses throughout anaphase in HeLa-Kyoto
cells. Lines represent the mean and the shaded area denotes SEM. 13 KIF22-GFP, 32 KIF22-GFP T463D,
and 24 KIF22-GFP T463A cells from 5 experiments. (F) Distance between separating chromosome
masses 7 minutes after anaphase onset. Bars indicate medians. p values from Kruskal-Wallis test. p values
are greater than 0.05 for comparisons without a marked p value. 13 KIF22-GFP, 32 KIF22-GFP T463D,
and 24 KIF22-GFP T463A cells from 5 experiments per condition. (G) Measured solidity of nuclei in
HeLa-Kyoto cell lines. Small circles represent the solidity of individual nuclei, and large circles with black
outlines indicate the median of each experiment. A dashed line marks a solidity value of 0.950, the fifth
percentile of solidity for control cells transfected with control siRNA and expressing GFP. (H) Percentage
of nuclei with abnormal shape, indicated by a solidity value less than 0.950, the fifth percentile of control
(control knockdown, GFP expression) cell solidity. A chi-square test of all data produced a p value <
0.0001. Plotted p values are from pairwise post-hoc chi-square tests comparing control (control
knockdown, GFP expression) cells to each other condition. Applying the Bonferroni correction for
multiple comparisons, a p value of less than 0.00714 was considered significant. p values are greater than
0.00714 for comparisons without a marked p value. Data in (G) and (H) represent 312 GFP cells
transfected with control siRNA, 362 GFP cells transfected with KIF22 siRNA, 314 KIF22-GFP cells
transfected with control siRNA, 320 KIF22-GFP cells transfected with KIF22 siRNA, 361 KIF22-GFP
T463D cells transfected with control siRNA, 376 KIF22-GFP T463D cells transfected with KIF22 siRNA,
312 KIF22-GFP T463A cells transfected with control siRNA, and 376 KIF22-GFP T463A cells
transfected with KIF22 siRNA from 3 experiments.
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Figure 3-13: Cells expressing KIF22-GFP T463A have broader anaphase chromosome masses. (AD) Quantification of KIF22 fluorescence intensity in untreated HeLa-Kyoto cells transfected with control
siRNA (A), cells treated with doxycycline to induce expression and transfected with control siRNA (B),
untreated cells transfected with KIF22 siRNA (C), and cells treated with doxycycline and transfected with
KIF22 siRNA (D) normalized to the mean intensity of uninduced, control knockdown cells (endogenous
KIF22 expression level) for each cell line (A). 32 GFP, 25 KIF22-GFP,28 KIF22-GFP T463D, and 31
KIF22-GFP T463A untreated cells transfected with control siRNA (A), 29 GFP, 27 KIF22-GFP, 27
KIF22-GFP T463D, and 29 KIF22-GFP T463A doxycycline-treated cells transfected with control siRNA
(B), 25 GFP, 26 KIF22-GFP, 23 KIF22-GFP T463D, and 26 KIF22-GFP T463A untreated cells
transfected with KIF22 siRNA (C), 28 GFP, 28 KIF22-GFP, 31 KIF22-GFP T463D, and 26 KIF22-GFP
T463A doxycycline-treated cells transfected with KIF22 siRNA (D), from 3 experiments. (E) Plotting
background-subtracted GFP intensity against the distance between separating chromosome masses at 7
minutes indicates that this distance is dependent on expression level (Spearman correlation coefficient 0.3964, one-tailed p value = 0.0004). Grey dashed line indicates mean background subtracted GFP
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intensity of 100. 13 KIF22-GFP, 32 KIF22-GFP T463D, and 24 KIF22-GFP T463A cells from 5
experiments. (F) Distance between separating chromosome masses of cells expressing lower levels of
KIF22-GFP (mean background subtracted GFP intensity less than 100). Lines represent the mean and the
shaded area denotes SEM. 7 KIF22-GFP cells from 4 experiments, 17 KIF22-GFP T463D cells from 5
experiments, and 14 KIF22-GFP T463A cells from 4 experiments. (G) Distance between separating
chromosome masses 7 minutes after anaphase onset of cells expressing lower levels of KIF22-GFP (mean
background subtracted GFP intensity less than 100). Bars indicate medians. p values from Kruskal-Wallis
test. p values are greater than 0.05 for comparisons without a marked p value. 7 KIF22-GFP cells from 4
experiments, 17 KIF22-GFP T463D cells from 5 experiments, and 14 KIF22-GFP T463A cells from 4
experiments. (H) DAPI-stained nuclei of Hela-Kyoto cells. Fixed approximately 24 hours after treatment
with doxycycline to induce expression. Scale bar 20 µm. Images are representative of 3 or more
experiments. (I) Schematic depicting the measurement of chromosome signal intensity in anaphase and
the use of the full width at half maximum (FWHM) as a measure of anaphase chromosome mass
broadness. (J) Full width at half maximum of the plotted intensities of separating chromosome masses of
HeLa-Kyoto cells expressing KIF22-GFP or KIF22-GFP T463A. Lines represent the mean and the shaded
area denotes SEM. (K) Minimum FWHM value, representing maximal anaphase chromosome
compaction, between cells expressing KIF22-GFP and KIF22-GFP T463A. p value from Mann-Whitney
test. Bars represent medians. Data in (J) and (K) represent 12 KIF22-GFP and 24 KIF22-GFP T463A cells
(24 KIF22-GFP and 48 KIF22-GFP T463A chromosome masses) from 5 experiments.

Mimicking phosphorylation of T158 in the a2 helix phenocopies pathogenic
mutations
The effect of mutations in the a2 helix on KIF22 function suggests the
involvement of this region of the motor domain in KIF22 inactivation. If this was true,
post-translational modification of a2 may contribute to the regulation of KIF22 activity,
analagous to the regulation of KIF22 inactivation via the dephosphorylation of T463 in the
tail. Phosphorylation of amino acids T134 in a2a (Kettenbach et al., 2011) and T158 in
a2b (J. V. Olsen et al., 2010; Rigbolt et al., 2011) has been documented in
phosphoproteomic

studies.

HeLa-Kyoto

cells

expressing

KIF22-GFP

with

phosphomimetic and phosphonull mutations at T134 and T158 were generated to test
whether either site may contribute to the regulation of KIF22 inactivation.
T134 is located in a2a, near the catalytic site of KIF22 (Figure 3-15 A). Both
phosphonull (T134A) and phosphomimetic (T134D) mutations at this site disrupted the
132

localization of KIF22. KIF22-GFP T134D and T134A localize to spindle microtubules
rather than to the chromosomes (Figure 3-15 B). Expression of KIF22-GFP T134D and
KIF22-GFP T134A also resulted in the formation of multipolar spindles in a subset of cells
(Figure 3-15 C). These phenotypes are consistent with previous work that used T134N as
a rigor mutation to test the necessity of KIF22 motor activity for spindle length
maintenance (Tokai-Nishizumi et al., 2005). The phenotypes observed in cells expressing
KIF22-GFP T134D or KIF22-GFP T134A are not the same as those observed in cells
expressing KIF22-GFP T463D, suggesting that phosphoregulation of T134 is not involved
in the inactivation of KIF22.
T158 is located in a2b, the same region of the a2 helix containing amino acids
P148 and R149, which are mutated in patients with SEMDJL2 (Figure 3-14 A).
Localization of KIF22 to chromosomes is not disrupted by phosphomimetic (T158D) or
phosphonull (T158A) mutations at this site. To assess the activity of KIF22-GFP T158D
and KIF22-GFP T158A, relative polar ejection forces were measured in monopolar
spindles (Figure 3-14 B). In the presence of endogenous KIF22, expression of neither
KIF22-GFP T158D nor KIF22-GFP T158A disrupted the generation of polar ejection
forces (Figure 3-14 C). In cells depleted of endogenous KIF22, expression of KIF22-GFP,
KIF22-GFP T158D, or KIF22-GFP T158A was sufficient to rescue polar ejection force
generation (Figure 3-14 D), indicating that KIF22 with mutations at T158 is active in
prometaphase and capable of generating polar ejection forces.
To test the effects of phosphomimetic and phosphonull mutations at T158 in
anaphase, distances between separating chromosome masses in cells expressing KIF22133

GFP, KIF22-GFP T158D, or KIF22-GFP T158A were measured. Expression of KIF22GFP T158D caused chromosome recongression, while expression of KIF22-GFP T158A
did not affect chromosome movements in anaphase (Figure 3-14 E-F). The distance
between separating chromosome masses 7 minutes after anaphase onset was reduced in
cells expressing KIF22-GFP T158D (median 6.4 µm) compared to cells expressing KIF22GFP (12.4 µm) or KIF22-GFP T158A (13.6 µm) (Figure 3-14 G). Mimicking
phosphorylation of T158 also affected daughter cell nuclear morphology. Nuclear solidity
was reduced in cells expressing KIF22-GFP T158D (Figure 3-14 H), and correspondingly
the percentage of cells with abnormally shaped nuclei, designated as a solidity value lower
than the 5th percentile solidity of control cells expressing GFP, was increased in cells
expressing KIF22-GFP T158D in the presence (36%) or absence (32%) of endogenous
KIF22 (Figure 3-14 I). Expression of KIF22-GFP (10%) or KIF22-GFP T158A (11%) in
the presence of endogenous KIF22 also resulted in a small increase in the percentage of
cells with abnormally shaped nuclei compared to control cells expressing GFP (5%). The
expression of KIF22-GFP T158D phenocopies the expression of KIF22-GFP T463D or
KIF22-GFP with pathogenic mutations, suggesting that dephosphorylation of T158
contributes to KIF22 inactivation in anaphase.
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Figure 3-14: Mimicking phosphorylation of T158 in the motor domain affects KIF22 inactivation.
A) Location of amino acid T158 in the a2 helix of the KIF22 motor domain (PDB 6NJE). (B)
Immunofluorescence images of monopolar HeLa-Kyoto cells. KIF22-GFP was visualized using an antiGFP antibody. Fixed approximately 2-3 hours after treatment with monastrol and 24 hours after siRNA
transfection and treatment with doxycycline to induce expression. Scale bar 5 µm. Images are
representative of 3 or more experiments. (C) Distance from the spindle pole to the maximum DAPI signal,

135

a measure of relative polar ejection force level, in HeLa-Kyoto cell lines expressing KIF22-GFP with
phosphomimetic and phosphonull mutations at T158. 33 GFP, 40 KIF22-GFP, 31 KIF22-GFP T158D,
and 36 KIF22-GFP T158A cells from 3 experiments. (D) Distance from the spindle pole to the maximum
DAPI signal in cells depleted of endogenous KIF22 and expressing KIF22-GFP with phosphomimetic and
phosphonull mutations at T158. 39 GFP, 35 KIF22-GFP, 34 KIF22-GFP T158D, and 34 KIF22-GFP
T158A cells from 3 experiments. For C-D, bars indicate means. p values from Brown-Forsythe and Welch
ANOVA with Dunnett’s T3 multiple comparisons test. p values are greater than 0.05 for comparisons
without a marked p value. (E) Time-lapse images of dividing HeLa-Kyoto cells. Cells expressing KIF22GFP T158D exhibit recongression of the chromosomes during anaphase. Times indicate minutes after
anaphase onset. Images are maximum intensity projections in z through the entirety of the spindle. Imaged
approximately 18 hours after treatment with doxycycline to induce expression. Scale bar 5 µm. Images
are representative of 3 or more experiments. (F) Distance between separating chromosome masses
throughout anaphase in HeLa-Kyoto cells. Lines represent the mean and the shaded area denotes SEM. 13
KIF22-GFP, 16 KIF22-GFP T158D, and 13 KIF22-GFP T158A cells from 5 experiments. (G) Distance
between separating chromosome masses 7 minutes after anaphase onset. Bars indicate medians. p values
from Kruskal-Wallis test. p values are greater than 0.05 for comparisons without a marked p value. 13
KIF22-GFP, 16 KIF22-GFP T158D, and 13 KIF22-GFP T158A cells from 5 experiments. (H) Measured
solidity of nuclei in HeLa-Kyoto cell lines. Small circles represent the solidity of individual nuclei, and
large circles with black outlines indicate the median of each experiment. A dashed line marks a solidity
value of 0.922, the fifth percentile of solidity for control cells transfected with control siRNA and
expressing GFP. (I) Percentage of nuclei with abnormal shape, indicated by a solidity value less than
0.922, the fifth percentile of control (control knockdown, GFP expression) cell solidity. A chi-square test
of all data produced a p value < 0.0001. Plotted p values are from pairwise post-hoc chi-square tests
comparing control (control knockdown, GFP expression) cells to each other condition. Applying the
Bonferroni correction for multiple comparisons, a p value of less than 0.00714 was considered significant.
p values are greater than 0.00714 for comparisons without a marked p value. Data in (H) and (I) represent
514 GFP control knockdown, 418 GFP KIF22 knockdown, 613 KIF22-GFP control knockdown, 584
KIF22-GFP KIF22 knockdown, 644 KIF22-GFP T158D control knockdown, 432 KIF22-GFP T158D
KIF22 knockdown, 477 KIF22-GFP T158A control knockdown, and 427 KIF22-GFP T158A KIF22
knockdown cells from 3 experiments.
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Figure 3-15: Mimicking phosphoregulation of T134 disrupts KIF22 localization. (A) Location of
amino acid T134 in the a2 helix of the KIF22 motor domain (PDB 6NJE). (B) Immunofluorescence
images of HeLa-Kyoto cells expressing KIF22-GFP constructs in metaphase. KIF22-GFP was visualized
using an anti-GFP antibody. Images are maximum intensity projections in z. Fixed approximately 24 hours
after treatment with doxycycline to induce expression. Scale bar 10 µm. (C) Immunofluorescence images
of multipolar HeLa-Kyoto cells expressing KIF22-GFP T134D or KIF22-GFP T134A. Images are
maximum intensity projections in z. Fixed approximately 24 hours after treatment with doxycycline to
induce expression. Scale bar 10 µm.
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Figure 3-16: Pathogenic mutations disrupt the anaphase, but not prometaphase, function of KIF22.
(A) Wild type KIF22 generates polar ejection forces to contribute to chromosome congression and
alignment in prometaphase. In anaphase, KIF22 inactivation results in the attenuation of polar ejection
forces (green arrows), allowing chromosomes to segregate toward the poles. Daughter cells form regularly
shaped nuclei and continue to proliferate. (B) In cells expressing KIF22 with pathogenic (P148L, P148S,
R149L, R149Q, V475G) or phosphomimetic (T158D, T463D) mutations, prometaphase proceeds as in
cells expressing wild type motor. Mutant KIF22 is capable of polar ejection force generation. In anaphase,
KIF22 fails to inactivate, resulting in continued generation of polar ejection forces, which disrupts
anaphase chromosome segregation. Daughter cells exhibit nuclear morphology defects. In about 30% of
cells expressing KIF22-GFP R149Q or KIF22-GFP V475G, cytokinesis fails, and proliferation rates are
reduced.

3.4 DISCUSSION
We have determined that pathogenic mutations in KIF22 disrupt anaphase
chromosome segregation, causing chromosome recongression, nuclear morphology
defects, reduced proliferation, and, in a subset of cells, cytokinesis failure. Wild type KIF22
is inactivated in anaphase (Soeda et al., 2016), resulting in an attenuation of polar ejection
forces, which allows chromosomes to move towards the spindle poles (Figure 3-16 A). The
phenotypes we observe in cells expressing KIF22-GFP with pathogenic mutations are
consistent with KIF22 remaining active in anaphase (Figure 3-16 B). Polar ejection forces
could cause recongression by continuing to push chromosomes away from the spindle
poles during anaphase A and disrupting spindle elongation during anaphase B. These forces
result in aberrant positioning of chromosomes during telophase and cytokinesis, which
could cause the nuclear morphology defects and cytokinesis failure we observe in cells
expressing mutant KIF22-GFP. Consistent with this model, mimicking phosphorylation of
T463 to prevent KIF22 inactivation in anaphase phenocopies the effects of pathogenic
mutations. Thus, we conclude that pathogenic mutations result in a gain of KIF22 function,
which aligns with findings that KIF22 mutations are dominant in heterozygous patients
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(Boyden et al., 2011; Min et al., 2011; Tüysüz et al., 2014). The effects of pathogenic
mutations on chromosome movements in anaphase are consistent with observations of
chromosome recongression in cells with altered CDK1 activity (Su et al., 2016; Wolf et
al., 2006) or altered tail structure (Soeda et al., 2016). Our work additionally demonstrates
the involvement of the motor domain a2 helix in this process and the consequences of
recongression on cytokinesis, daughter cell nuclear morphology, and proliferation.
Mutations in both the motor domain (P148L, P148S, R149L, and R149Q) and the
coiled-coil domain (V475G) of KIF22 disrupt chromosome segregation in a manner
consistent with a failure of KIF22 inactivation in anaphase. Additionally, mimicking
phosphorylation of T158 in the motor domain or T463 in the tail also disrupts chromosome
segregation. These findings demonstrate that the motor domain a2 helix participates in the
process of KIF22 inactivation, adding to studies that demonstrate that deletion of the tail
microtubule binding domain and deletion or disruption of the coiled-coil domain prevent
the inactivation of KIF22 in anaphase (Soeda et al., 2016).
The physical mechanism of KIF22 inactivation is unknown, and our results can be
interpreted in the context of several models, which are not mutually exclusive. Previous
work has proposed that the tail of KIF22 may interact with microtubules to suspend polar
ejection force generation (Soeda et al., 2016). In this framework, the mutation in the tail
of KIF22 (V745G) could disrupt anaphase chromosome segregation by altering this
interaction with microtubules. Whether or how the a2 helix could contribute to this
mechanism is less clear. The a2 helix faces away from the surface of the microtubule, and
we would not predict that mutations in this structure would directly alter the association of
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the motor domain with the microtubule. It is possible that this region of the motor domain
could facilitate or strengthen an interaction between the tail and the microtubule surface
indirectly.
Alternatively, given that mutations in the tail and motor domain of KIF22 both
disrupt chromosome segregation, the tail and motor domain may interact to inactivate the
motor. Head-tail autoinhibition is a known regulatory mechanism of other members of the
kinesin superfamily (Blasius et al., 2021; Coy et al., 1999; Espeut et al., 2008; Friedman &
Vale, 1999; Hammond et al., 2009; 2010; Imanishi et al., 2006; Ren et al., 2018; Verhey
et al., 1998; Verhey & Hammond, 2009), and disruption of autoinhibition can be a
mechanism of disease pathogenesis (Asselin et al., 2020; Bianchi et al., 2016; Blasius et
al., 2021; Cheng et al., 2014; Pant et al., 2022; van der Vaart et al., 2013). Mutations in
either the tail or motor domain could disrupt this interaction, preventing KIF22 inactivation
in anaphase. Dephosphorylation of both T463 in the tail and T158 in the motor domain
could facilitate this interaction.
Rather than physically interacting with the motor domain, it is also possible that
structural changes in the tail of KIF22 could have allosteric effects on the motor domain.
An allosteric mechanism by which conformational changes are propagated down the stalk
to the motor domain has recently been proposed to contribute to the inactivation of kinesin1 motors by kinesin light chain, which binds the tail (Chiba et al., 2021). KIF22 inactivation
may be caused by altered motor domain mechanochemistry, which changes in the tail could
affect allosterically and modification of a2 could affect directly. This could explain the
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effect of tail and motor domain mutations, as well as the effects of mimicking tail and
motor domain phosphorylation, on KIF22 activity.
An additional consideration is that pathogenic mutations may affect the inactivation
of KIF22 in anaphase by altering phosphoregulation of KIF22 activity. If mutations
prevented the dephosphorylation of T158 and T463 in anaphase this could cause anaphase
recongression. However, addition of a phosphonull T463A mutation to KIF22 with coiledcoil or microtubule binding domain deletions does not rescue anaphase chromosome
recongression defects (Soeda et al., 2016), suggesting that the role of the KIF22 tail in
motor inactivation is not only to facilitate dephosphorylation of T463. Future studies using
structural approaches will be required to distinguish between these possible mechanisms.
The regulation of the motor domain a2 helix in KIF22 inactivation may inform our
understanding of additional kinesin motors, as amino acids P148 and R149 are conserved
in a number of members of the kinesin superfamily (Figure 3-1 D). Similarly,
phosphorylation or acetylation of amino acids in the a2 helix has been reported for
members of the kinesin-3 (KIF13A S134) (Dephoure et al., 2008), kinesin-5 (KIF11 Y125,
K146) (Bickel et al., 2017; Choudhary et al., 2009), kinesin-6 (KIF20B S182, KIF23 S125)
(Hegemann et al., 2011; Sharma et al., 2014; Shiromizu et al., 2013), and kinesin-14
(KIFC3 S557) (Sharma et al., 2014) families. Phosphorylation of Y125 (Bickel et al., 2017)
and acetylation of K146 (Muretta et al., 2018) in KIF11 (Eg5) have been shown to
modulate motor activity, and the functions of the remaining reported post-translation
modifications in the a2 helix are yet to be characterized. Acetylation of KIF11 at K146
increases the stall force of the motor and slows anaphase spindle pole separation (Muretta
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et al., 2018). This post-translational modification represents a mechanism by which the
activity of KIF11 could be regulated at the metaphase to anaphase transition to generate
sliding forces for spindle assembly in prometaphase and control spindle pole separation in
anaphase, analogous to how post-translational modifications of KIF22 regulate motor
activity to ensure both chromosome congression and alignment in prometaphase and
chromosome segregation in anaphase.
While chromosomes in some cells, particularly those expressing KIF22-GFP at
high levels, completely failed to segregate and decondensed in the center of the spindle,
most cells demonstrated chromosome recongression wherein poleward motion of
chromosomes begins, but then chromosomes switch direction and move anti-poleward.
These dynamics may be due to differences in microtubule density closer to the poles
compared to the center of the spindle. This model is consistent with work demonstrating
that in monopolar spindles, poleward movement of chromosomes is limited by
chromosomes reaching a threshold density of microtubules at which polar ejection forces
are sufficient to cause chromosomes to switch to anti-poleward movement (Cassimeris,
Rieder, & Salmon, 1994). We observed that chromosomes on the periphery of the spindle
remain closer to the poles while central chromosomes are pushed further away from the
poles during recongression in cells expressing KIF22-GFP with pathogenic mutations. This
could also be explained by the central chromosomes encountering a higher density of
microtubules, and KIF22 bound to these chromosomes therefore generating higher levels
of polar ejection forces. In addition, this mechanism is consistent with observations that
oscillations of peripheral chromosomes are reduced compared to chromosomes at the
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center of the spindle (Cameron et al., 2006; Cimini, Cameron, & Salmon, 2004;
Civelekoglu-Scholey et al., 2013; Stumpff et al., 2008), which could also be explained by
reduced peripheral microtubule density limiting peripheral polar ejection force generation.
Our assessment of the relative trajectories of chromosomes, centromeres, and
spindle poles offers insight into the relative magnitudes of polar ejection forces and other
anaphase forces. Expression of KIF22-GFP with pathogenic mutations did not alter the
distance between centromeres and spindle poles, indicating that while anaphase polar
ejection forces altered the position of chromosome arms within the spindle, these forces
were not sufficient to prevent the shortening of k-fibers. However, the expression of mutant
KIF22-GFP did alter the movements of the spindle poles, allowing assessment of the
relative magnitude of polar ejection forces compared to the forces generated by the sliding
of antiparallel spindle microtubules to separate the spindle poles in anaphase (BrustMascher et al., 2004; Fu et al., 2009; Nislow et al., 1992; Sawin et al., 1992; Straight et al.,
1998; Tanenbaum et al., 2009; van Heesbeen et al., 2014; Vukušić et al., 2019; 2021). In
cells expressing mutant KIF22-GFP, spindle pole separation stalled, and poles moved
closer to one another during anaphase chromosome recongression. This suggests that the
polar ejection forces collectively generated by mutant KIF22 motors are of greater
magnitude than the forces sliding the spindle poles apart during anaphase B. Although it is
important to note that this phenotype was observed with moderate overexpression of
mutant KIF22, the observed effects on spindle pole separation underscore the importance
of KIF22 inactivation, and imply that reducing polar ejection forces is required for both
anaphase A and anaphase B. This force balance may differ between cell types, as tail
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domain deletions that alter chromosome movements do not disrupt anaphase B in mouse
oocyte meiosis (Soeda et al., 2016).
Patients with mutations in KIF22 exhibit defects in skeletal development. The
pathology observed in the patient heterozygous for the V475G mutation differs from those
seen in SEMDJL2 patients with motor domain mutations (Figure 3-1 E-F) (Boyden et al.,
2011; Min et al., 2011; Tüysüz et al., 2014). However, a meaningful comparison of
pathologies between patients is limited both by the fact that only a single patient with a
mutation in the tail of KIF22 has been identified, and by the considerable variation in
clinical presentation between patients with motor domain mutations, even between patients
with the same point mutation (Boyden et al., 2011; Min et al., 2011; Tüysüz et al., 2014).
The defects in chromosome segregation we observed in cells expressing mutant KIF22GFP may contribute to skeletal developmental pathogenesis. Mutations could cause
reduced proliferation of growth plate chondrocytes, which in turn could limit bone growth.
Disrupting cytokinesis in the growth plate causes shorter bones and stature in mice (Gan et
al., 2019), and mutations in KIF22 could affect development via this mechanism. The
presence of pathologies in other cartilaginous tissues, including the larynx and trachea, in
patients with mutations in the motor domain of KIF22 (Boyden et al., 2011) is also
consistent with a disease etiology based in aberrant chondrocyte proliferation. Defects in
mitosis could result in tissue-specific patient pathology based on differences in force
balance within anaphase spindles in different cell types arising from different expression
or activity levels of mitotic force generators or regulators. Growth plate chondrocytes,
particularly, are organized into columns and must divide under geometric constraints
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(Dodds, 1930), which could increase sensitivity to anaphase force imbalances.
Additionally, we cannot exclude the possibility that these mutations may affect the function
of interphase cells, which could affect development via a mechanism independent from the
effects of the mutations on mitosis. Future work will be required to distinguish among these
possible explanations.

3.5 MATERIALS AND METHODS
Patient assessment
Clinical exome sequencing was performed by the Department of Laboratory
Medicine and Pathology at Mayo Clinic in Rochester, Minnesota, USA as previously
described (Cousin et al., 2019). Carbohydrate deficient transferrin testing for congenital
disorders of glycosylation was performed at Mayo Clinic Laboratories, Rochester,
Minnesota, USA (Lefeber, Morava, & Jaeken, 2011).

Cell culture
HeLa-Kyoto and RPE-1 cell lines were grown in Minimum Essential Media a
(Gibco #12561-056) supplemented with 10% fetal bovine serum (Gibco #16000-044) at
37°C with 5% CO2. Cell lines were validated by short tandem repeat (STR) DNA typing
using the Promega GenePrint 10 System according to the manufacturer’s instructions
(Promega #B9510). Cells were cryopreserved in Recovery Cell Culture Freezing Medium
(Gibco #12648-010). HeLa-Kyoto and RPE-1 acceptor cell lines for recombination (both
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gifts from Ryoma Ohi, University of Michigan) were maintained in media supplemented
with 10 µg/mL blasticidin (Thermo Fisher Scientific #R21001).

Transfection
siRNA transfection was performed using Lipofectamine RNAiMax Transfection
Reagent (Thermo Fisher Scientific #13778150) in Opti-MEM Reduced Serum Media
(Gibco #31985-062). KIF22 was targeted for siRNA-mediated depletion using a Silencer
Validated

siRNA

(Ambion

GCUGCUCUCUAGAGAUUGCTT).

#AM51331,

sense

sequence

Control cells were transfected with Silencer

Negative Control siRNA #2 (Ambion #AM4613). DNA transfections were performed
using Lipofectamine LTX (Thermo Fisher Scientific #15338100) in Opti-MEM Reduced
Serum Media (Gibco #31985-062).

Plasmids
Plasmids related to the generation of inducible cell lines are described in Table 32. A C-terminally tagged KIF22-GFP plasmid was constructed by adding EcoRI and KpnI
sites to the KIF22 open reading frame (from pJS2161 (Stumpff et al., 2012)), performing
a restriction digest, and ligating the products into a digested pEGFP-N2 vector (Clontech)
(pAT4206). Site-directed mutagenesis was performed to add silent mutations for siRNA
resistance (pAT4226). The open reading frame from pAT4226 and the pEM791 vector
(Khandelia, Yap, & Makeyev, 2011) were amplified and combined using Gibson Assembly
(New England BioLabs) to generate a plasmid for recombination-mediated construction of
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inducible cell lines (pAT4250). Site-directed mutagenesis was performed on pAT4250 to
generate plasmids encoding KIF22-GFP P148L, P148S, R149L, R149Q, V475G, T463D,
T463A, T134D, T158D, and T158A for recombination. A plasmid encoding KIF22-GFP
T134A for recombination was generated using Gibson Assembly of a synthesized DNA
fragment (Thermo Fisher Scientific) and pAT4250. See Table 3-2 for primer sequences.
The mCh-CAAX plasmid was a gift from Alan Howe (University of Vermont).
The mCh-NLS plasmid was generated by Michael Davidson and obtained from Addgene
(mCh-Nucleus-7, #55110). The pericentrin-RFP plasmid (Gillingham & Munro, 2000) was
a gift from Sean Munro (MRC Laboratory of Molecular Biology). The CENPB-mCh
plasmid (D. Liu et al., 2010) was generated by Michael Lampson and obtained from
Addgene (#45219).

Table 3-2: Plasmids for inducible cell line generation.
Plasmid

Description

pEM784

nlCre
recombinase

pEM791

EGFP for
recombination

Primers (5' to 3', Fw: Forward, Rev: Reverse)
NA

NA

NA
pJS2161

GFP-KIF22

pAT4206

KIF22-GFP

pAT4226

KIF22-GFP,
siRNA
resistant

Fw: TACGTGGAATTCCACCATGGCCGCGGGCGGC
TCGA
Rev: GTGACTGGTACCTGGAGGCGCCACAGCGCT
GGC
Fw: GGGCATGGACAGCTGCTCACTCGAAATCGCT
AACTGGAGGAACCAC
Rev: GTGGTTCCTCCAGTTAGCGATTTCGAGTGAG
CAGCTGTCCATGCCC
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Source
Khandelia
2011
PMID
21768390
Khandelia
2011
PMID
21768390
Stumpff
2012
PMID
22595673
This
study
This
study

pAT4250

KIF22-GFP,
siRNA
resistant, for
recombination

pAT4251

KIF22-GFP
R149Q

pAT4258

KIF22-GFP
V475G

pAT4260
pAT4261
pAT4264
pAT4269
pAT4270

KIF22-GFP
T463D
KIF22-GFP
T463A
KIF22-GFP
R149L
KIF22-GFP
P148L
KIF22-GFP
P148S

pSS4279

KIF22-GFP
T134A

pSS4281

KIF22-GFP
T134D

pNA4285
pNA4284

KIF22-GFP
T158A
KIF22-GFP
T158D

Fragment Fw: CTGGGCACCACCATGGCCGCG
Fragment Rev: GCTAGCTCGATTACTTGTACAGCTC
GTCCATGCC
Vector Fw: GTACAAGTAATCGAGCTAGCATAT
GGATCCATATAACT
Vector Rev: CATGGTGGTGCCCAGTGCCTCACG
ACC
Fw: GGGGTGATCCCGCAGGCTCTCATGGAC
Rev: GTCCATGAGAGCCTGCGGGATCACCCC
Fw: TGCTAATGAAGACAGGAGAAGAGAAGGAC
CT
Rev: AGGTCCTTCTCTTCTCCTGTCTTCATTAGCA
Fw: CCCCTCTGTTGAGTGACCCAAAGCGAGAGC
Rev: GCTCTCGCTTTGGGTCACTCAACAGAGGGG
Fw: CCTCTGTTGAGTGCCCCAAAGCGAG
Rev: CTCGCTTTGGGGCACTCAACAGAGG
Fw: GGGTGATCCCGCTGGCTCTCATGGAC
Rev: GTCCATGAGAGCCAGCGGGATCACCC
Fw: CCTGGGGTGATCCTGCGGGCTCTCATG
Rev: CATGAGAGCCCGCAGGATCACCCCAGG
Fw: CTGGGGTGATCTCGCGGGCTCTCATG
Rev: CATGAGAGCCCGCGAGATCACCCCAG
Fragment Fw: AGCTGCTCACTCGAAATCGC
Fragment Rev: AGTCTTTCTCGGATTACCAGG
Vector Fw: CCTGGTAATCCGAGAAGACT
Vector Rev: GCGATTTCGAGTGAGCAGCT
Fw: CAGGAGCTGGGAAGGATCACACAATGCTGG
GC
Rev: GCCCAGCATTGTGTGATCCTTCCCAGCTCC
TG
Fw: AGCTCGCAAGGGAGGAGGGTG
Rev: GAGTACCTGGAGGACGTCGA
Fw: CCTCCTGCAGCTCAGGGAGGAGGGTG
Rev: CACCCTCCTCCCTGAGCTGCAGGAGG

This
study

This
study
This
study
This
study
This
study
This
study
This
study
This
study
This
study
This
study
This
study
This
study

Generation of inducible cell lines
Inducible cell lines were generated using recombination-mediated cassette
exchange as previously described (Khandelia et al., 2011). Briefly, plasmids (see Table 32) encoding siRNA-resistant KIF22-GFP constructs were cotransfected with a plasmid
encoding nuclear-localized Cre recombinase (pEM784) into HeLa-Kyoto (Sturgill et al.,
2016) or RPE-1 acceptor cells using Lipofectamine LTX transfection (Thermo Fisher
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Scientific #15338100). For HeLa-Kyoto cell lines, 24 hours after transfection cells were
treated with 1 µg/mL puromycin (Thermo Fisher Scientific #A11139-03) for 48 hours, then
2 µg/mL puromycin for 48 hours for more stringent selection, and finally 1 µg/mL
puromycin until puromycin-sensitive cells were eliminated. Selection of RPE-1 cells was
accomplished via treatment with 5 µg/mL puromycin for 48 hours beginning 24 hours after
transfection, then 10 µg/mL puromycin for 48 hours, and finally 5 µg/mL puromycin until
puromycin-sensitive cells were eliminated. Inducible cell lines were maintained in
puromycin (HeLa-Kyoto 1 µg/mL, RPE-1 5 µg/mL) for continued selection. To confirm
the sequence of inserted DNA in the selected cell populations, genomic DNA was extracted
using the QIAmp DNA Blood Mini Kit (Qiagen #51106) and subjected to sequencing
(Eurofins). Expression of inserted DNA sequences was induced via treatment with 2
µg/mL doxycycline (Thermo Fisher Scientific #BP26531).

Immunofluorescence
For fixed cell imaging, cells were grown on 12 mm glass coverslips in 24-well
plates. Cells were fixed in 1% paraformaldehyde in ice-cold methanol for 10 minutes on
ice. Cells were blocked for 1 hour using 20% goat serum (Gibco #16210-064) in antibody
dilution buffer (AbDil, 1% bovine serum albumin (Sigma Aldrich #B4287), 0.1% Triton
X-100 (Sigma Aldrich #93443), 0.02% sodium azide (Fisher Scientific #BP9221) in TBS)
and incubated with the following primary antibodies for one hour at room temperature:
mouse anti-a-tubulin (DM1a) 1:500 (Millipore Sigma #T6199), rat anti-tubulin clone
YL1/2 1:1500 (Millipore Sigma #MAB1864), rabbit anti-KIF22 1:500 (GeneTex
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#GTX112357), mouse anti-centrin 1:500 (Millipore Sigma #04-1624), or rabbit anti-GFP
1:1000 (Invitrogen #A11121). Cells were incubated with secondary antibodies conjugated
to AlexaFluor 488, 594, or 647 (Invitrogen Molecular Probes #A11034, A11037, A21245,
A11029, A11032, A21236, A11007) for one hour at room temperature. All incubations
were performed on an orbital shaker. Coverslips were mounted on slides using Prolong
Gold mounting medium with DAPI (Invitrogen Molecular Probes #P36935).

Microscopy
Images were acquired using a Nikon Ti-E or Ti-2E inverted microscope driven by
NIS Elements software (Nikon Instruments). Images were captured using a Clara cooled
charge-coupled device (CCD) camera (Andor) or Prime BSI scientific complementary
metal-oxide-semiconductor (sCMOS) camera (Teledyne Photometrics) with a Spectra-X
light engine (Lumencore). Samples were imaged using Nikon objectives Plan Apo 40X
0.95 numerical aperture (NA), Plan Apo λ 60X 1.42 NA, and APO 100X 1.49 NA. For live
imaging, cells were imaged in CO2-independent media (Gibco #18045-088) supplemented
with 10% fetal bovine serum (Gibco #16000-044) in a 37º C environmental chamber.
Images were processed and analyzed using Image J/FIJI (Schindelin et al., 2012;
Schneider, Rasband, & Eliceiri, 2012).

KIF22-GFP expression level quantitation
HeLa-Kyoto or RPE-1 cells were treated with 2 µg/mL doxycycline to induce
expression and transfected with control or KIF22 siRNA approximately 24 hours prior to
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fixation. Metaphase cells were imaged for measurement of KIF22 expression levels.
Measurements of KIF22 immunofluorescence intensity were made in a background region
of interest (ROI) containing no cells and an ROI representing the chromosomes, identified
by thresholding DAPI signal. The mean background subtracted KIF22 signal on the
chromosomes was calculated by subtracting the product of the mean background intensity
and the chromosome ROI area from the chromosome ROI integrated density and dividing
by the area of the chromosome ROI. KIF22 intensities were normalized to the mean KIF22
intensity in control cells (control knockdown, uninduced) in each experimental replicate.

Metaphase chromosome spreads
RPE-1 cells were grown in 60 mm dishes for approximately 24 hours. Media was
exchanged to fresh growth media for 2 hours to promote mitosis. Cells were arrested in
0.02 µg/mL colcemid (Gibco KaryoMAX #15212012) for three hours at 37°C, then
trypsinized, pelleted, and gently re-suspended in 500 µL media. 5 mL 0.56% KCl
hypotonic solution was added dropwise to the cell suspension, which was then incubated
for 15 minutes in a 37°C water bath. Cells were pelleted, gently resuspended, and fixed via
the addition of 1 mL ice-cold 3:1 methanol:glacial acetic acid. Cells were pelleted and
resuspended in fixative an additional three times, then stored at -20°C. Metaphase
chromosome spreads were prepared by humidifying the surface of glass slides by exposing
them to the steam above a 50°C water bath, placing the slides at an angle relative to the
work surface, and dropping approximately 100 µL of ice-cold cell suspension onto the slide
from a height of approximately one foot. Slides were dried on a hot plate, then covered
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with Prolong Gold mounting medium with DAPI (Invitrogen Molecular Probes #P36935)
and sealed.

Fluorescence recovery after photobleaching
HeLa-Kyoto cells were seeded in glass-bottom 35 mm dishes (Greiner Bio-One
#627975 and #627965) and treated with 2 µg/mL doxycycline to induce expression 18-24
hours before imaging. Cells were imaged at 5 second intervals for 25 seconds before
bleaching, photobleached using a point-focused 405 nm laser, and imaged at 20 second
intervals for 10 minutes after bleaching. Fluorescence intensities in bleached, unbleached,
and background regions of each frame were measured using a circular ROI, area 0.865
µm2. For interphase and metaphase cells, unbleached measurements were made on the
opposite side of the nucleus or chromosome mass as the bleached measurements. For
anaphase cells, one segregating chromosome mass was bleached, and unbleached
measurements were made on the opposite chromosome mass. Background intensities,
measured in cell-free area, were subtracted from bleached and unbleached intensities.
Background-subtracted intensities were normalized to the intensity of the first frame
imaged.

Polar ejection force assay
HeLa-Kyoto cells were treated with 2 µg/mL doxycycline to induce expression and
transfected with control or KIF22 siRNA approximately 24 hours prior to fixation. Cells
were arrested in 100 µM monastrol (Selleckchem #S8439) for 2-3 hours before fixation.
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Monopolar mitotic cells oriented perpendicular to the coverslip were imaged at the focal
plane of the spindle pole for polar ejection force measurements. A circular ROI with a 12.5
µm radius was centered around the spindle pole of each cell, and the radial profile of DAPI
signal intensity at distances from the pole was measured (Radial Profile Plot plugin,
https://imagej.nih.gov/ij/plugins/radial-profile.html). The distance from the pole to the
maximum DAPI signal was calculated for each cell as a measure of relative polar ejection
forces (A. F. Thompson, Vandal, & Stumpff, 2022) (Appendix B).

Analyses of anaphase chromosome segregation
HeLa-Kyoto or RPE-1 cells were treated with 2 µg/mL doxycycline to induce
expression approximately 18 hours before imaging. For HeLa-Kyoto cells, media was
exchanged to CO2-indpendent media containing 2 µg/mL doxycycline and 100 nM SiRTubulin (Spirochrome #SC002) approximately 1-1.5 hours before imaging. For RPE-1
cells, media was exchanged to CO2-indpendent media containing 2 µg/mL doxycycline,
20-100 nM SiR-Tubulin (Spirochrome #SC002), and 10 µM verapamil (Spirochrome
#SCV01) approximately 1.5-3 hours before imaging. Cells were imaged at 1 minute time
intervals. Distances between segregating chromosome masses were measured by plotting
the KIF22-GFP signal intensity along a line drawn through both spindle poles (macro
available at https://github.com/StumpffLab/Image-Analysis). This data set was split at the
center distance to generate two plots, each representing one half-spindle/segregating
chromosome mass. The distance between the maximum of each intensity plot was
calculated using MATLAB (Mathworks, Version R2018a) (script available at
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https://github.com/StumpffLab/Image-Analysis). To assess the broadness of segregating
chromosome masses in cells expressing KIF22-GFP T463A, a Gaussian curve was fit to
the same intensity plots and the full width at half maximum was calculated in MATLAB.
To measure the movements of spindle poles and kinetochores in anaphase, HeLaKyoto cells were seeded in glass-bottom 24-well plates (Cellvis #P24-1.5H-N) and
cotransfected with PCM-RFP and mCh-CENPB using Lipofectamine LTX (Thermo Fisher
Scientific #15338100) approximately 24 hours before imaging. Cells were treated with 2
µg/mL doxycycline to induce expression approximately 12-18 hours before imaging. Cells
were imaged at 20 second time intervals. To more clearly visualize spindle poles and
kinetochores, images of PCM-RFP and mCh-CENPB signal were background subtracted
by duplicating each frame, applying a gaussian blur (sigma 30 pixels), and subtracting this
blurred image from the original. For each frame, a line was drawn between spindle poles
(PCM-RFP signal) to measure the distance between them, and the intensity of KIF22-GFP
and mCh-CENPB along this line was plotted. These data sets were split at the center
distance to generate two plots, and the distance between plot maxima and the distance from
maxima to the spindle poles were calculated using MATLAB (scripts available at
https://github.com/StumpffLab/Image-Analysis).

Assessment of cytokinesis failure
To visualize cell boundaries, HeLa-Kyoto cells were transfected with mChCAAX using Lipofectamine LTX approximately 24-32 hours before imaging and treated
with 2 µg/mL doxycycline approximately 8 hours before imaging. Cells were imaged at 3154

minute intervals. Cells were scored as failing cytokinesis if the product of mitosis was a
single cell with a single boundary of mCh-CAAX signal.

Nuclear morphology quantification
HeLa-Kyoto or RPE-1 cells were treated with 2 µg/mL doxycycline to induce
expression approximately 24 hours before fixation. Nuclear solidity was measured for each
interphase nucleus in each imaged field. The 5th percentile of solidity for control cells
(transfected with control siRNA and expressing GFP) was used as a threshold below which
nuclear solidity was considered abnormal.
To assess the ability of nuclei to retain nuclear-localized proteins, cells were
transfected with mCh-NLS using Lipofectamine LTX approximately 24-32 hours before
imaging and treated with 2 µg/mL doxycycline approximately 8 hours before imaging.
Cells were imaged at 3-minute intervals during and after division, and the presence of mChNLS signal in all nuclear structures (KIF22-GFP positive regions) was assessed.

Assessment of spindle dependence of nuclear morphology defects
To assess whether nuclear morphology defects caused by KIF22 depend on force
generation within the mitotic spindle, cells were treated with 2 µg/mL doxycycline
approximately 8 hours before imaging, SPY595-DNA (1X per manufacturer’s instructions)
(Spirochrome #SC301) approximately 1.5-2 hours before imaging, and 500 nM nocodazole
(Selleckchem #S2775) and 900 nM reversine (Cayman Chemical #10004412)
approximately 0.5-1 hour before imaging. Cells were imaged at 5-minute intervals. Nuclear
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solidity was measured 15 minutes before chromosome condensation and 100 minutes after
chromosome decondensation.

Proliferation assay
HeLa-Kyoto cells were seeded in a 96-well plate and treated with 2 µg/mL
doxycycline to induce expression or transfected with KIF22 siRNA approximately eight
hours before the first assay timepoint. Automated bright field imaging using a Cytation 5
Cell Imaging Multi-Mode Reader (Biotek) (4X Plan Fluorite 0.13 NA objective
(Olympus)) driven by Gen5 software (Biotek) was used to measure cell proliferation
(Marquis et al., 2021). Images were collected every 4 hours for 96 hours. Gen5 software
was used to process images and count the number of cells in each imaged field. Cell counts
were normalized to the cell count in the first image acquired at time 0. Only wells with first
frame cell counts between 10,000 and 20,000 were analyzed to account for the effects of
cell density. Fold change at 96 hours was calculated by dividing the cell count at 96 hours
by the cell count at time 0. Predicted cell counts at 48 hours were calculated using an
experimentally determined doubling time of 20.72 hours for the control case where all cells
%

divide (𝐶𝑒𝑙𝑙𝑠9 = 2(&'.)&) ), the case where nuclear morphology defects limit proliferation
%

and 60% of cells do not divide (𝐶𝑒𝑙𝑙𝑠9 = 1.4(&'.)&) ), and the case where cytokinesis failure
%

limits proliferation and 30% of cells do not divide (𝐶𝑒𝑙𝑙𝑠9 = 1.7(&'.)&) ).

Statistical analyses
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Statistical tests were performed using GraphPad Prism software (GraphPad
Software, Inc.), version 9.2.0. Specific statistical tests and n values for reported data are
indicated in the figure legends. All data represent a minimum of three independent
experiments.

3.6 ACKNOWLEDGEMENTS
This work was supported by NIH F31AR074887 to AFT, NIH R01GM130556 to
JKS, NIH R01GM121491 to JKS, and the Ballenger Ventures Fund for Research
Excellence. We thank the Mayo Clinic Center for Individualized Medicine (CIM) for
supporting this research through the CIM Investigative and Functional Genomics program.
We thank Alan Howe for the mCh-CAAX plasmid, and Ryoma Ohi for reagents and
acceptor cells for recombination-mediated cassette exchange. We thank Rachel Stadler for
technical assistance with data analysis and thank Laura Reinholdt and Matthew Warman
for constructive discussions regarding this work.

3.7 REFERENCES
Adzhubei, I. A., Schmidt, S., Peshkin, L., Ramensky, V. E., Gerasimova, A., Bork, P., et
al. (2010). A method and server for predicting damaging missense mutations. Nature
Methods, 7(4), 248–249. http://doi.org/10.1038/nmeth0410-248
Antonio, C., Ferby, I., Wilhelm, H., Jones, M., Karsenti, E., Nebreda, A. R., & Vernos, I.
(2000). Xkid, a chromokinesin required for chromosome alignment on the metaphase
plate. Cell, 102(4), 425–435. http://doi.org/10.1016/s0092-8674(00)00048-9
Asbury, C. L. (2017). Anaphase A: Disassembling Microtubules Move Chromosomes
toward Spindle Poles. Biology, 6(1), 15. http://doi.org/10.3390/biology6010015
Asselin, L., Alvarez, J. R., Heide, S., Bonnet, C. S., Tilly, P., Vitet, H., et al. (2020).
Mutations in the KIF21B kinesin gene cause neurodevelopmental disorders through
imbalanced canonical motor activity. Nature Communications, 1–18.
http://doi.org/10.1038/s41467-020-16294-6
157

Bianchi, S., van Riel, W. E., Kraatz, S. H. W., Olieric, N., Frey, D., Katrukha, E. A., et al.
(2016). Structural basis for misregulation of kinesin KIF21A autoinhibition by
CFEOM1
disease
mutations.
Scientific
Reports,
6(1),
30668–16.
http://doi.org/10.1038/srep30668
Bickel, K. G., Mann, B. J., Waitzman, J. S., Poor, T. A., Rice, S. E., & Wadsworth, P.
(2017). Src family kinase phosphorylation of the motor domain of the human kinesin5,
Eg5.
Cytoskeleton
(Hoboken,
N.J.),
74(9),
317–330.
http://doi.org/10.1002/cm.21380
Bieling, P., Kronja, I., & Surrey, T. (2010). Microtubule Motility on Reconstituted Meiotic
Chromatin.
Current
Biology,
20(8),
763–769.
http://doi.org/10.1016/j.cub.2010.02.067
Blasius, T. L., Yue, Y., Prasad, R., Liu, X., Gennerich, A., & Verhey, K. J. (2021).
Sequences in the stalk domain regulate auto-inhibition and ciliary tip localization of
the immotile kinesin-4 KIF7. Journal of Cell Science, 134(13).
http://doi.org/10.1242/jcs.258464
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C. P., Morin, G. B., et al.
(1998). Extension of life-span by introduction of telomerase into normal human cells.
Science
(New
York,
N.Y.),
279(5349),
349–352.
http://doi.org/10.1126/science.279.5349.349
Boyden, E. D., Campos-Xavier, A. B., Kalamajski, S., Cameron, T. L., Suarez, P.,
Tanackovic, G., et al. (2011). Recurrent dominant mutations affecting two adjacent
residues in the motor domain of the monomeric kinesin KIF22 result in skeletal
dysplasia and joint laxity. American Journal of Human Genetics, 89(6), 767–772.
http://doi.org/10.1016/j.ajhg.2011.10.016
Brouhard, G. J., & Hunt, A. J. (2005). Microtubule movements on the arms of mitotic
chromosomes: polar ejection forces quantified in vitro. Proceedings of the National
Academy
of
Sciences,
102(39),
13903–13908.
http://doi.org/10.1073/pnas.0506017102
Brust-Mascher, I., Civelekoglu-Scholey, G., Kwon, M., Mogilner, A., & Scholey, J. M.
(2004). Model for anaphase B: role of three mitotic motors in a switch from poleward
flux to spindle elongation. Proceedings of the National Academy of Sciences, 101(45),
15938–15943. http://doi.org/10.1073/pnas.0407044101
Cameron, L. A., Yang, G., Cimini, D., Canman, J. C., Kisurina-Evgenieva, O., Khodjakov,
A., et al. (2006). Kinesin 5-independent poleward flux of kinetochore microtubules in
PtK1
cells.
The
Journal
of
Cell
Biology,
173(2),
173–179.
http://doi.org/10.1083/jcb.200601075
Cassimeris, L., Rieder, C. L., & Salmon, E. D. (1994). Microtubule Assembly and
Kinetochore Directional Instability in Vertebrate Monopolar Spindles - Implications
for the Mechanism of Chromosome Congression. Journal of Cell Science, 107, 285–
297.
Cheng, L., Desai, J., Miranda, C. J., Duncan, J. S., Qiu, W., Nugent, A. A., et al. (2014).
Human CFEOM1 Mutations Attenuate KIF21A Autoinhibition and Cause Oculomotor
Axon Stalling. Neuron, 82(2), 334–349. http://doi.org/10.1016/j.neuron.2014.02.038
158

Chiba, K., Ori-McKenney, K. M., Niwa, S., & McKenney, R. J. (2021). Reconstitution of
Kinesin-1 Activation. Biorxiv.org
. http://doi.org/10.1101/2021.03.12.434960
Choudhary, C., Kumar, C., Gnad, F., Nielsen, M. L., Rehman, M., Walther, T. C., et al.
(2009). Lysine acetylation targets protein complexes and co-regulates major cellular
functions.
Science
(New
York,
N.Y.),
325(5942),
834–840.
http://doi.org/10.1126/science.1175371
Cimini, D., Cameron, L. A., & Salmon, E. D. (2004). Anaphase spindle mechanics prevent
mis-segregation of merotelically oriented chromosomes. Current Biology, 14(23),
2149–2155. http://doi.org/10.1016/j.cub.2004.11.029
Civelekoglu-Scholey, G., He, B., Shen, M., Wan, X., Roscioli, E., Bowden, B., & Cimini,
D. (2013). Dynamic bonds and polar ejection force distribution explain kinetochore
oscillations in PtK1 cells. The Journal of Cell Biology, 201(4), 577–593.
http://doi.org/10.1083/jcb.201301022
Cousin, M. A., Conboy, E., Wang, J.-S., Lenz, D., Schwab, T. L., Williams, M., et al.
(2019). RINT1 Bi-allelic Variations Cause Infantile-Onset Recurrent Acute Liver
Failure and Skeletal Abnormalities. American Journal of Human Genetics, 105(1),
108–121. http://doi.org/10.1016/j.ajhg.2019.05.011
Coy, D. L., Hancock, W. O., Wagenbach, M., & Howard, J. (1999). Kinesin's tail domain
is an inhibitory regulator of the motor domain. Nature Cell Biology, 1(5), 288–292.
http://doi.org/10.1038/13001
Dephoure, N., Zhou, C., Villén, J., Beausoleil, S. A., Bakalarski, C. E., Elledge, S. J., &
Gygi, S. P. (2008). A quantitative atlas of mitotic phosphorylation. Proceedings of the
National Academy of Sciences of the United States of America, 105(31), 10762–10767.
http://doi.org/10.1073/pnas.0805139105
Dodds, G. S. (1930). Row formation and other types of arrangement of cartilage cells in
endochondral ossification. The Anatomical Record, 46(4), 385–399.
http://doi.org/10.1002/ar.1090460409
Espeut, J., Gaussen, A., Bieling, P., Morin, V., Prieto, S., Fesquet, D., et al. (2008).
Phosphorylation Relieves Autoinhibition of the Kinetochore Motor Cenp-E.
Molecular Cell, 29(5), 637–643. http://doi.org/10.1016/j.molcel.2008.01.004
Friedman, D. S., & Vale, R. D. (1999). Single-molecule analysis of kinesin motility reveals
regulation by the cargo-binding tail domain. Nature Cell Biology, 1(5), 293–297.
http://doi.org/10.1038/13008
Fu, C., Ward, J. J., Loiodice, I., Velve-Casquillas, G., Nedelec, F. J., & Tran, P. T. (2009).
Phospho-Regulated Interaction between Kinesin-6 Klp9p and Microtubule Bundler
Ase1p Promotes Spindle Elongation. Developmental Cell, 17(2), 257–267.
http://doi.org/10.1016/j.devcel.2009.06.012
Funabiki, H., & Murray, A. W. (2000). The Xenopus chromokinesin Xkid is essential for
metaphase chromosome alignment and must be degraded to allow anaphase
chromosome movement. Cell, 102(4), 411–424.
Gan, H., Xue, W., Gao, Y., Zhu, G., Chan, D., Cheah, K. S. E., & Huang, J. (2019). KIF5B
modulates central spindle organization in late-stage cytokinesis in chondrocytes. Cell
& Bioscience, 1–16. http://doi.org/10.1186/s13578-019-0344-5
159

Gillingham, A. K., & Munro, S. (2000). The PACT domain, a conserved centrosomal
targeting motif in the coiled-coil proteins AKAP450 and pericentrin. EMBO Reports,
1(6), 524–529. http://doi.org/10.1093/embo-reports/kvd105
Haila, S., Hästbacka, J., Böhling, T., Karjalainen-Lindsberg, M. L., Kere, J., & SaarialhoKere, U. (2001). SLC26A2 (diastrophic dysplasia sulfate transporter) is expressed in
developing and mature cartilage but also in other tissues and cell types. The Journal of
Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society,
49(8), 973–982. http://doi.org/10.1177/002215540104900805
Hammond, J. W., Blasius, T. L., Soppina, V., Cai, D., & Verhey, K. J. (2010).
Autoinhibition of the kinesin-2 motor KIF17 via dual intramolecular mechanisms. The
Journal of Cell Biology, 189(6), 1013–1025. http://doi.org/10.1083/jcb.201001057
Hammond, J. W., Cai, D., Blasius, T. L., Li, Z., Jiang, Y., Jih, G. T., et al. (2009).
Mammalian Kinesin-3 Motors Are Dimeric In Vivo and Move by Processive Motility
upon Release of Autoinhibition. PLOS Biology, 7(3), e1000072–14.
http://doi.org/10.1371/journal.pbio.1000072
Hatch, E. M., Fischer, A. H., Deerinck, T. J., & Hetzer, M. W. (2013). Catastrophic Nuclear
Envelope Collapse in Cancer Cell Micronuclei. Cell, 154(1), 47–60.
http://doi.org/10.1016/j.cell.2013.06.007
Hegemann, B., Hutchins, J. R. A., Hudecz, O., Novatchkova, M., Rameseder, J., Sykora,
M. M., et al. (2011). Systematic phosphorylation analysis of human mitotic protein
complexes. Science Signaling, 4(198), rs12. http://doi.org/10.1126/scisignal.2001993
Hershko, A. (1999). Mechanisms and regulation of the degradation of cyclin B.
Philosophical Transactions of the Royal Society of London. Series B, Biological
Sciences,
354(1389),
1571–5–
discussion
1575–6.
http://doi.org/10.1098/rstb.1999.0500
Iemura, K., & Tanaka, K. (2015). Chromokinesin Kid and kinetochore kinesin CENP-E
differentially support chromosome congression without end-on attachment to
microtubules. Nature Communications, 6, 1–11. http://doi.org/10.1038/ncomms7447
Imanishi, M., Endres, N. F., Gennerich, A., & Vale, R. D. (2006). Autoinhibition regulates
the motility of the C. elegans intraflagellar transport motor OSM-3. The Journal of
Cell Biology, 174(7), 931–937. http://doi.org/10.1083/jcb.200605179
Ioannidis, N. M., Rothstein, J. H., Pejaver, V., Middha, S., McDonnell, S. K., Baheti, S.,
et al. (2016). REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare
Missense Variants. The American Journal of Human Genetics, 99(4), 877–885.
http://doi.org/10.1016/j.ajhg.2016.08.016
Kettenbach, A. N., Schweppe, D. K., Faherty, B. K., Pechenick, D., Pletnev, A. A., &
Gerber, S. A. (2011). Quantitative phosphoproteomics identifies substrates and
functional modules of Aurora and Polo-like kinase activities in mitotic cells. Science
Signaling, 4(179), rs5. http://doi.org/10.1126/scisignal.2001497
Khandelia, P., Yap, K., & Makeyev, E. V. (2011). Streamlined platform for short hairpin
RNA interference and transgenesis in cultured mammalian cells. Proceedings of the
National Academy of Sciences of the United States of America, 108(31), 12799–12804.
http://doi.org/10.1073/pnas.1103532108
160

Lefeber, D. J., Morava, E., & Jaeken, J. (2011). How to find and diagnose a CDG due to
defective N-glycosylation. Journal of Inherited Metabolic Disease, 34(4), 849–852.
http://doi.org/10.1007/s10545-011-9370-0
Levesque, A. A., & Compton, D. A. (2001). The chromokinesin Kid is necessary for
chromosome arm orientation and oscillation, but not congression, on mitotic spindles.
The
Journal
of
Cell
Biology,
154(6),
1135–1146.
http://doi.org/10.1083/jcb.200106093
Levesque, A. A., Howard, L., Gordon, M. B., & Compton, D. A. (2003). A functional
relationship between NuMA and kid is involved in both spindle organization and
chromosome alignment in vertebrate cells. Molecular Biology of the Cell, 14(9), 3541–
3552. http://doi.org/10.1091/mbc.E03-02-0082
Liu, D., Vleugel, M., Backer, C. B., Hori, T., Fukagawa, T., Cheeseman, I. M., & Lampson,
M. A. (2010). Regulated targeting of protein phosphatase 1 to the outer kinetochore by
KNL1 opposes Aurora B kinase. The Journal of Cell Biology, 188(6), 809–820.
http://doi.org/10.1083/jcb.201001006
Liu, Y., Mi, Y., Mueller, T., Kreibich, S., Williams, E. G., Van Drogen, A., et al. (2018).
Genomic, Proteomic and Phenotypic Heterogeneity in HeLa Cells across Laboratories:
Implications for Reproducibility of Research Results. bioRxiv, 307421.
http://doi.org/10.1101/307421
Marquis, C., Fonseca, C. L., Queen, K. A., Wood, L., Vandal, S. E., Malaby, H. L. H., et
al. (2021). Chromosomally unstable tumor cells specifically require KIF18A for
proliferation. Nature Communications, 1–14. http://doi.org/10.1038/s41467-02121447-2
Marshall, W. F., Marko, J. F., Agard, D. A., & Sedat, J. W. (2001). Chromosome elasticity
and mitotic polar ejection force measured in living Drosophila embryos by fourdimensional microscopy-based motion analysis. Current Biology, 11(8), 569–578.
http://doi.org/10.1016/s0960-9822(01)00180-4
Min, B.-J., Kim, N., Chung, T., Kim, O.-H., Nishimura, G., Chung, C. Y., et al. (2011).
Whole-exome sequencing identifies mutations of KIF22 in spondyloepimetaphyseal
dysplasia with joint laxity, leptodactylic type. American Journal of Human Genetics,
89(6), 760–766. http://doi.org/10.1016/j.ajhg.2011.10.015
Morgan, D. O. (1995). Principles of CDK regulation. Nature, 374(6518), 131–134.
http://doi.org/10.1038/374131a0
Muretta, J. M., Reddy, B. J. N., Scarabelli, G., Thompson, A. F., Jariwala, S., Major, J., et
al. (2018). A posttranslational modification of the mitotic kinesin Eg5 that enhances
its mechanochemical coupling and alters its mitotic function. Proceedings of the
National
Academy
of
Sciences,
74,
201718290–10.
http://doi.org/10.1073/pnas.1718290115
Nislow, C., Lombillo, V. A., Kuriyama, R., & McIntosh, J. R. (1992). A plus-end-directed
motor enzyme that moves antiparallel microtubules in vitro localizes to the interzone
of mitotic spindles. Nature, 359(6395), 543–547. http://doi.org/10.1038/359543a0
Ohsugi, M., Adachi, K., Horai, R., Kakuta, S., Sudo, K., Kotaki, H., et al. (2008). KidMediated Chromosome Compaction Ensures Proper Nuclear Envelope Formation.
Cell, 132(5), 771–782. http://doi.org/10.1016/j.cell.2008.01.029
161

Ohsugi, M., Tokai-Nishizumi, N., Shiroguchi, K., Toyoshima, Y. Y., Inoue, J.-I., &
Yamamoto, T. (2003). Cdc2-mediated phosphorylation of Kid controls its distribution
to spindle and chromosomes. The EMBO Journal, 22(9), 2091–2103.
http://doi.org/10.1093/emboj/cdg208
Olsen, J. V., Vermeulen, M., Santamaria, A., Kumar, C., Miller, M. L., Jensen, L. J., et al.
(2010). Quantitative phosphoproteomics reveals widespread full phosphorylation site
occupancy
during
mitosis.
Science
Signaling,
3(104),
ra3.
http://doi.org/10.1126/scisignal.2000475
Pant, D., Parameswaran, J., Rao, L., Shi, L., Chilukuri, G., McEachin, Z. T., et al. (2022).
ALS-linked KIF5A ΔExon27 mutant causes neuronal toxicity through gain of
function. Biorxiv.org. http://doi.org/10.1101/2022.03.05.483071
Quang, D., Chen, Y., & Xie, X. (2015). DANN: a deep learning approach for annotating
the pathogenicity of genetic variants. Bioinformatics (Oxford, England), 31(5), 761–
763. http://doi.org/10.1093/bioinformatics/btu703
Ren, J., Wang, S., Chen, H., Wang, W., Huo, L., & Feng, W. (2018). Coiled-coil 1mediated fastening of the neck and motor domains for kinesin-3 autoinhibition.
Proceedings of the National Academy of Sciences of the United States of America,
115(51), E11933–E11942. http://doi.org/10.1073/pnas.1811209115
Rentzsch, P., Witten, D., Cooper, G. M., Shendure, J., & Kircher, M. (2018). CADD:
predicting the deleteriousness of variants throughout the human genome, 1–9.
http://doi.org/10.1093/nar/gky1016
Rieder, C. L., & Salmon, E. D. (1994). Motile kinetochores and polar ejection forces dictate
chromosome position on the vertebrate mitotic spindle. The Journal of Cell Biology,
124(3), 223–233. http://doi.org/10.1083/jcb.124.3.223
Rieder, C. L., Davison, E. A., Jensen, L. C., Cassimeris, L., & Salmon, E. D. (1986).
Oscillatory movements of monooriented chromosomes and their position relative to
the spindle pole result from the ejection properties of the aster and half-spindle. The
Journal of Cell Biology, 103(2), 581–591. http://doi.org/10.1083/jcb.103.2.581
Rigbolt, K. T. G., Prokhorova, T. A., Akimov, V., Henningsen, J., Johansen, P. T.,
Kratchmarova, I., et al. (2011). System-wide temporal characterization of the proteome
and phosphoproteome of human embryonic stem cell differentiation. Science
Signaling, 4(164), rs3. http://doi.org/10.1126/scisignal.2001570
Ris, H. (1949). The anaphase movement of chromosomes in the spermatocytes of the
grasshopper. The Biological Bulletin, 96(1), 90–106.
Rossi, A., & Superti-Furga, A. (2001). Mutations in the diastrophic dysplasia sulfate
transporter (DTDST) gene (SLC26A2): 22 novel mutations, mutation review,
associated skeletal phenotypes, and diagnostic relevance. Human Mutation, 17(3),
159–171. http://doi.org/10.1002/humu.1
Samwer, M., Schneider, M. W. G., Hoefler, R., Schmalhorst, P. S., Jude, J. G., Zuber, J.,
& Gerlich, D. W. (2017). DNA Cross-Bridging Shapes a Single Nucleus from a Set of
Mitotic
Chromosomes.
Cell,
170(5),
956–972.e23.
http://doi.org/10.1016/j.cell.2017.07.038

162

Sawin, K. E., LeGuellec, K., Philippe, M., & Mitchison, T. J. (1992). Mitotic spindle
organization by a plus-end-directed microtubule motor. Nature, 359(6395), 540–543.
http://doi.org/10.1038/359540a0
Schindelin, J., Arganda-Carreras, I., Frise, E., Kaynig, V., Longair, M., Pietzsch, T., et al.
(2012). Fiji: an open-source platform for biological-image analysis. Nature Methods,
9(7), 676–682. http://doi.org/10.1038/nmeth.2019
Schneider, C. A., Rasband, W. S., & Eliceiri, K. W. (2012). NIH Image to ImageJ: 25 years
of image analysis. Nature Methods, 1–5. http://doi.org/10.1038/nmeth.2089
Schwarz, J. M., Rödelsperger, C., Schuelke, M., & Seelow, D. (2010). MutationTaster
evaluates disease-causing potential of sequence alterations. Nature Publishing Group,
1–2. http://doi.org/10.1038/nmeth0810-575
Serra-Marques, A., Houtekamer, R., Hintzen, D., Canty, J. T., Yildiz, A., & Dumont, S.
(2020). The mitotic protein NuMA plays a spindle-independent role in nuclear
formation and mechanics. The Journal of Cell Biology, 219(12), 348–23.
http://doi.org/10.1083/jcb.202004202
Sharma, K., D'Souza, R. C. J., Tyanova, S., Schaab, C., Wisniewski, J. R., Cox, J., & Mann,
M. (2014). Ultradeep Human Phosphoproteome Reveals a Distinct Regulatory Nature
of Tyr and Ser/Thr-Based Signaling. Cell Reports, 8(5), 1583–1594.
http://doi.org/10.1016/j.celrep.2014.07.036
Shiroguchi, K., Ohsugi, M., Edamatsu, M., Yamamoto, T., & Toyoshima, Y. Y. (2003).
The Second Microtubule-binding Site of Monomeric Kid Enhances the Microtubule
Affinity. The Journal of Biological Chemistry, 278(25), 22460–22465.
http://doi.org/10.1074/jbc.M212274200
Shiromizu, T., Adachi, J., Watanabe, S., Murakami, T., Kuga, T., Muraoka, S., &
Tomonaga, T. (2013). Identification of missing proteins in the neXtProt database and
unregistered phosphopeptides in the PhosphoSitePlus database as part of the
Chromosome-centric Human Proteome Project. Journal of Proteome Research, 12(6),
2414–2421. http://doi.org/10.1021/pr300825v
Soeda, S., Yamada-Nomoto, K., & Ohsugi, M. (2016). The microtubule-binding and
coiled-coil domains of Kid are required to turn off the polar ejection force at anaphase.
Journal of Cell Science, 129(19), 3609–3619. http://doi.org/10.1242/jcs.189969
Straight, A. F., Sedat, J. W., & Murray, A. W. (1998). Time-lapse microscopy reveals
unique roles for kinesins during anaphase in budding yeast. The Journal of Cell
Biology, 143(3), 687–694. http://doi.org/10.1083/jcb.143.3.687
Stumpff, J., Dassow, von, G., Wagenbach, M., Asbury, C., & Wordeman, L. (2008). The
Kinesin-8 Motor Kif18A Suppresses Kinetochore Movements to Control Mitotic
Chromosome
Alignment.
Developmental
Cell,
14(2),
252–262.
http://doi.org/10.1016/j.devcel.2007.11.014
Stumpff, J., Wagenbach, M., Franck, A., Asbury, C. L., & Wordeman, L. (2012). Kif18A
and Chromokinesins Confine Centromere Movements via Microtubule Growth
Suppression and Spatial Control of Kinetochore Tension. Developmental Cell, 22(5),
1017–1029. http://doi.org/10.1016/j.devcel.2012.02.013

163

Sturgill, E. G., Norris, S. R., Guo, Y., & Ohi, R. (2016). Kinesin-5 inhibitor resistance is
driven by kinesin-12. The Journal of Cell Biology, 213(2), 213–227.
http://doi.org/10.1083/jcb.201507036
Su, K.-C., Barry, Z., Schweizer, N., Maiato, H., Bathe, M., & Cheeseman, I. M. (2016). A
Regulatory Switch Alters Chromosome Motions at the Metaphase-to-Anaphase
Transition.
Cell
Reports,
17(7),
1728–1738.
http://doi.org/10.1016/j.celrep.2016.10.046
Takagi, J., Itabashi, T., Suzuki, K., & Ishiwata, S. (2013). Chromosome position at the
spindle equator is regulated by chromokinesin and a bipolar microtubule array.
Scientific Reports, 3, 746–7. http://doi.org/10.1038/srep02808
Tanenbaum, M. E., Macůrek, L., Janssen, A., Geers, E. F., Alvarez-Fernández, M., &
Medema, R. H. (2009). Kif15 Cooperates with Eg5 to Promote Bipolar Spindle
Assembly.
Current
Biology,
19(20),
1703–1711.
http://doi.org/10.1016/j.cub.2009.08.027
Thompson, A. F., Vandal, S., & Stumpff, J. (2022). Quantifying Changes in Chromosome
Position to Assess Chromokinesin Activity. Methods in Molecular Biology (Clifton,
N.J.), 2415, 139–149. http://doi.org/10.1007/978-1-0716-1904-9_10
Tokai, N., Fujimoto-Nishiyama, A., Toyoshima, Y., Yonemura, S., Tsukita, S., Inoue, J.,
& Yamamoto, T. (1996). Kid, a novel kinesin-like DNA binding protein, is localized
to chromosomes and the mitotic spindle. The EMBO Journal, 15(3), 457–467.
Tokai-Nishizumi, N., Ohsugi, M., Suzuki, E., & Yamamoto, T. (2005). The chromokinesin
kid is required for maintenance of proper metaphase spindle size. Molecular Biology
of the Cell, 16(11), 5455–5463. http://doi.org/10.1091/mbc.E05-03-0244
Tüysüz, B., Yılmaz, S., Erener-Ercan, T., Bilguvar, K., & Günel, M. (2014).
Spondyloepimetaphyseal dysplasia with joint laxity, leptodactylic type: longitudinal
observation of radiographic findings in a child heterozygous for a KIF22 mutation.
Pediatric Radiology, 45(5), 771–776. http://doi.org/10.1007/s00247-014-3159-x
Uhlen, M., Fagerberg, L., Hallström, B. M., Lindskog, C., Oksvold, P., Mardinoglu, A., et
al. (2015). Tissue-based map of the human proteome. Science (New York, N.Y.),
347(6220), 1260419–1260419. http://doi.org/10.1126/science.1260419
van der Vaart, B., van Riel, W. E., Doodhi, H., Kevenaar, J. T., Katrukha, E. A., Gumy,
L., et al. (2013). CFEOM1-Associated Kinesin KIF21A Is a Cortical Microtubule
Growth
Inhibitor.
Developmental
Cell,
27(2),
145–160.
http://doi.org/10.1016/j.devcel.2013.09.010
van Heesbeen, R. G. H. P., Tanenbaum, M. E., & Medema, R. H. (2014). Balanced Activity
of Three Mitotic Motors Is Required for Bipolar Spindle Assembly and Chromosome
Segregation. Cell Reports, 8(4), 948–956. http://doi.org/10.1016/j.celrep.2014.07.015
Vaser, R., Adusumalli, S., Leng, S. N., Sikic, M., & Ng, P. C. (2015). SIFT missense
predictions
for
genomes.
Nature
Protocols,
11(1),
1–9.
http://doi.org/10.1038/nprot.2015-123
Verhey, K. J., & Hammond, J. W. (2009). Cytoskeletal motors: Traffic control: regulation
of kinesin motors, 1–13. http://doi.org/10.1038/nrm2782
Verhey, K. J., Lizotte, D. L., Abramson, T., Barenboim, L., Schnapp, B. J., & Rapoport,
T. A. (1998). Light chain-dependent regulation of Kinesin's interaction with
164

microtubules.
The
Journal
of
Cell
Biology,
143(4),
1053–1066.
http://doi.org/10.1083/jcb.143.4.1053
Vukušić, K., Buđa, R., & Tolić, I. M. (2019). Force-generating mechanisms of anaphase
in human cells. Journal of Cell Science, 132(18), jcs231985–11.
http://doi.org/10.1242/jcs.231985
Vukušić, K., Ponjavić, I., Buđa, R., Risteski, P., & Tolić, I. M. (2021). Microtubule-sliding
modules based on kinesins EG5 and PRC1-dependent KIF4A drive human spindle
elongation. Developmental Cell, 1–42. http://doi.org/10.1016/j.devcel.2021.04.005
Wandke, C., Barisic, M., Sigl, R., Rauch, V., Wolf, F., Amaro, A. C., et al. (2012). Human
chromokinesins promote chromosome congression and spindle microtubule dynamics
during mitosis. The Journal of Cell Biology, 198(5), 847–863.
http://doi.org/10.1083/jcb.201110060
Wolf, F., Wandke, C., Isenberg, N., & Geley, S. (2006). Dose-dependent effects of stable
cyclin B1 on progression through mitosis in human cells. The EMBO Journal, 25(12),
2802–2813. http://doi.org/10.1038/sj.emboj.7601163
Yajima, J., Edamatsu, M., Watai-Nishii, J., Tokai-Nishizumi, N., Yamamoto, T., &
Toyoshima, Y. Y. (2003). The human chromokinesin Kid is a plus end-directed
microtubule-based
motor.
The
EMBO
Journal,
22(5),
1067–1074.
http://doi.org/10.1093/emboj/cdg102
Zhang, P., Knowles, B. A., Goldstein, L. S., & Hawley, R. S. (1990). A kinesin-like protein
required for distributive chromosome segregation in Drosophila. Cell, 62(6), 1053–
1062.

165

CHAPTER 4: DISCUSSION
Mitosis requires the spatial and temporal control of kinesin motors to form the
mitotic spindle and segregate cellular structures equally to daughter cells. This work
characterizes mechanisms that control two mitotic kinesins, KIF11 (Eg5) and KIF22 (Kid).
Post-translational modification of KIF11, specifically acetylation of lysine 146, alters its
mechanochemical properties (Chapter 2). Mimicking acetylation of K146 makes KIF11
more likely to stall rather than dissociate from the microtubule under load, which slows
spindle pole separation in prometaphase (Figure 4-1). An increased stall force and
decreased probability of detachment allows KIF11 K146Q motors to function more
effectively as an ensemble than wild type KIF11 motors.

166

Figure 4-1: Control of the functions of KIF11 (Eg5) and KIF22 (Kid) in mitosis. Expression of mChKIF11 K146Q to mimic acetylation slows the separation of the spindle poles in prometaphase (top two
rows). Expression of KIF22-GFP with pathogenic mutations (P148L, P148S, R149L, R149Q, or V475G)
or phosphomimetic mutations (T158D or T463D) causes the aberrant generation of polar ejection forces
in anaphase, disrupting chromosome segregation.

This modification may serve as a mechanism by which cells could control the rate
of spindle pole separation by tuning the activity of KIF11 motors from a deacetylated state
optimized for antiparallel microtubule sliding at maximum velocity to an acetylated state
in which KIF11 could, by slowing and stalling under load, act as a brake to limit the rate
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of pole separation. The need for this braking activity is evolutionarily conserved: in C.
elegans, a kinesin-5 family member, BMK-1, has a motor domain structure that, like
acetylation of K146 in KIF11, prevents the formation of a salt bridge between helices a1
and a2. Loss of BMK-1 does not result in a failure of spindle pole separation in early
mitosis. Instead, it results in faster spindle pole separation in anaphase, indicating that
BMK-1 acts as a brake to slow anaphase pole separation (Saunders et al., 2007). Temporal
control of KIF11 acetylation could allow cells to alter force generation by KIF11 between
pro- and prometaphase, when pole separation is required for the creation of a bipolar
spindle, and anaphase, when poles must be separated to segregate chromosomes to
daughter cells. Different KIF11 activities and microtubule sliding velocities may be
required for these tasks because, while time in each phase varies from cell to cell and
between different cell types, the events of prometa- and metaphase occur over a longer
time (approximately 15-30 minute in HeLa cells) than the events of anaphase
(approximately 5-10 minutes in HeLa cells) (Meraldi, Draviam, & Sorger, 2004).
Additionally, changes in the activity of motors that balance forces generated by KIF11,
including dynein, KIFC1, and KIFC3 may require changes in KIF11 mechanochemistry.
The effect of mimicking acetylation of KIF11 K146 in anaphase is unknown. Live
imaging of cells expressing mCh-KIF11 K146Q and fluorescently labeled tubulin or a pole
marker, such as centrin, could be used to assess this. If the effect of mimicking K146
acetylation in anaphase is the same as in prometaphase, slowed spindle pole separation (a
change in anaphase B) would be predicted.
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The activity of KIF22 is controlled in order to switch from polar ejection force
generation in prometa- and metaphase to chromosome segregation in anaphase. This is
disrupted by pathogenic mutations in KIF22, which prevent motor inactivation and polar
ejection force attenuation at the metaphase to anaphase transition (Chapter 3) (Figure 4-1).
The aberrant generation of polar ejection forces in anaphase causes chromosome
recongression, results in daughter cells with abnormally shaped nuclei, and, in a subset of
cells, prevents the completion of cytokinesis.
The inactivation of KIF22 is also regulated by post-translational modification.
Previous studies have demonstrated that mimicking phosphorylation of T463, in the tail of
KIF22, causes recongression (Soeda et al., 2016). This work investigated whether posttranslational modification of the motor domain may also contribute to this process.
Mimicking phosphorylation of the motor domain residue T158 also disrupts anaphase
chromosome segregation and causes abnormal nuclear morphology in daughter cells.
The acetylation status of KIF11 K146 and the phosphorylation status of KIF22
T158 during different phases of mitosis have not been determined. KIF11 K146 was
identified in an asynchronous population of cells (Choudhary et al., 2009), and while
KIF22 phosphorylated at T158 was identified in mitotic cells (J. V. Olsen et al., 2010), the
relative T158 phosphorylation levels at different times in the cell cycle are not known.
Mass spectrometry of proteins prepared from cells arrested in specific stages of mitosis or
collected at time intervals after a coordinated mitotic entry could be used to assess the posttranslational modification of KIF11 and KIF22 over time. However, if modifications are
present in low abundance they may not be detected (Choudhary et al., 2009; Witze, Old,
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Resing, & Ahn, 2007). If antibodies were raised against modified forms of KIF11 and
KIF22, this could allow for the assessment of spatial and temporal changes in acetylation
and phosphorylation, respectively.
Identifying the enzymes responsible for post-translational modifications could
also offer insight into the spatial and temporal control of KIF11 and KIF22. This could be
particularly useful for understanding whether phosphorylation of KIF22 at T158, in the
motor domain, and T463, in the tail, occur at the same time as part of a single inactivation
process or are separate modifications that may alter KIF22 function at different time points.
T463 is phosphorylated by CDK1 in prometa- and metaphase and dephosphorylated in
anaphase when CDK1 activity levels drop (Morgan, 1995; 1999; Ohsugi et al., 2003). If
T158 was also phosphorylated by CDK1, it would likely be phosphorylated during the
same phases of mitosis as T463. However, the amino acid sequence around T158
(152MDLLWLTREEGAE164) does not include the minimal CDK1 consensus motif S/T-P
(Moreno & Nurse, 1990) or the non-canonical CDK1 motifs S/T-X-X-R/K or P-X-S/T-XR/K (K. Suzuki et al., 2015). Predictions of which kinase may phosphorylate T158 based
on consensus motifs varied based on the algorithm used (Table 4-1). CDK1 was among the
predicted candidate kinases, but only using one of three algorithms. Two predicted kinases,
VRK1 (Campillo-Marcos, García-González, Navarro-Carrasco, & Lazo, 2021) and ATR
(Saldivar, Cortez, & Cimprich, 2017), are involved in DNA damage response and repair
pathways, which makes them interesting candidates for phosphorylating KIF22, which
binds to chromosomes. CK2, a predicted kinase selected by two of the three algorithms,
has a reported role in regulating mitotic entry upstream of CDK1 (Yde, Olsen, Meek,
170

Watanabe, & Guerra, 2008), phosphorylates kinetochore proteins, and is required for
anaphase spindle elongation and chromosome segregation in yeast (Peng et al., 2011). The
mitotic functions of CK2, combined with the in silico kinase predictions, make it a
candidate kinase for KIF22 T158 phosphorylation that merits further investigation.

Table 4-1: Predictions of kinases phosphorylating KIF22 T158. The three highest scoring predictions
from each algorithm are listed, with the highest prediction first.

Algorithm
GPS 5.0 {Wang:2020gn}
NetPhos 3.1
{Blom:2004ky}
PhosphoNET (Pelech,
2019)

Prediction
VRK1 (Vaccinia-related kinase)
GRK2 (G protein-coupled receptor kinase 2)
IKBKE (Inhibitor of nuclear factor kappa-B kinase)
CK2 (Casein kinase 2)
CDK1 (Cyclin-dependent kinase 1)
CaMKII (Calcium/calmodulin-dependent protein kinase II)
ATR (Ataxia telangiectasia and Rad3-related)
MAP2K1 (Mitogen-activated protein kinase kinase 1)
CK2 (Casein kinase 2)

This work characterizes pathogenic mutations (KIF22 P148L, P148S, R149L, and
R149Q) and sites of post-translational modification (KIF11 K146 acetylation and KIF22
T158 phosphorylation) in the same substructure of the kinesin motor domain, the a2 helix
(Figure 4-2). This helix is split by a flexible region, designated loop 5 (Turner et al., 2001).
Loop 5 is important for structural changes in the motor domain that occur upon ATP
binding and hydrolysis, and mutating loop 5 slows the dissociation of KIF11 from
microtubules (Behnke-Parks et al., 2011). Loop 5 is longer in KIF11 (18 amino acids) than
in KIF22 (7 amino acids). Single amino acid structural changes in a2 alter the function of
both KIF11 (Chapter 2) and KIF22 (Chapter 3), emphasizing the importance of this helix
for the control of kinesin function.
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Figure 4-2: Residues in the a2 helix important for the control of KIF11 and KIF22. Crystal structures
of the motor domains of KIF11 (left) (PDB 1II6) and KIF22 (right) (PDB 6NJE). The a2 helix is colored
dark grey in both structures, and key amino acids in KIF11 and KIF22 are colored magenta and green,
respectively.

Multiple sites of post-translational modification have been identified in this region
in both KIF11 and KIF22. In addition to acetylation of K146 in a2 (Chapter 2), KIF11 is
phosphorylated at Y125 in loop 5, and the phosphomimetic mutation Y125E reduces the
velocity of KIF11 (Bickel et al., 2017). An improved understanding of how posttranslational modifications in a2 and loop5 affect the function of KIF11 may be relevant
in the context of anti-cancer therapeutics, as loop 5 is part of the binding site of KIF11
inhibitors, including monastrol and S-trityl-L-cysteine (Harrington et al., 2011; Kaan,
Ulaganathan, Hackney, & Kozielski, 2009; E. D. Kim et al., 2010; Maliga & Mitchison,
2006; Yan et al., 2004).
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In addition to the T134 and T158 a2 phosphorylation sites discussed in Chapter
3, KIF22 is phosphorylated at S140 in loop 5 (Mertins et al., 2013). The effects of S140
phosphorylation on KIF22 function have not been characterized. Additional work
characterizing the phosphorylation of KIF22 T134 is also warranted. We have
demonstrated that phosphomimetic and phosphonull mutations of T134 cause KIF22-GFP
to localize to spindle microtubules rather than chromosomes and increase the percentage
of cells forming multipolar spindles. Mutation of T134 to asparagine has been previously
reported to increase binding of KIF22 to microtubules in co-sedimentation assays and in
cells (Ohsugi et al., 2003). However, the structural and biochemical changes underlying
this phenotype have not been studied. Further cell biological studies are also needed to
understand how mislocalization of KIF22 causes multipolar spindles.
Post-translational modification of a2 helix and loop 5 residues may be a
mechanism by which the activity of additional kinesin motors are controlled as well, as
other kinesins also have reported modifications in this region (Table 4-2). Several of those
motors have reported roles in cell division, including the kinesin-6 family members
KIF20B, which acts during cytokinesis and abscission (Janisch et al., 2013; 2018), and
KIF23 (MKLP1), which bundles central spindle microtubules in anaphase as part of the
centralspindlin complex (Pavicic-Kaltenbrunner, Mishima, & Glotzer, 2007). KIF11 and
KIF23 contribute to spindle pole separation in anaphase, and both KIF11 and KIF23
contribute to the chirality and twist of the mitotic spindle by stepping chirally along
microtubules (Trupinić et al., 2022). Changes in spindle chirality alter spindle mechanics
and spindle chirality changes as mitosis progresses (Trupinić et al., 2022). a2 helix post173

translational modifications of KIF11 and KIF23 may tune the contributions of these motors
in parallel to regulate spindle pole separation or torque generation for spindle chirality. The
minus-end directed mitotic kinesin KIFC3 also has a reported post-translational
modification in a2 (Sharma et al., 2014). This motor opposes the forces generated by
KIF11 to control the rate of centrosome separation (Hata et al., 2019). It is possible that
post-translational modification tunes the activities of both motors to ensure balanced force
generation during this process. Assessing the effects of phosphomimetic and phosphonull
mutations in each motor individually and both motors simultaneously on centrosome
separation could help determine if this is the case.

Table 4-2: Kinesin motors with reported sites of post-translational modification in the a2 helix or
loop 5. Post-translational modifications (PTMs) were identified by searching PhosphoSite Plus
{Hornbeck:2015fo}. The a2 helix of each kinesin was designated via alignment of structures or, if no
structure was available, predicted structural models. The PDB code or AlphaFold model number used for
each kinesin is indicated in the Structure column. Only modifications identified in at least one peerreviewed publication are listed {Kettenbach:2011jp, Rigbolt:2011cd, Olsen:2010ko,
Mertins:2013ke, Dephoure:2008bl, Choudhary:2009jm, Bickel:2017fa, Shiromizu:2013fn,
Sharma:2014kg}, and sites of ubiquitination are not shown.

Kinesin Family

Kinesin

Structure

Residue

PTM

3

KIF13A

AF-Q9H1H9-F1

5

KIF11

1II6

6

KIF20B
KIF23

AF-Q96Q89-F1
AF-Q02241-F1

10

KIF22

6NJE

14

KIFC3

5WDE

S134
Y125
K146
S182
S125
T134
S140
T158
S557

Phosphorylation
Phosphorylation
Acetylation
Phosphorylation
Phosphorylation
Phosphorylation
Phosphorylation
Phosphorylation
Phosphorylation

Pathogenic mutations in the KIF22 a2 helix and mimicking phosphorylation of
a2 helix residue T158 prevent the inactivation of KIF22 at the metaphase to anaphase
transition (Chapter 3). Previous work identified that the second microtubule-binding and
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coiled-coil domains in the tail of KIF22 were required for this inactivation, and that
mimicking phosphorylation of tail residue T463, located between the second microtubulebinding and coiled coil domains, could prevent anaphase inactivation (Soeda et al., 2016).
Our work demonstrates that, in addition to the tail, the motor domain, specifically the a2
helix, of KIF22 is involved in the inactivation process. However, the mechanism by which
KIF22 is inactivated is unknown. The identification of tail domains as necessary for KIF22
inactivation led to the proposal of a model wherein the interaction of the tail with the
microtubule inactivates KIF22 (Soeda et al., 2016) (Figure 4-3). The authors of this study
noted that data does not support the tail simply tethering KIF22 in place along spindle
microtubules or shifting KIF22 localization from the chromosomes to microtubules and
concluded that the structural and functional changes in the interactions between KIF22,
microtubules, and chromosomes that underlie inactivation were still unclear (Soeda et al.,
2016). Our data demonstrating the involvement of the a2 helix further complicate a model
in which KIF22 is inactivated via a tail-microtubule interaction. The a2 helix faces away
from the surface of the microtubule, and changes in this helix would not be predicted to
alter the association of the motor domain with the microtubule directly. However, an
interaction between the a2 helix and the tail could facilitate or strengthen an interaction
between the tail and the microtubule.
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Figure 4-3: Tail-microtubule interaction model of KIF22 inactivation. One proposed mechanism for
KIF22 inactivation suggests that KIF22 is inactivated in anaphase by an interaction between the tail of
KIF22 and the microtubule, and that phosphorylation prevents this inactivation in prometaphase to allow
the generation of polar ejection forces (Soeda et al., 2016).

Given that pathogenic mutations in both the tail and the motor domain of KIF22
disrupt inactivation, a parsimonious alternative explanation is that the tail and the motor
domain interact to inactivate KIF22 (Figure 4-4). This head-tail interaction is an established
mechanism by which other members of the kinesin superfamily are inactivated (Blasius et
al., 2021; Coy et al., 1999; Espeut et al., 2008; Friedman & Vale, 1999; Hammond et al.,
2009; 2010; Imanishi et al., 2006; Ren et al., 2018; Verhey et al., 1998; Verhey &
Hammond, 2009), and, analogous to our demonstration that pathogenic mutations in KIF22
disrupt inactivation, pathogenic mutations that disrupt head-tail interactions have been
identified in other kinesin motors (Asselin et al., 2020; Bianchi et al., 2016; Blasius et al.,
2021; Cheng et al., 2014; Pant et al., 2022; van der Vaart et al., 2013). In this model,
pathogenic mutations in or post-translational modification of either the a2 helix or the tail
could weaken the head-tail interaction and limit inactivation. To test this model,
fluorescently labeled motor domain and tail fragments were expressed in cells and
immunoprecipitation was performed to test for an interaction between these two domains
(Appendix C). No co-immunoprecipitation was observed, indicating no strong and longlasting interaction between the head and tail of KIF22 under the conditions of this assay.
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However, such an interaction may occur under different conditions, and testing different
lysis buffers, tag locations, or fragment lengths may be warranted. Additionally, negative
results from immunoprecipitation experiments cannot rule out weak, short-lived, or
dynamic interactions between domains. Structural studies could help clarify whether the
tail and motor domain physically interact. Cryo-electron microscopy has been used to
determine whether the tail of KIF11 regulated motor function by interacting with the motor
domain or the microtubule (Bodrug et al., 2020) (Appendix A), and a similar approach may
be informative for understanding the function of the tail of KIF22. Additionally, in vitro
biochemical or biophysical studies of KIF22 function could help elucidate whether a headtail interaction regulates the activity of KIF22. Parameters such as the ATPase rate,
velocity, or force generated by KIF22 could be compared between constructs with tail
mutations, and assays could be performed in the presence and absence of tail fragments to
determine whether the tail affects the activity of the motor domain.
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Figure 4-4: Head-tail interaction model of KIF22 inactivation. KIF22 may be inactivated by an
interaction between the tail and the motor domain (head). Phosphorylation could prevent this interaction
in prometaphase to allow the generation of polar ejection forces, and pathogenic mutations in the head or
the tail could disrupt the head-tail interaction interface, preventing inactivation and allowing aberrant
generation of polar ejection forces in anaphase.

It is also possible that the motor domain and the tail of KIF22 may interact
allosterically rather than physically binding one another. Long-range allosteric interaction
between the motor domain and tail of a kinesin-1 motor was recently proposed as a
mechanism of autoinhibition in response to the observation that mutating the hinge region
in the tail or residues previously described as involved in head-tail contact did not prevent
the inhibition of the motor by the binding of kinesin light chain to the tail. The authors
suggested that the binding of kinesin light chain could result in a conformational change
propagated down the tail to the motor domain (Chiba et al., 2021). In KIF22, structural
changes in the tail, including dephosphorylation of T463 or mutation at V475, could
contribute to inactivation by similarly inducing a conformational change that propagates to
the motor domain and alters mechanochemistry.
Since we know the inactivation of KIF22 is regulated by dephosphorylation of
T463 (Soeda et al., 2016), we can consider that pathogenic mutations may prevent
inactivation not by altering the structure or function of KIF22 directly but by altering
phosphoregulation of the motor. When CDK1 activity drops at the metaphase to anaphase
transition, the continued activity of protein phosphatases would dephosphorylate T463
(Nasa & Kettenbach, 2018). If the V475G mutation in the tail of KIF22 altered tail structure
in a way that limited phosphatase access to T463, this could then prevent
dephosphorylation and inactivation of KIF22. The time course of T158 phosphorylation
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and dephosphorylation is not yet known, but mutations in residues in a2 could similarly
prevent dephosphorylation of T158 to prevent inactivation. To test this, KIF22 with both
pathogenic mutations and nearby phosphonull mutations at regulatory sites (e.g.
R149Q/T158A or V475G/T463A) could be expressed in cells. If mutations prevent KIF22
inactivation by limiting dephosphorylation of nearby phosphorylation sites, phosphonull
mutations would be expected to rescue inactivation and prevent anaphase chromosome
recongression. If cells expressing pathogenic and phosphonull mutation pairs demonstrated
anaphase chromosome recongression, this would indicate that the effects of mutations on
KIF22 inactivation are not solely due to altering phosphoregulation. Preliminary data
demonstrate that expression of KIF22-GFP R149Q/T158A or V475G/T463A causes
anaphase chromosome recongression and abnormally shaped nuclei, suggesting that the
effects of pathogenic mutations are not rescued by preventing phosphorylation, but further
study of these cell lines is needed.
In a number of kinesin motors, including KIF11 (J. E. Scholey et al., 2014),
coiled-coil domains in the tail facilitate dimerization to allow kinesins to move
processively along microtubules (Verhey & Hammond, 2009). The tail of KIF22 includes
a predicted coiled-coil domain, but KIF22 expressed in E. coli or mammalian cells was
determined be monomeric by sucrose density gradient centrifugation. This was shown for
full length motor and for truncated constructs lacking the coiled-coil domain (Shiroguchi
et al., 2003; Yajima et al., 2003). However, processive movement of full length GFP-KIF22
expressed in insect cells has been observed in single molecule total internal reflection
fluorescence (TIRF) assays (Stumpff et al., 2012), suggesting that KIF22 is capable of
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dimerization or oligomerization. If KIF22 dimerizes or oligomerizes in cells, control of its
oligomerization state may be part of the mechanism by which the motor is inactivated.
It is important to note that these models of KIF22 inactivation are not mutually
exclusive. This is particularly key when considering that the control of KIF22 may not
consist of only two states, one in which the motor is fully active and another in which it is
fully inactive. The activity level of KIF22 may be tuned via different mechanisms to adjust
motor function in different ways at different time points in mitosis.
A failure to inactivate KIF22 at anaphase onset results in aberrant generation of
polar ejection forces, which disrupt anaphase chromosome segregation. The distance
between chromosome masses and spindle poles are both reduced in cells expressing
KIF22-GFP with pathogenic mutations, but the distance from the centromeres to the poles
is not affected. This indicates that mutations affect anaphase A by limiting the poleward
movement of chromosome arms, but not the shortening of k-fibers, and affect anaphase B
by altering spindle pole separation. The forces separating the spindle poles are generated
by kinesin motors, including KIF11 and KIF23 (MKLP1) (Brust-Mascher et al., 2004; Fu
et al., 2009; Kashina et al., 1997; Krüger et al., 2019; Nislow et al., 1992; Straight et al.,
1998; Vukušić et al., 2021). The forces generated by mutant KIF22 in anaphase are
sufficient to overcome the forces driving antiparallel microtubule sliding, suggesting that
the polar ejection forces generated by KIF22 motors active in anaphase are of greater
magnitude than the sliding forces that separate the poles. However, it is not clear how
forces generated on the chromosome arms by KIF22 are translated to the poles. It is
possible that polar ejection forces prevent the chromosomes from moving away from the
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center of the cell, and that the depolymerization of kinetochore microtubules, which must
shorten the distance between kinetochores and the poles, then pulls the poles towards the
effectively stationary chromosome masses. It is also possible that the activity of KIF22
effectively cross-links spindle microtubules, which would resist sliding forces generated
by KIF11 and KIF23. KIF22 is capable of cross-linking microtubules in vitro (Shiroguchi
et al., 2003), but the tail microtubule binding domain is not required for constitutive
activation of KIF22 and subsequent anaphase chromosome recongression (Soeda et al.,
2016), suggesting that the tail of individual KIF22 molecules does not disrupt anaphase
chromosome segregation via microtubule binding. However, the interaction of KIF22
molecules on a single chromosome with multiple microtubules may act as a collective,
larger scale cross-link to limit the effect of microtubule sliding forces in anaphase B.
Patients with mutations in KIF22 present with tissue-specific defects in
development. Mutations in KIF22 disrupt skeletal development, causing short stature, short
limbs, and leptodactyly (Boyden et al., 2011; Min et al., 2011; Tüysüz et al., 2014). We
have demonstrated that pathogenic mutations in KIF22 disrupt the function of the motor in
mitosis (Chapter 3). However, we have not established whether these mitotic defects occur
in patients with SEMDJL2. Patient tissue samples could help answer this question. Growth
plate biopsies would be maximally informative, as this could show whether chondrocytes
exhibit anaphase chromosome bridges or abnormally shaped nuclei, but this type of biopsy
is invasive and not performed due to concerns that damage from the biopsy could alter the
growth of the child (Epperson, Williams, Rogers, Maxwell, & Stevens, 2021). Samples
from other tissues that may be obtained via less invasive methods could still be assessed
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for mitotic defects or abnormal nuclear morphology. This could help establish whether the
mitotic phenotypes observed in cultured cells occur in vivo and distinguish whether
mutations in KIF22 affect mitosis only in chondrocytes or affect mitosis globally but have
the most severe consequences in the skeletal system. Alternatively, induced pluripotent
stem cells (iPSCs) can be differentiated to mesenchymal stem cells or chondrocytes (De
Kinderen et al., 2022; Guzzo, Gibson, Xu, Lee, & Drissi, 2013; I. G. Kim et al., 2020), so
minimally invasive skin or blood samples could be obtained from patients to generate
iPSCs for differentiation and further study.
The three-dimensional architecture of the proliferative zone of the growth plate is
unique, and this geometric constraint on chondrocyte division may be important to explain
why mutations in KIF22 specifically affect the development of the skeletal system.
Expression of KIF22 with pathogenic mutations causes chromosomes to recongress in
anaphase, and to decondense closer to one another than in control cells. In the proliferative
zone, spindle poles or daughter cells cannot move away from one another because they are
constrained by the width of the column. This may impair spindle pole separation in
anaphase, or may impair cytokinesis, as the pulling of daughter cells away from one
another can contribute to this process (LaFlamme, Nieves, Colello, & Reverte, 2008; Y.L. Wang, 2005). Alternatively, skeletal development may be uniquely sensitive to gain of
function mutations in KIF22 not because the tissue architecture of the growth plate
exacerbates the cellular phenotype, but because the cellular phenotype (defects in anaphase
and cytokinesis) disrupts the tissue architecture. Loss of function of a different kinesin
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motor, KIF5B, in chondrocytes impairs cytokinesis, disrupts the organization of the
proliferative zone in murine growth plates, and causes short bones (Gan et al., 2019).
The possible connection between mitotic defects and skeletal development is
strengthened by the identification of a consanguineous family with skeletal developmental
defects and mutations in the centrosomal protein Ninein (Grosch et al., 2013). These
individuals presented with short stature, joint laxity, midface hypoplasia, scoliosis, and
leptodactyly, consistent with SEMDJL2 (Grosch et al., 2013). Ninein localizes to the minus
ends of microtubules at the centrosome, contributes to microtubule anchoring and
positioning, and promotes microtubule nucleation by anchoring the g-tubulin ring complex
(Delgehyr, Sillibourne, & Bornens, 2005; Mogensen, Malik, Piel, Bouckson-Castaing, &
Bornens, 2000). Ninein is present at the spindle poles in mitotic cells, and siRNA-mediated
depletion of Ninein results in aberrant spindle structures, mitotic catastrophe, and cell death
(Kimura et al., 2019). In Drosophila, loss of function of Blastoderm specific gene 25D
(Bsg25D), the only Ninein-like protein identified in Drosophila, causes mitotic defects,
including anaphase chromosome bridges and multipolar spindles, and disrupts
development (Kowanda et al., 2016). An intriguing area of future study is whether the
pathogenic mutation in Ninein identified in patients with skeletal dysplasia, N2082D,
disrupts mitosis, and if so, how these defects and those caused by mutations in KIF22 both
result in tissue-specific patient pathology.
It is possible that mutations in KIF22 affect human development via a mechanism
independent from the effects of mutations on mitosis. KIF22 localizes to the nucleus of
interphase cells (Levesque & Compton, 2001; Tokai et al., 1996), and its functional role,
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if any, in the nucleus is unknown. If KIF22 affected chromatin organization in the nucleus,
this could alter gene expression and affect skeletal development. Outside of the nucleus, a
role for KIF22 in the regulation of the coxsackievirus and adenovirus receptor (CAR) and
epidermal growth factor receptor (EGFR) has been proposed (Pike, Ortiz-Zapater,
Lumicisi, Santis, & Parsons, 2018), and mutations may disrupt this interphase function of
KIF22, disrupting signaling and, therefore, skeletal development.
This work has assessed the consequences of pathogenic mutations in KIF22 on
mitosis and proliferation in HeLa-Kyoto and RPE-1 cells. While these cells are well
characterized for making quantitative assessments of changes in mitosis, connecting
mitotic defects to patient pathology would benefit from exploring the consequences of
expressing mutant KIF22 in chondrocytes. Primary chondrocytes would not support the
generation of stable cell lines and, as such, would have limited feasibility for these studies.
Additionally, imaging-based studies of mitosis require cells growing in relatively flat
geometries. This precludes the use of micromass culture techniques to differentiate mouse
embryonic fibroblasts (Lengner et al., 2004) or mesenchymal stem cells to chondrocytes
in vitro. Based on these limitations, an immortalized chondrocyte cell line would be best
suited for continued studies of the consequences of pathogenic mutations in KIF22.
Commercially available immortalized chondrocytes include cells transformed with simian
virus 40 (SV40) and cells expressing human telomerase reverse transcriptase (hTERT).
SV40 transformation results in genomically unstable cells (RAY, PEABODY, COOPER,
CRAM, & KRAEMER, 1990), while cells immortalized with hTERT have stable diploid
karyotypes (Cui et al., 2002). hTERT-immortalized CHON-001 cells would be preferred
184

for future studies, as the genomic stability of these cells better matches growth plate
chondrocytes in vivo.
Expressing mutant KIF22 in chondrocytes would allow similar assays to those
described in Chapter 3 to be used to characterize the effects of mutations on anaphase
chromosome segregation, cytokinesis, nuclear morphology, and proliferation rate in a cell
type more relevant to patient pathology. Additionally, cultured chondrocytes could be used
to test whether the geometric constraints of the growth plate proliferative zone contribute
to the tissue specific consequences of KIF22 mutations. The effects of expressing mutant
KIF22 in chondrocytes grown in a monolayer could be compared to the effects of mutant
KIF22 expression in cells grown in structures designed to mimic the geometry of the
growth plate. Cells could be confined in two dimensions using collagen micropatterned
stripes the width of growth plate proliferative zone columns, or in three dimensions using
polydimethylsiloxane (PDMS) channels the width of columns, open at the top to allow
cells to be seeded. If mitotic defects and effects on proliferation caused by expression of
mutant KIF22 are more severe in constrained cultured chondrocytes than in cells grown in
a monolayer this would suggest that the tissue architecture of the growth plate contributes
to the tissue specificity of SEMDJL2 pathology.
While cultured cells represent a tractable tool for studying the effects of mutations
in KIF22 on mitosis, the best system to rigorously assess the question of tissue specificity
is a vertebrate organismal model. Mice are well-established as a system in which to study
skeletal development, include endochondral ossification and chondrodysplasias (McLean
& Olsen, 2001). Generating mice heterozygous for homologous mutations to those
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identified in human patients would allow body and limb size to be measured over time and
would provide the opportunity to section growth plate samples at different developmental
time points. These histological samples could be examined for any disturbance in growth
plate architecture, changes in cell numbers or density, mitotic defects, or abnormal nuclear
shapes. This approach has been used previously to identify growth plate architecture
disruption and evidence of cytokinesis failure in mice with short limbs (Gan et al., 2019).
A KIF22 knockout mouse model has been developed (Ohsugi et al., 2008), but as
pathogenic mutations are not loss of function mutations the phenotypes of mice with
pathogenic mutations would be expected to differ from this model. Zebrafish represent an
alternative vertebrate system in which the effects of KIF22 mutations could be studied at
the organismal level. A small number of bones in zebrafish, including the radial bones of
the pectoral fins, form via a process of endochondral ossification similar to that of
mammals (Weigele & Franz-Odendaal, 2016), and zebrafish have been used as a model in
which to study other skeletal developmental disorders (Carnovali, Banfi, & Mariotti, 2019).
Mouse limbs are more similar to human long bones than zebrafish radials, but advantages
to building a zebrafish model expressing mutant KIF22 include that early embryonic
divisions can be observed, and that zebrafish are largely transparent. These properties
would facilitate imaging-based approaches to studying the tissue-specific consequences of
KIF22 mutations.
In summary, human development requires an astonishing number of cell division
events, and in each division, a careful balance of mechanical forces is needed to build the
mitotic spindle and segregate chromosomes to daughter cells. Control of the activity of
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kinesin motors, including KIF11 and KIF22, is, therefore, essential. Post-translational
modifications, such as acetylation and phosphorylation, represent one mechanism by which
the activities of KIF11 and KIF22 may be controlled. Mutations in KIF22 disrupt the
regulation of motor activity, which upsets the balance of forces within the spindle, resulting
in mitotic defects. Expanding our knowledge of the mechanisms of control of kinesin
motors improves our understanding of the vital process of mitosis.
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APPENDIX A: THE TAIL DOMAIN OF EG5 (KIF11) CONTROLS THE
LOCALIZATION OF THE MOTOR TO THE MITOTIC SPINDLE
Material in this appendix has been included in the following publication, distributed under
the terms of a Creative Commons Attribution License that permits unrestricted use and
redistribution provided that the original author and source are credited:
Bodrug, T., Wilson-Kubalek, E. M., Nithianantham, S., Thompson, A. F., Alfieri, A.,
Gaska, I., et al. (2020). The kinesin-5 tail domain directly modulates the mechanochemical
cycle of the motor domain for anti-parallel microtubule sliding. eLife, 9.
http://doi.org/10.7554/eLife.51131
INTRODUCTION
Kinesin-5 motors represent a unique and highly conserved kinesin subfamily that
is essential for mitotic spindle assembly during metaphase and for spindle elongation
during anaphase (Kashina, Scholey, Leszyk, & Saxton, 1996). In contrast to the majority
of dimeric kinesin classes, kinesin-5 motors form a unique and conserved bipolar
homotetrameric organization, composed of two dimeric subunits folded in an antiparallel
arrangement mediated by the assembly of a 60-nm long central minifilament (Acar et al.,
2013; Kashina et al., 1996; J. E. Scholey et al., 2014; Singh, Pandey, Al-Bassam, & Gheber,
2018). Through this conserved bipolar organization, kinesin-5 motors promote microtubule
crosslinking and their sliding apart during mitotic spindle assembly and elongation. This
activity can be recapitulated in vitro with purified kinesin-5 orthologs from a variety of
species (Kapitein et al., 2005; 2008; van den Wildenberg et al., 2008). Metazoan kinesin5 orthologs such as D. melanogaster KLP61F or human Eg5 (KIF11) undergo slow plusend directed motility especially during antiparallel microtubule sliding (Kapitein et al.,
2005; 2008; Shimamoto, Forth, & Kapoor, 2015; van den Wildenberg et al., 2008).
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The conserved plus-end directed microtubule sliding activity is essential for mitotic
spindle assembly by generating forces exerted on microtubules emanating from opposite
spindle poles during metaphase and stabilizing the characteristic bipolar spindle
organization (Brust-Mascher et al., 2009; Forth & Kapoor, 2017; Subramanian & Kapoor,
2012; H. Wang, Brust-Mascher, & Scholey, 2014). The microtubule sliding activity is
critical for the elongation of mitotic spindles at the midzone region during anaphase
(Goshima & Scholey, 2010). Defects in mammalian kinesin-5 orthologs or their
inactivation via inhibitory compounds, such as monastrol, result in monopolar spindles by
disruption in the balance of mechanical forces within the spindle (Goshima & Scholey,
2010; Goshima, Wollman, Stuurman, Scholey, & Vale, 2005).
Each kinesin-5 motor consists of a conserved organization including an N-terminal
motor domain, a-helical neck and bipolar assembly regions, and a C-terminal tail domain.
The motor domain is connected via neck-linker to a dimerizing neck a-helical coiled-coil
(Turner et al., 2001; Valentine et al., 2006b; Valentine, Fordyce, & Block, 2006a). The
parallel a-helical coiled-coil neck forms a part of the 60-nm central antiparallel
homotetrameric a-helical minifilament (Acar et al., 2013; Kashina et al., 1996). At the
center of this minifilament is a 27-nm antiparallel four a-helical bundle termed the bipolar
assembly (BASS) region (J. E. Scholey et al., 2014). The kinesin-5 BASS tetramer orients
two parallel neck coiled-coils and their associated motor domains to be off-set through a
100°-lateral rotation with respect to each other, potentially mediating their preference in
binding and sliding two antiparallel microtubules (J. E. Scholey et al., 2014). An extended
section of unknown structure connects the C-terminal end of the BASS to the tail domain,
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which resides in close proximity to the motor domains of the antiparallel subunits (Acar et
al., 2013). Thus, each kinesin-5 end consists of twin tail and twin motor domains
originating from two sets of antiparallel folded dimeric subunits that emerge in close
proximity at each end of the bipolar homotetramer (Acar et al., 2013; J. E. Scholey et al.,
2014).
The kinesin-5 tail domain contains a conserved BimC box, which is a consensus
motif that is phosphorylated by cdk2, a mitotic cdc2-dependent kinase (Blangy et al., 1995;
Sharp et al., 1999). Mitotic phosphorylation at the BimC box induces kinesin-5 motors to
concentrate along the mitotic midzone, where they promote the elongation of the mitotic
spindle during late anaphase by sliding apart antiparallel microtubules (Sharp et al., 1999).
However, a role for this phosphorylation in kinesin-5 activity remains unknown. Deletion
studies of the S. cerevisiae yeast ortholog, Cin8, show the tail domain is essential for
kinesin-5 function, and its deletion leads to a lethal mitotic arrest phenotype in the absence
of Kip1(Hildebrandt, Gheber, Kingsbury, & Hoyt, 2006). The tail domain of the Xenopus
Eg5 was suggested to form a secondary microtubule binding site during microtubule
sliding motility, yet the function of the kinesin-5 tail-microtubule interaction remains
unclear (Weinger, Qiu, Yang, & Kapoor, 2011). Despite extensive structural, kinetics and
functional analyses of kinesin-5 orthologs, the origin of their highly conserved microtubule
sliding activity remains poorly understood. It remains to be determined how kinesin-5 slide
their microtubule tracks, in contrast to other kinesin classes which mobilize themselves and
cargos along microtubule tracks.
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Here, we describe a mechanism for the tail to motor domain regulation at each end
of homotetrameric kinesin-5 and its fundamental role during microtubule sliding motility.
Using biochemical methods, we show the kinesin-5 tail domain down-regulates
microtubule-activated ATP hydrolysis binding and stabilizing the microtubule-bound
motor domains in their ADP or rigor states. Cryo-EM structures reveal that the tail
stabilizes the open conformation of the motor N-terminal subdomain by binding the a0helix element at its tip. We show that human Eg5 motor undergo very slow motility and
form clusters along single microtubules, whereas Eg5 motors with their tails deleted
undergo rapid motility and without clustering along single microtubules. Single motor
spiking assays show that Eg5 motors slow down within active microtubule sliding zones
and undergo slow unidirectional motility, whereas tail-deleted Eg5 motors undergo rapid
motility with frequent direction switching along either microtubule within sliding zones.
Optical trapping and microtubule sliding assays reveal that the tail is essential for Eg5
motors to zipper two microtubules into sliding zones and produce substantial pushing
forces. In contrast, tail deleted Eg5 motors exhibit severe defects in zippering two
microtubules due to their poor capacity to generate forces. Tail deletion leads to loss of
Eg5 mitotic spindle localization in mammalian cells, despite retaining microtubule binding
activity. Our studies suggest a revised kinesin-5 microtubule sliding model in which the
tail domain downregulates microtubule-activated ATP hydrolysis at each end of the
homotetramer. The tail-motor interface enhances force production for zippering and sliding
apart microtubules and stabilizes dual microtubule-bound states of kinesin-5 during
walking motility along both sliding microtubules.
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MATERIALS AND METHODS
Generation of Constructs
A pcDNA-3.1 plasmid containing Eg5 full-length fused to mCherry (Eg5 FL-mCh)
inserted between the EcoR1 and Not1 sites was used as a template. Plasmid pAT4206,
encoding Eg5-Δtail, which encoded reidues 1-912, fused to mCherry (Eg5 DTail-mCh),
was generated using the Phusion Site-Directed Mutagenesis Kit (Thermo Scientific). These
clone contained silent mutations for siRNA-resistance: T2124C, C2130T, G2133T, and
G2136A. The forward and reverse primer sequences used to generate Eg5 DTail-mCh were
5’-GGAGCGCCAATGGTGAGCAA-3’

and

5’-

AAAGCAATTAAGCTTAGTCAAACCAATTTT-3’, respectively.

Transfection and Imaging of HeLa Cells
HeLa cells were cultured in Minimal Essential Media-a (Gibco) supplemented with
10% fetal bovine serum (Gibco). HeLa cells were authenticated by STR genotyping by the
Vermont Integrative Genomics Resource. Cells were maintained at 37°C with 5% CO2.
Transient transfections of plasmid DNA were performed via electroporation using a
Nucleofector 4D system, pulse code CN114, and Cell Line SE reagents (Lonza). Cells were
plated onto 12 mm glass coverslips (Electron Microscopy Sciences) for fixed cell
immunofluorescence, 4-chamber 35 mm glass-bottom dishes (Greiner Bio-One) for live
cell imaging, or 60 mm polystyrene tissue culture dishes for lysate collection.
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For western blot assessment of Eg5-mCh construct expression, cells were arrested
in 100 µM monastrol (Selleckchem) overnight and lysed in PHEM buffer (60 mM PIPES,
25 mM HEPES, 10 mM EGTA, 4 mM MgSO4) with Halt Protease and Phosphatase
Inhibitor cocktail (Thermo-Fisher) on ice. Lysates were extracted on ice for 10 minutes
and centrifuged at 21,130 x g for 10 minutes. An equal volume of 4X Laemmli buffer (BioRad) was added to the supernatant and samples were heated to 95°C for 10 minutes.
Lysates were separated by electrophoresis on 4-15% Tris-glycine polyacrylamide gels
(Bio-Rad) and transferred to polyvinylidene fluoride membranes (Bio-Rad). Membranes
were blocked in Odyssey blocking reagent (LI-COR) diluted 1:1 in tris-buffered saline for
1 hour, incubated with rabbit anti-mCh (diluted 1:1000, AbCam) and mouse anti-GAPDH
(diluted 1:10,000, Thermo-Fisher) primary antibodies overnight, and incubated with
IRDye 800- and IRDye 680-tagged fluorescent secondary antibodies (LI-COR) for 1 hour.
Blot fluorescence was imaged using an Odyssey CLx system (LI-COR) and analyzed using
Image Studio Lite (LI-COR).
Fixed and live cell imaging was performed using a Nikon Ti-E inverted microscope
controlled by NIS Elements software (Nikon Instruments) with a Plan APO 60X/1.42 NA
oil immersion objective or APO 100X/1.49 NA oil immersion objective (Nikon
Instruments), Spectra-X light engine (Lumencore), and Clara CCD camera (Andor). Image
processing was performed using NIS Elements (Nikon Instruments) and ImageJ (NIH).
Data analysis and statistical comparisons were performed using Excel (Microsoft) and
Prism (GraphPad Software).
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For assessment of mCh and Eg5-mCh expression levels and localization at
metaphase in fixed HeLa cells, cells were treated with 20 µM MG132 (Selleckchem) 2
hours prior to fixation. Cells were fixed for 10 minutes in 1% paraformaldehyde (Electron
Microscopy Sciences) in ice-cold methanol (Thermo-Fisher). Cells were blocked using
20% goat serum in antibody-diluting buffer (AbDil, 1X tris-buffered saline with 2% bovine
serum albumin, 0.1% Triton-X 100, and 0.1% sodium azide) for 1 hour, incubated with
mouse anti-a-tubulin primary antibodies (DM1a, Sigma-Aldrich, diluted 1:750 in AbDil)
for 1 hour, and incubated in fluorescent secondary antibodies conjugated to Alexa Fluor
488 or 647 (Life Technologies, diluted 1:500 in AbDil) for 1 hour. Cells were mounted in
ProLong Gold with DAPI (Thermo-Fisher). Expression levels of mCh-tagged proteins
were compared by drawing elliptical regions of interest (ROIs) around mitotic cells using
a-tubulin staining, measuring mCh fluorescence intensity within the cellular ROIs, and
subtracting averaged intensity from two background ROIs containing no visible cells.
Localization was assessed by defining an ROI as the spindle based on a-tubulin staining
and an ROI as cytoplasm by subtracting this spindle ROI from an ellipse that encompassed
the cell. Intensity of mCh signal was measured in both the spindle and cytoplasm ROIs,
and a ratio of spindle-to-cytoplasm intensity calculated.
For live cell imaging, growth media was exchanged for CO2-Independent Media
(Gibco) supplemented with 10% fetal bovine serum (Gibco) and penicillin/streptomycin
(Gibco). For assessment of localization after treatment with BRD-9876 (Tocris
Bioscience), HeLa cells were treated with 20 µM MG132 (Selleckchem) for 2 hours prior
to imaging. Cells were imaged prior to drug addition, 1 minute after addition of 5 µM BRD222

9876, and subsequently once every 5 minutes. For assessment of localization in anaphase,
cells in metaphase were identified and imaged at 2-minute intervals through anaphase. For
both live cell assays, localization of proteins to the spindle was quantified as described for
fixed cell imaging, with the spindle ROI defined by GFP-tubulin signal.

THE TAIL DOMAIN IS CRITICAL FOR EG5 (KIF11) LOCALIZATION TO
METAPHASE AND ANAPHASE MITOTIC SPINDLES
We determined the role of the kinesin-5 tail domain in motor localization of Eg5
(KIF11) in metaphase and anaphase in HeLa cells. Cells were transfected with human GFPa-tubulin to visualize microtubules, and either FL-Eg5-mCherry (FL-Eg5-mCh), Eg5Δtail-mCherry (Eg5-Δtail-mCh), or mCherry alone (mCh). Expression of each construct
in HeLa cells was assessed by western blot (Figure A-1 A). In fixed metaphase cells, FLEg5-mCh localized to spindle microtubules, while in contrast localization of Eg5-ΔtailmCh was more diffuse, with increased cytoplasmic signal (Figure A-1 B). This difference
in localization was quantified as the ratio of mCh signal localized to the mitotic spindle
and mCh signal in the cytoplasm. In cells with comparable mCh-construct expression
levels (Figure A-1 C, left), this spindle-to-cytoplasm ratio was high for FL-Eg5-mCh (2.39
± 0.08, mean ± SEM) and significantly reduced for Eg5-Δtail-mCh (1.37 ± 0.02, p<0.0001,
ANOVA with Tukey’s multiple comparisons test), indicating that deletion of the tail causes
a defect in localization to metaphase spindle microtubules (Figure A-1 C, right). Treatment
with the compound BRD-9876, which locks Eg5 in a rigor-like state (G.-Y. Chen et al.,
2017), only partially rescued the localization of Eg5-Δtail-mCh to metaphase spindle
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microtubules, potentially due to defects in both the on- and off-rates (Figure A-1 D, A-1
E).
Live cell imaging was used to assess whether this tail deletion localization defect
was present in anaphase as well as metaphase mitotic spindles. Measurement of spindleto-cytoplasm mCh intensity ratios in anaphase showed a similar reduction, indicating
decreased localization to spindle microtubules, for Eg5-Δtail-mCh compared to FL-Eg5mCh as seen in metaphase cells (ratios 1.36 ± 0.04 and 2.21 ± 0.17, mean ± SEM,
respectively, p < 0.0001, ANOVA with Tukey’s multiple comparisons test) (Figure A-1 F,
A-1 G). As HeLa cells progressed from metaphase to anaphase, the deletion of the tail
consistently reduced the localization of Eg5 to spindle microtubules (Figure A-1 F, A-1
H). These data support a critical role for the tail domain in kinesin-5 mitotic spindle
microtubule localization.
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Figure A-1: Deletion of the kinesin-5 tail domain disrupts localization of the motor to the mitotic
spindle in metaphase and anaphase. A. Western blot for mCherry (mCh, green) and GAPDH (red)
indicating the expression of FL-Eg5-mCherry (FL-Eg5-mCh, green) and Eg5-Δtail-mCherry (Eg5-ΔtailmCh, green) in HeLa cells. Results are representative of three independent experiments. B. Localization
of mCh, FL-Eg5-mCh, and Eg5-Δtail-mCh in HeLa cells arrested in metaphase via treatment with MG132. FL-Eg5-mCh localized to spindle microtubules. Tail deletion disrupted localization, and Eg5-ΔtailmCh signal was distributed between spindle microtubules and the cytoplasm. Scale bar 10 µm. Images
are representative of three independent experiments. C. Left panel, mCh fluorescence intensities of
single cells used for quantification of localization to spindle microtubules (n = 13-29 cells per
transfection condition, three independent experiments). Right panel, the ratio of mCh fluorescence signal
on the spindle to signal in the cytoplasm was significantly lower in fixed metaphase cells expressing
Eg5-Δtail-mCh compared to FL-Eg5-mCh, indicating reduced localization of Eg5-Δtail-mCh to spindle
microtubules (n = 13-29 cells per transfection condition, three independent experiments, p values from
ANOVA with Tukey’s post hoc test). D. Treatment of live HeLa cells expressing Eg5-mCh constructs
and GFP-Tubulin with the Eg5 rigor inhibitor BRD-9876 resulted in a rapid (< 1 minute) increase in FLEg5-mCh signal on the spindle. Inhibitor treatment increased, but did not fully rescue, localization of
Eg5-Δtail-mCh to the spindle. Scale bar 10 µm. Images are representative of three independent
experiments. E. The ratio of mCh fluorescence signal on the spindle to signal in the cytoplasm rapidly
increased after treatment with BRD-9876 in cells expressing FL-Eg5-mCh or Eg5-Δtail-mCh. The
spindle-to-cytoplasm intensity ratio of Eg5-Δtail-mCh expressing cells never reached that of cells
expressing FL-Eg5-mCh, indicating only partial rescue of motor localization with rigor inhibitor
treatment. BRD-9876 treatment did not alter the ratio of mCh control cells (n = 7-13 cells per
transfection condition, three independent experiments). F. Deletion of the tail domain disrupted
localization of Eg5 to the spindle in anaphase. Paired rows of images demonstrate the localization of FLEg5-mCh and Eg5-Δtail-mCh as HeLa cells expressing GFP-tubulin transitioned from metaphase to
anaphase. FL-Eg5-mCh signal was observed at the spindle throughout the metaphase to anaphase
transition and the motor localized to the midzone after anaphase onset (see 4-6 min panels). Increased
cytoplasmic and reduced spindle signal was observed in cells expressing Eg5-Δtail-mCh throughout the
metaphase to anaphase transition. Scale bar 10 µm. Images are representative of three independent
experiments. G. The ratio of mCh fluorescence signal on the spindle to signal in the cytoplasm was
measured six minutes after anaphase onset. As in metaphase cells, localization of Eg5-Δtail-mCh to the
spindle was significantly reduced compared to FL-Eg5-mCh (n = 7-12 cells per transfection condition,
three independent experiments, p values from ANOVA with Tukey’s post hoc test). H. The spindle-tocytoplasm intensity ratio of cells expressing Eg5-Δtail-mCh was lower than that of cells expressing FLEg5-mCh throughout the metaphase to anaphase transition, indicating a persistent localization defect
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caused by deletion of the tail domain (n = 7-12 cells per transfection condition, three independent
experiments).
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APPENDIX B: QUANTIFYING CHANGES IN CHROMOSOME POSITION TO
ASSESS CHROMOKINESIN ACTIVITY
ABSTRACT
The chromokinesin KIF22 (Kid, kinesin-10 family) is the primary generator of
polar ejection forces, which contribute to chromosome positioning and alignment in mitotic
cells. Assessment of KIF22 function requires quantitative comparison of relative polar
ejection forces between experimental conditions. This is facilitated by the generation of
monopolar spindles to reduce the impact of bioriented microtubule attachment at
kinetochores on chromosome positions and increase the dependence of chromosome
positions on chromokinesin activity. Radial profile plots measure the intensity of chromatin
signal in concentric circles around the poles of monopolar cells and represent an expedient
quantitative measure of relative polar ejection forces. As such, this assay can be used to
measure changes in polar ejection forces resulting from chromokinesin depletion or
perturbation.

INTRODUCTION
The chromokinesin KIF22 (or Kid) generates forces on chromosome arms that
contribute to congression and alignment in metaphase (Iemura & Tanaka, 2015; Levesque
& Compton, 2001; Stumpff et al., 2012) and the compaction of chromosomes in anaphase
(Ohsugi et al., 2008; Soeda et al., 2016). Inhibition of KIF22 activity via siRNA-mediated
depletion or inhibitory antibodies reduces polar ejection forces (Brouhard & Hunt, 2005;
Levesque & Compton, 2001; Stumpff et al., 2012). However, measuring a loss of polar
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ejection forces is challenging because chromosome positioning in bipolar mitotic spindles
depends on the forces generated both by dynamic microtubules and multiple families of
kinesin motors. Due to these complementary forces, depletion of KIF22 has a relatively
subtle phenotypic effect on chromosome positions in bipolar mitotic cells. As such, polar
ejection forces are most effectively quantified under conditions that limit the forces
generated from the bioriented attachment of microtubules to kinetochores and increase the
dependence of chromosome positions on polar ejection forces. The dependence of
chromosome positioning on polar ejection forces can be increased by depleting the
kinetochore component Hec1 to reduce the attachment of microtubules to kinetochores
(DeLuca et al., 2005; Iemura & Tanaka, 2015), or by generating monopolar spindles via
inhibiting the activity of the kinesin-5 motor Eg5 (KIF11) (Cane, Ye, Luks-Morgan, &
Maresca, 2013; Cassimeris et al., 1994; Levesque & Compton, 2001; Stumpff et al., 2012).
Published methods for quantifying relative polar ejection force within monopolar
spindles have measured the distance between the spindle poles and the centromeres
(Barisic, Aguiar, Geley, & Maiato, 2014; Stumpff et al., 2012; Tipton, Wren, Daum,
Siefert, & Gorbsky, 2017) or fluorescent DNA stain intensity across a monopolar cell using
a line scan (Soeda et al., 2016). While both methods have successfully been used to
investigate chromokinesin function, these approaches have limitations. Measuring the
distance from the poles to centromeres is not an ideally sensitive measure of relative polar
ejection force because KIF22 localizes along chromosome arms, and the position of the
arms varies more than the position of the centromeres upon KIF22 depletion (Figure B-1).
Line scans across a cell report the position of only a subset of chromosomes, and this
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technique has not been used to quantitatively compare relative polar ejection force strength
under different experimental conditions. To improve upon these methods for quantifying
relative polar ejection forces in monopolar spindles, we have employed a radial profile plot
analysis to quantify the positions of fluorescently labeled chromosomes relative to the
spindle poles. This approach measures signal intensity in concentric circles around a
designated central point and has been used previously to assess X-ray and electron
diffraction patterns (Baggethun, 2019) and the positioning of mitochondria in mitotic cells
(J. Y.-M. Chung, Steen, & Schwarz, 2016). Specifically, we use this analytical scheme to
measure the intensity of DNA staining at a series of distances from the poles of a monopolar
spindle, which we designate as the center of the concentric circles. The values obtained
using this method depend on the position of the chromosome arms rather than only the
centromeres, and the radial profile plots of cells with experimentally manipulated polar
ejection forces can be compared quantitatively with those of control cells to obtain a
measure of relative polar ejection force.
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Figure B-1: Monopolar spindles in HeLa cells. Example control (top) and KIF22-depleted (bottom)
HeLa cells treated with monastrol to induce monopolar spindles demonstrate that a loss of polar ejection
forces has a more pronounced effect on the positions of chromosome arms (stained with DAPI) than on
centromeres (visualized using indirect immunofluorescence).

MATERIALS
Materials for HeLa Cell Culture and Treatment
1. HeLa cell media: Minimum Essential Media a (MEM-a) supplemented with
10% fetal bovine serum.
2. Coverslips: Acid wash 12 mm glass coverslips to increase cell adherence.
Sterilize coverslips with ethanol before use.
3. siRNA: siRNA-mediated depletion of KIF22 represents a positive control for
loss of polar ejection forces. A paired scrambled control siRNA should be used
as a negative control. We have transfected siRNA using Lipofectamine
RNAiMax (Thermo Fisher) and Opti-MEM reduced serum media (Gibco).
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4. Monastrol: Treatment of cells with monastrol inhibits the activity of the
kinesin-5 family member Eg5 (KIF11) to prevent spindle pole separation
(Blangy et al., 1995). Mitotic monastrol-treated cells form monopolar spindles.

Alternative Eg5 inhibitors, such as ispinesib (Burris et al., 2010; Lad et al., 2008)
or S-trityl-L-cysteine (STLC) (Skoufias et al., 2006), also generate monopolar
spindles, and may be used in this assay.
Materials for Fixation and Immunofluorescence
1. Reverse action forceps: Two pairs of forceps are needed to manipulate
coverslips. Reverse action forceps open when pressure is applied and reduce
the likelihood of dropping coverslips or breaking coverslips by squeezing too
tightly.
2. Tris-buffered saline (TBS): For 1X buffer, dissolve 8g NaCl, 0.2g KCl, and 3g
tris base in 800 mL distilled water. pH to 7.4 with HCl and bring to a final
volume of 1 L. Autoclave to sterilize. A 10X stock may be prepared, autoclaved,
and diluted to 1X with distilled water as needed.
3. Fixative: Dilute high-quality paraformaldehyde in ice cold methanol to a final
concentration of 1% paraformaldehyde.
4. Antibody dilution buffer (AbDil): Prepare 1% bovine serum albumin (BSA),
0.1% Triton X-100, and 0.02% sodium azide in 1X TBS. Filter sterilize and
store at 4°C.
5. Block: Prepare 20% goat serum in AbDil. Filter sterilize and store at 4°C.
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6. Primary and fluorescent secondary antibodies: Dilute antibodies in AbDil.
Dilutions may be stored at 4°C.
7. Mounting medium: Select an anti-fade mounting medium that contains a DNA
stain, such as DAPI or use an alternative fluorescent DNA stain (see Note 7),
as visualization of chromosomes is essential.
Materials for Imaging and Image Analysis
1. Microscope: Image cells with a widefield or confocal fluorescence microscope.
The use of an objective with a shallow depth of field is optimal for this analysis
method, as the use of such an objective will restrict in focus chromosomes to
only those in the same focal plane as the spindle poles. Filter sets to image
markers for chromosomes (ex. DAPI) and spindle poles are necessary.
2. Image analysis software: Use ImageJ (http://imagej.nih.gov/ij) (Eliceiri, 2017;
Schindelin et al., 2012; Schneider et al., 2012) with the Radial Profile Plot plugin

(http://imagej.nih.gov/ij/plugins/radial-profile.html)

installed

to

measure

chromosome positions. Both tools are freely available. The specific commands
in this protocol refer to ImageJ version 2.0.0 and Radial Profile Plot plugin
version 2009/05/14.

METHODS
HeLa Cell Culture and Treatment
HeLa Cell Culture and Plating
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1. Grow HeLa cells in Minimum Essential Media a (MEM-a) supplemented
with 10% fetal bovine serum at 37°C with 5% CO2 (see Notes 1 and 2).
2. Maintain cells in 100 mm plates containing 10 mL media, and passage HeLa
cells using sterile technique when they reach 70% confluency.
3. Place one 12 mm coverslip in each well of a 24-well plate using sterile
forceps. Ensure that each well contains only one coverslip, and that the
coverslips are lying flat at the bottom of each well.
4. Seed cells on coverslips at a density of 20,000 cells per coverslip, to a total
volume of 500 µL media per well. Gently shake the plate side-to-side after
adding cells to ensure an even distribution of cells across the coverslip
surface.
5. Place the plate in the incubator to allow cells to adhere and spread before
further treatment. Overnight incubation prior to siRNA knockdown is
optimal.
siRNA-mediated Depletion of KIF22
1. Warm Opti-MEM, RNAiMax, and siRNA to room temperature.
2. Mix RNAiMax and siRNA each separately with Opti-MEM in microfuge
tubes. Scale the volumes below, for one well, to the number of transfections
you must perform.
•

25 µL Opti-MEM + 15 pmol siRNA

•

25 µL Opti-MEM + 1.5 µL RNAiMax
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3. Combine the diluted siRNA and RNAiMax and mix gently. Allow the
mixture to complex for 10 minutes at room temperature.
4. Add 50 µL complexed siRNA dropwise to each designated well containing
cells adhered to a coverslip.
5. Return the plate to the incubator for 24-48 hours (see Note 3).
Monastrol Treatment to Generate Monopolar Spindles
1. Prepare a 10X (1 mM) stock of monastrol in HeLa media.
2. Add 55 µL 10X monastrol per well to a final 1X concentration of 100 µM
and a final volume of 555 µL per well.
3. Return the plate to the incubator for 2-3 hours before fixation. Increasing
the time of monastrol treatment will increase the number of monopolar
spindles observed, but cell viability may be adversely affected by prolonged
monastrol arrest.
Fixation and Immunofluorescence
Fixation
1. Place a beaker on ice and place a coverslip staining rack inside the beaker.
2. Prepare a volume of 1% paraformaldehyde in ice cold methanol (see Note
4) that will ensure coverslips on the staining rack are completely
submerged. Add this fixative to the beaker containing the staining rack.
3. Use forceps to move each coverslip from the 24-well plate into the coverslip
staining rack submerged in fixative. Track which side of each coverslip has
adherent cells.
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4. Fix cells for 10 minutes on ice.
5. Prepare three beakers of 1X TBS for washing coverslips. Move the staining
rack sequentially to each beaker for three five-minute washes. Minimize
time the rack spends in air between beakers to prevent coverslip drying and
lower the rack slowly into liquid to reduce coverslips floating off the rack.
Immunofluorescence
1. Prepare a humidified chamber for staining by lining the bottom of a lidded
container (for example, a Petri dish) with Parafilm and arranging damp
Kimwipes around the sides of the container.
2. Mark Parafilm to track the identity of each coverslip during staining.
3. Using forceps, remove each coverslip from the staining rack, touch the edge
of the coverslip to a Kimwipe to wick away excess liquid, and place each
coverslip on the Parafilm surface, cell side up (see Note 5).
4. Pipette 25 µL block (20% goat serum in AbDil) onto each coverslip.
5. Place the staining chamber on a horizontal shaker set to a low speed.
Incubate coverslips in block for one hour, shaking, at room temperature.
6. Prepare two beakers of 1X TBS for washing coverslips. Place the staining
rack in the first TBS wash beaker and transfer coverslips to the rack using
forceps. Perform two five-minute washes in 1X TBS.
7. Dilute primary antibodies in AbDil (see Note 6).
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8. Transfer washed coverslips to the humidified chamber and pipette 25 µL
primary antibodies onto each coverslip. Incubate, shaking, for one hour at
room temperature.
9. Wash coverslips two times in 1X TBS, five minutes each.
10. Dilute fluorescent secondary antibodies in AbDil.
11. Transfer coverslips to the humidified chamber and pipette 25 µL secondary
antibodies onto each coverslip. Cover the chamber (ex. with aluminum foil)
to protect the fluorescent antibodies from light. Incubate, shaking, for one
hour at room temperature.
12. Wash coverslips three times in 1X TBS, five minutes each.
13. To mount each coverslip, place a drop of cell mounting media with DAPI
(see Note 7) on a slide. Remove each coverslip from the staining rack with
forceps, touch the edge of the coverslip to a Kimwipe to wick away excess
liquid, and invert the coverslip to place it on the mounting media cell-side
down.
14. Gently blot the mounted coverslip with a Kimwipe to remove excess
mounting media.
15. Cure the mounted coverslips at room temperature in the dark overnight.
After curing, use a Kimwipe wet with deionized water to gently remove
dried mounting media from the top of the coverslip.
16. After curing, store slides at 4°C in the dark.
Imaging and Image Analysis
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Image Acquisition
1. Identify mitotic cells with monopolar spindles (see Note 8). Focus on the
plane of the spindle poles.
2. At minimum, image the DNA stain and spindle pole marker signal at the
spindle pole focal plane. Capturing a series of images in z around this plane
of focus is ideal, as these images can help confirm that the spindle is
oriented perpendicular to the coverslip and that the best focal plane has been
selected at the time of analysis.
3. Ensure that the same illumination and acquisition settings are used for every
image to facilitate downstream quantitative analyses. Settings should be
selected that optimize the dynamic range of the DNA stain signal.

Image Analysis
1. Open several representative images in order to choose a size for the region
of interest (ROI) that will be used for analysis. Draw a circular ROI that
will enclose the chromosomes. Test this ROI on the largest monopolar
spindles you must analyze to ensure it will enclose all chromatin in these
images.
2. Use the ROI manager tool (Analyze menu, Tools, ROI Manager) to save
this ROI (select More, Save…) and use the same one to analyze each
image. The ROI manager tool can also be used to open a saved ROI (More,
Open…).
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3. Confirm that each monopolar spindle is suitable for analysis.
•

Ensure there is a single focal plane where the spindle pole signal
from both poles is in focus.

•

Ensure the spindle is oriented perpendicular to the coverslip and
isn’t tilted at an angle. Assessing whether the microtubules go in
and out of focus symmetrically around the spindle poles can help
assess whether a monopolar cell is tilted.

4. Identify the focal plane where the poles are best in focus – all analyses
will be performed on this focal plane.
5. Position the ROI using the spindle pole signal so that the poles are at the
center of the ROI (Figure B-2).
6. Leave the ROI in position centered around the spindle poles and switch to
the DAPI channel (Figure B-2).
7. Confirm that all chromosomes are contained within the ROI and that the
ROI does not include any chromatin from neighboring cells. If both of
these conditions are not met, do not analyze this cell.
8. Run the Radial Profile Plot plugin (Plugins menu, Radial Profile) to
measure the DAPI signal intensity around the spindle poles. Ensure that
“Use Spatial Calibration” is checked. This will report distances in
calibrated units (microns) rather than pixels (Figure B-2).
9. Export the plotted values (Data, Copy All Data) to Excel, Graphpad Prism,
or a similar tool for analysis. X values are distance from the center of the
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ROI (spindle poles) in microns, and Y values are DAPI channel
normalized intensity.
10. Plotting X and Y values will allow visual comparison of radial profile
plots between conditions. Additionally, measures such as the distance
from the spindle poles to the maximum DAPI signal or the area under the
curve for each monopole can be used to quantitatively compare
chromosome positions between conditions (see Note 9).

Figure B-2: Radial profile plots of DAPI signal intensity. To create a radial profile plot of DAPI signal
intensity as a function of distance from the spindle poles, begin by centering a circular region of interest
over the spindle poles (A). Using this region of interest in the same position in the DAPI channel image
(B), run the Radial Profile Plot plugin. This generates a displayed plot of intensity as a function of distance
from the poles (C), as well as a series of x (distance) and y (signal intensity) values for export and further
analysis.

NOTES
1. We describe the application of this analysis method to chromosome positions
in HeLa cells. However, loss of polar ejection forces upon KIF22 depletion has
been described in other cell types as well (Barisic et al., 2014; Levesque &
Compton, 2001; Soeda et al., 2016), and this method could be extended to other

adherent cell lines.
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2. The use of antibiotic-free media is optimal for subsequent siRNA transfection.
3. Antibody-mediated depletion of KIF22 is confirmed by western blot or singlecell immunofluorescence 24 hours after siRNA transfection. Media can be
exchanged 6 or more hours after siRNA transfection if necessary for additional
pharmacological treatment or to improve cell viability.
4. Fixing cells in ice-cold methanol without paraformaldehyde is not
recommended. Under these conditions, chromosomes appear swollen and
larger, which limits informative measurement of chromosome positions.
Fixation in methanol only rather than 1% paraformaldehyde in methanol
changes the radial profile plot measurements obtained for cells depleted of the
chromokinesin KIF4A (Figure B-3). The effect of methanol fixation on
chromosome structure and position in monopolar spindles may partially explain
conflicting reports on the effect of KIF4A depletion on polar ejection forces
(Barisic et al., 2014; Stumpff et al., 2012; Tipton et al., 2017; Wandke et al., 2012).
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Figure B-3: Effects of fixation method choice on chromosomes in monopolar spindles. Fixing in icecold methanol without paraformaldehyde (A, right) causes visible chromosome swelling compared to
fixing in ice-cold methanol with 1% paraformaldehyde (A, left). This difference in chromosome structure
affects measurements of relative polar ejection forces after chromokinesin depletion (B). Error bars
represent the mean ± SEM. Relative polar ejection forces in cells depleted of KIF4A appear lower in cells
fixed in methanol only but not in cells fixed in methanol with paraformaldehyde.

5. Move coverslips one at a time for each step requiring a transfer from the
staining rack to the humidified chamber. Apply liquid (ex. block or antibodies)
to each coverslip immediately after placing it in the chamber to prevent drying.
6. Antibodies to label the spindle poles are essential for this method. Select a pole
marker that provides crisp signal so that the correct focal plane for analysis can
be selected. We have used antibodies against centrin or gamma-tubulin
successfully. Primary antibodies against tubulin are recommended for
visualization of the structure of monopolar spindles and for confirming spindle
orientation. Antibodies against KIF22 may be used to confirm siRNA
knockdown of the motor on a cell-by-cell basis.
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7. Visualization of chromatin is essential for assessing the position of
chromosomes within monopolar spindles via this method. If mounting media
without DAPI is selected, addition of a DNA dye staining step or alternative
strategy to visualize chromatin must occur.
8. Imaging tubulin staining best facilitates identification of monopolar spindles.
The microtubules of these cells form a characteristic starburst shape. The use
of DNA signal to identify monopolar spindles is not recommended, as
chromosome positioning will vary when polar ejection forces are perturbed.
9. Both the distance from the spindle poles to the maximum DAPI signal and the
area under the curve of the radial profile plot provide quantitative information
about relative polar ejection forces in monopolar spindles (Figure B-4). Both
measurements have advantages: the distance from poles to maximum signal is
less sensitive to variation in DAPI signal intensity between cells or image sets,
while the area under the curve better characterizes very flat curves (for example,
in cells with very collapsed chromosomes at the pole), as these curves do not
have pronounced maxima.
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Figure B-4: Parameters to compare radial profile plots. Quantitative parameters to compare radial
profile plots of chromosome positions around the spindle poles include the distance from the poles to the
maximum DAPI signal and area under the curve. Graphed plots are from one control knockdown and one
KIF22 knockdown HeLa cell each. The distance from the spindle poles to the maximum DAPI signal (A,
dashed vertical lines) is reduced after KIF22 depletion. This measurement does not require normalization
of DAPI signal intensity. Alternatively, if the DAPI intensity values are normalized to the DAPI intensity
at the spindle poles (B), the area under the curve, either total area or area above 1 (dashed horizontal line),
can be compared between treatments.

10. Ideally, copies of images should be deidentified so that ROI placement and
radial profile plot generation is performed blind, and data assigned to an
experimental condition only after image analysis is complete.
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APPENDIX C: INVESTIGATING THE FUNCTION OF THE KIF22 TAIL
INTRODUCTION
KIF22 activity is reduced at anaphase onset to allow chromosome segregation
(Soeda et al., 2016; Su et al., 2016; Wolf et al., 2006). The physical mechanism by which
KIF22 is inactivated is unknown. Previous studies have proposed that the interaction of the
tail of KIF22 with microtubules inactivates the motor (Soeda et al., 2016), but investigation
of pathogenic mutations in KIF22 and a reported phosphorylation site in the motor domain
(Chapter 3) indicate that the motor domain is also involved in the inactivation process. To
explore the function of the tail of KIF22 and its potential to interact with the motor domain,
fluorescently tagged motor domain and tail constructs were expressed in HeLa-Kyoto cells
(Figure C-1).

Figure C-1: Domains of KIF22. The amino acids corresponding to each domain of KIF22 are indicated.
The lengths of the Motor Domain-GFP construct (1-383) and mCh-Tail constructs (442-506 and 420-520)
are shown below the domains.

MATERIALS AND METHODS
Plasmids
Plasmids encoding Motor Domain-GFP (1-383) and mCh-Tail (442-506 and 420520) are summarized in Table C-1. mCh-Tail constucts were generated using Gibson
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Assembly of the KIF22 open reading frame from pAT4250 (see Chapter 3) and the
backbone of the mCh-CAAX plasmid (gift from Alan Howe, University of Vermont).
Motor Domain-GFP was created by deleting the DNA bases encoding KIF22 amino acids
384-651 from pAT4250 (see Chapter 3).

Table C-1: Plasmids generated to assess the function of the KIF22 tail. Primers are written 5’ to 3’,
Fw: Forward, Rev: Reverse.

Plasmid

Description

pAT4291

mCh-Tail 442-506

pAT4292

mCh-Tail 420-520

pAT4294

Motor Domain-GFP
1-383

Primers
Fragment Fw: ccggactcagatctcgaggacgcctcctcagcttggaccg
Fragment Rev: ctgattatgatcagttatctgttctccttttcctcagccttctg
Vector Fw: aggctgaggaaaaggagaacagataactgatcataatcagccatac
Vector Rev: cggtccaagctgaggaggcgtcctcgagatctgagtccgg
Fragment Fw: ccggactcagatctcgaggagcctctgcctcccagaaact
Fragment Rev: ctgattatgatcagttatctgactgtgcgatgtgaaaggg
Vector Fw: ccctttcacatcgcacagtcagataactgatcataatcagccatac
Vector Rev: agtttctgggaggcagaggctcctcgagatctgagtccgg
Fw: aggtaccgcgggcccgggat
Rev: ccaatgagagcctgcagcctcatgccttg

Generation of Motor Domain-GFP Inducible Cell Line and Transfection of mCh-Tail
The Motor Domain-GFP HeLa-Kyoto cell line was generated using
recombination-mediated cassette exchange (Khandelia et al., 2011) as described in Chapter
3. Expression of Motor Domain-GFP was induced via treatment with 2 µg/mL doxycycline
(Thermo Fisher Scientific #BP26531). mCh-Tail constructs were expressed transiently in
cells with inducible expression of Motor Domain-GFP. Transfections were performed
using Lipofectamine LTX (Thermo Fisher Scientific #15338100) in Opti-MEM Reduced
Serum Media (Gibco #31985-062).

RESULTS
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mCh-Tail Constructs Localize to the Cytoplasm in Interphase and Mitosis
The tail of KIF22 contains two nuclear localization signals (NLSs) (400KRAR403
and 556RKRKL560), each of which is sufficient for nuclear localization (Tahara et al., 2008).
As such, mCh-Tail constructs were designed to exclude both NLSs to prevent nuclear
import. Imaging of cells expressing mCh-Tail 442-506 and mCh-Tail 420-520 confirmed
cytoplasmic localization in interphase and mitosis. Interestingly, despite containing the
second microtubule binding domain neither mCh-Tail construct localized to microtubules
in interphase, metaphase, or anaphase (Figure C-2). These data are not consistent with the
tail of KIF22 interacting strongly with the microtubule surface as was proposed in the
model of microtubule binding-mediated KIF22 inactivation (Soeda et al., 2016). This
finding agrees with previous assessment of KIF22 motility, which demonstrated that
deletion of the microtubule binding domain does not alter the velocity of KIF22, which
also does not indicate a strong or long-lasting interaction between this domain and the
microtubule (Shiroguchi et al., 2003). However, the localization of tail fragments does not
preclude weak or dynamic interactions between the tail and the microtubule surface
contributing to the inactivation of KIF22. It is also possible that a longer region of the tail
is necessary for strong tail-microtubule interactions, or that such interactions also require
the presence of the motor domain.
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Figure C-2: Localization of mCh-Tail in dividing cells. mCh-Tail 442-506 and mCh-Tail 420-520
demonstrated diffuse cytoplasmic localization in live metaphase (A) and anaphase (B) cells. Neither
construct localized to the mitotic spindle (SiR-Tubulin). Images are maximum intensity projections in Z.
Scale bar 10 µm.

The Tail and Motor Domains of KIF22 Do Not Co-Immunoprecipitate
Immunoprecipitation (IP) experiments were performed to test for interaction
between Motor Domain-GFP and mCh-Tail 442-506 or mCh-Tail 420-520 in HeLa-Kyoto
cell lysates. Motor Domain-GFP was detected in samples after anti-GFP IP, but neither
mCh-Tail 442-506 nor mCh-Tail 420-520 co-immunoprecipitated with Motor DomainGFP (Figure C-3). To confirm this result, the reciprocal IP again mCh was performed. In
this assay, immunoprecipitation of mCh and mCh-Tail constructs was observed, but co-IP
of Motor Domain-GFP was not. Finally, given that phosphorylation of T463 in the KIF22
tail by CDK1 regulates the inactivation of KIF22 (Soeda et al., 2016) and may, therefore,
regulate any interaction between the tail and the motor domain, we repeated the IP using
lysates from cells treated with the CDK1 inhibitor RO-3306 (Vassilev et al., 2006). Under
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these conditions we again did not observe co-IP of mCh-Tail 442-506 or mCh-Tail 420520 with Motor Domain-GFP.

Figure C-3: mCh-Tail and Motor Domain-GFP do not co-immunoprecipitate. Motor domain-GFP
(70 kDa) was detected in input cell lysates and after anti-GFP immunoprecipitation (IP). While mCh (28
kDa), mCh-Tail 442-506 (35 kDa), and mCh-Tail 420-520 (39 kDa) were present in input cell lysates,
bands representing these peptides were not observed after anti-GFP IP. The bands of lower molecular
weight visible in the mCh blot may represent a breakdown fragment of mCh as has been previously
observed in cells overexpressing mCh (Pena et al., 2020).

These data suggest that a strong, long-lasting physical interaction between the tail
and the motor domain of KIF22 did not occur under the conditions of our assays. However,
a number of parameters could be altered to continue to test for interactions. The buffer
conditions for lysis and IP, the lengths of the tail and motor domain constructs, and the
locations of fluorescent tags all could affect the ability of the KIF22 tail and motor domain
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to interact. Additionally, immunoprecipitation experiments cannot rule out that a head-tail
interaction may be weak or dynamic, and, therefore, not detectable by IP.
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